Sentence,class,file
Lancet 2010;375:1545-55. http://dx.doi.org/10.1016/S0140-6736(10)60206-1.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
"Eleven consecutive ye-ars of respiratory syncytial virus outbreaks in Croatia, Pedia-tr Int  2009;51:237-40. http://dx.doi.org/10.1111/j.1442-200-X.2008.02723.x.",Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Viro-logy J 2008;5:18. http://dx.doi.org/10.1186/1743-422X-5-18.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Arch Dis Child 2003;88:1065-9. http://dx.doi.org/10.1136/adc.88.12.1065.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
http://dx.doi.org/10.1186/cc4984.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Int J Biochem Cell Biol 2010;42:1416-29. http://dx.doi.org/10.1016/j.biocel.2010.04.005.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Crit Care 2006;10:159. http://dx.doi.org/10.1186/cc5012.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Pedi-atr Int 2009;51:484-7. http://dx.doi.org/10.1111/j.1442-200-X.2008.02768.x.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Dig Dis Sci 2010;55:1182-5. http://dx.doi.org/10.1007/s10620-009-0835-z.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
http://dx.doi.org/10.2353/ajpath.2006.050875.16.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Clin  Liver Dis 2003;7:351-67. http://dx.doi.org/10.1016/S1089-3261(03)00025-4.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Intensive Care Med 2004;30:931-4. http://dx.doi.org/10.1007/s00134-004-2236-2.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Scand J Infect Dis 2002;34:235. http://dx.doi.org/10.1080/00365540110077191.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Pediatr Int 2010;52:866-71. http://dx.doi.org/10.1111/j.1442-200X.2010.03265.x.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
J Pediatr En-docrinol Metab 2010;23:927-30. http://dx.doi.org/10.1515/jpem.2010.148.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Pediatr Allery Immnol 2008;19:148-56. http://dx.doi.org/10.1111/j.1399-3038.2007.00611.x.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Curr Allergy Asthma Rep 2012;12:574-81. http://dx.doi.org/10.1007/s11882-012-0306-z.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
http://dx.doi.org/10.1016/S0014-2999(01)01320-6.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Pediatrics 2004; 113:1776-82. http://dx.doi.org/10.1542/peds.113.6.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
http://dx.doi.org/10.1165/rcmb.2008-0330OC.,OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Pe-diatr Res 2003;53:843-49. http://dx.doi.org/10.1203/01.PDR.0000057983.95219.0B.,Non-OADS,/arxiv_data1/oa_pdf/e5/b7/biochem_med-23-1-112-13.PMC3900097.pdf
Biochemia Medica 2013;23(1):16–8  http://dx.doi.org/10.11613/BM.2013.004 16Abstract Plagiarism remains at the top in terms of interest to the scient ifi  c community.,Non-OADS,/arxiv_data1/oa_pdf/14/87/biochem_med-23-1-16-4.PMC3900098.pdf
"http://dx.doi.org/10.11613/BM.2013.004 Biochemia Medica 2013;23(1):16–8   17Supak Smolcic V, Bilic-Zulle L. Patchwork plagiarism reading and using literature while writing.",Non-OADS,/arxiv_data1/oa_pdf/14/87/biochem_med-23-1-16-4.PMC3900098.pdf
"Biochemia Medica 2013;23(1):16–8  http://dx.doi.org/10.11613/BM.2013.004 18Supak Smolcic V, Bilic-Zulle L. Patchwork plagiarism publication practices according to the Committee  on Publication Ethics (COPE) (7).",Non-OADS,/arxiv_data1/oa_pdf/14/87/biochem_med-23-1-16-4.PMC3900098.pdf
Q J Med  2003;96:243-4. http://dx.doi.org/10.1093/qjmed/hcg036.,OADS,/arxiv_data1/oa_pdf/14/87/biochem_med-23-1-16-4.PMC3900098.pdf
Available from: http://ori.hhs.gov/avoiding-plagiarism-self-plagiari-sm-and-other-questionable-writing-practices-guide-ethi-cal-writing.,Non-OADS,/arxiv_data1/oa_pdf/14/87/biochem_med-23-1-16-4.PMC3900098.pdf
Sci Eng Ethics 2012;18:223-9. http://dx.doi.org/10.1007/s11948-011-9347-2.,Non-OADS,/arxiv_data1/oa_pdf/14/87/biochem_med-23-1-16-4.PMC3900098.pdf
J Cardiovasc Pharmacol 2010;56:709. http://dx.doi.org/10.1097/FJC.0b013e3182004ee2.,Non-OADS,/arxiv_data1/oa_pdf/14/87/biochem_med-23-1-16-4.PMC3900098.pdf
Available from: http://publicatio-nethics.org/resources/discussion-documents.,Non-OADS,/arxiv_data1/oa_pdf/14/87/biochem_med-23-1-16-4.PMC3900098.pdf
Available at: http://publicationethics.org/resources/fl  owcharts.,Non-OADS,/arxiv_data1/oa_pdf/14/87/biochem_med-23-1-16-4.PMC3900098.pdf
"Biochemia Medica 2013;23(1):28–42  http://dx.doi.org/10.11613/BM.2013.006 28Review Abstract Infl  ammatory bowel disease (IBD) is a heterogeneous group of ch ronic infl  ammatory disorders of the gastrointestinal tract with two main distingu- ishable entities, Crohn’s disease (CD) and ul cerative colitis (UC).",Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
"http://dx.doi.org/10.11613/BM.2013.006 Biochemia Medica 2013;23(1):28–42   29Tesija Kuna A. Serological markers in IBD Feature Crohn’s disease Ulcerative colitis Clinical featuresDiarrhea Fairly common Very commonRectal bleeding Fairly common Very commonSites of involevmentIleum and colon (ileocolonic region) 50% of patients NeverIleum 30% of patients NeverColon 20% of patients ExclusivelyUpper parts of GIT Infrequent NeverEndoscopic fi  ndings Discontinuous lesions, cobblestoning,  aphthous and linear ulcerations, stricturesContinous lesions, pseudopolyps Histologic fi  ndings Transmural infl  ammation Mucosal/submucosal infl  ammationTABLE  1.",Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
"Biochemia Medica 2013;23(1):28–42  http://dx.doi.org/10.11613/BM.2013.006 30Tesija Kuna A. Serological markers in IBD Anti-glycan antibodies These antibodies targets cell wall carbohydrate  epitopes found in microbiota such as yeasts and bacteria (18,19).",Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.11613/BM.2013.006 Biochemia Medica 2013;23(1):28–42   31Tesija Kuna A. Serological markers in IBD and fl  agellin CBir1 has been identifi  ed as an immu- nodominant colitogenic antigen.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Biochemia Medica 2013;23(1):28–42  http://dx.doi.org/10.11613/BM.2013.006 32Tesija Kuna A. Serological markers in IBD CD and UC for autoantibodies by the IIF method  using 19 diff  erent human tissues as antigenic sub- strates.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.11613/BM.2013.006 Biochemia Medica 2013;23(1):28–42   33Tesija Kuna A. Serological markers in IBD c a n  b e  m a d e  w i t h  h i g h  c e r t a i n t y .,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Biochemia Medica 2013;23(1):28–42  http://dx.doi.org/10.11613/BM.2013.006 34Tesija Kuna A. Serological markers in IBD says from 0–63% in UC samples across fi  ve diff  er- ent laboratories suggests that these assays obvi-ously do not detect the same spectrum of antigens (28).,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.11613/BM.2013.006 Biochemia Medica 2013;23(1):28–42   35Tesija Kuna A. Serological markers in IBD Diagnosis Antibody Sensitivity (%) Specifi  city (%) PPV NPV CDASCA + 37–72 82–100 87–95 36–68 pANCA - 52 91 85 65 ACCA 9–21 84–97 78–87 24–52 ALCA 15–26 92–96 78–90 25–53 AMCA 12–28 82–97 65–92 25–52 Anti-C 10–25 90–98 87–88 29–39 Anti-L 18–26 93–97 90–91 30–40 Anti-OmpC 20–55 81–88 83 25 Anti-I2 42 76 NR NR PAB 22–46 77–100 69–100 48–75 ASCA+/pANCA- 46–64 92–99 86–97 44–82 PAB+/ANCA- 22–42 98–100 87–100 48–74 PAB+/ASCA+/pANCA- 16–34 97–100 100 66–72 UCpANCA 50–71 75–98 74–95 49–84 pANCA+/ASCA- 42–58 81–100 93–100 43 GAB 12*–46 98 75–93 70–74 pANCA or GAB+/PAB- 82 98 96 89 * in pediatric population.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Biochemia Medica 2013;23(1):28–42  http://dx.doi.org/10.11613/BM.2013.006 36Tesija Kuna A. Serological markers in IBD and PPV for certain IBD subtype.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.11613/BM.2013.006 Biochemia Medica 2013;23(1):28–42   37Tesija Kuna A. Serological markers in IBD Similar results were obtained in the paediatric  population.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
"Biochemia Medica 2013;23(1):28–42  http://dx.doi.org/10.11613/BM.2013.006 38Tesija Kuna A. Serological markers in IBD Regarding the association with response to thera- py, there was no relationship between ASCA or pANCA and response to therapy in a study con-d u c t e d  o n  2 7 9  C D  p a t i e n t s  b e f o r e  s t a r t i n g  a n t i -TNF therapy (infl  iximab).",OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.11613/BM.2013.006 Biochemia Medica 2013;23(1):28–42   39Tesija Kuna A. Serological markers in IBD important clinical utility of serological markers  could be in stratifying patients according to risk for aggressive disease phenotype or postoperative complications.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
N Engl J Med 2011;  365:1713-25. http://dx.doi.org/10.1056/NEJMra1102942.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
N Engl J Med  2002;347:417-29. http://dx.doi.org/10.1056/NEJMra020831.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
N Engl  J Med 2009;361:2066-78. http://dx.doi.org/10.1056/NEJ-Mra0804647.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1097/01.MIB.0000195385.19268.68.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1136/gut.2005.081950b.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1136/gut.2 004.043372.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Po-stgrad Med 2010;122:177-85. http://dx.doi.org/10.3810/pgm.2010.07.2184.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
World J Gastroenterol 2009;15:521-55. http://dx.doi.org/10.3748/wjg.15.521.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1002/ibd.21304.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Wien Klin Wochenschr 2010;122(Suppl 2):19-25. http://dx.doi.org/10.1007/s00508-010-1344-y.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1016/S0399-8320(09)73151-3.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1053/bega.2002.0347.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Lupus 2006;15:442-50. http://dx.doi.org/10.1191/0961203306lu2331oa.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1159/000198932.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1111/j.1574-6968.1992.tb04997.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gastroenterology 2006;130:1764-75. http://dx.doi.org/10.1053/j.gastro.2006.02.009.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Clin Chim Acta 2003;335:9-20. http://dx.doi.org/10.1016/S0009-8981-(03)00286-9.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Biochemia Medica 2013;23(1):28–42  http://dx.doi.org/10.11613/BM.2013.006 40Tesija Kuna A. Serological markers in IBD 26.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Infl  a-mm Bowel Dis 2012;18:1340-55. http://dx.doi.org/10.1002/ibd.21903.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Clin Chem 2006;52:171-81. http://dx.doi.org/10.1373/clinchem.2005.058560.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gastro- enterology 2006;131:366-78. http://dx.doi.org/10.1053/j.gastro.2006.04.030.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
World J Gastroenterol 2008;14:5115-24. http://dx.doi.org/10.3748/wjg.14.5115.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1159/000320396.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Am J Gastroenterol  2009;104:1426-34. http://dx.doi.org/10.1038/ajg.2009.79.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Infect Immun 2000;68:1542-8. http://dx.doi.org/10.1128/IAI.68.3.1542-1548.2000.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gastroenterology 2002;123:689-99. http://dx.doi.org/10.1053/gast.2002.35379.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 2006;55:1667-9. http://dx.doi.org/10.1136/gut.2005.089623.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gastroenterology 2000;119:23-31. http://dx.doi.org/10.1053/gast.2000.8519.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1128/IAI.70.12.6567-6575.2002.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Am J Clin Pathol 2003;120:312-8. http://dx.doi.org/10.1309/WA-EPADW0K4LPUHFN.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Nat Clin Pract Rheumatol 2006;2:661-70. http://dx.doi.org/10.1038/ncprheum0355.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Rheumatology 2002;41:481-3. http://dx.doi.org/10.1093/rheumatology/41.5.481.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
J Allergy Clin Immu-nol 1990;86:202-10. http://dx.doi.org/10.1016/S0091-6749-(05)80067-3.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1016/S0171-2985(11)80509-7.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
J Clin Immunol 1995;15:293-9. http://dx.doi.org/10.1007/BF01541319.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Contemporary Challenges in Autoimmunity: Ann N Y Acad Sci 2009;1173:161-5. http://dx.doi.org/10.1111/j.1749-6632.2009.04752.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Scand J Gastroenterol 1987;22(Suppl 139):41-52. http://dx.doi.org/10.3109/00365528709089774.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 2009;58:1620-8. http://dx.doi.org/10.1136/gut.2008.162495.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut Microbes 2010;1:407-10. http://dx.doi.org/10.4161/gmic.1.6.14078.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.11613/BM.2013.006 Biochemia Medica 2013;23(1):28–42   41Tesija Kuna A. Serological markers in IBD 54.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
FEMS Immunol Med Microbiol 2008;52:2-12. http://dx.doi.org/10.1111/j.1574-695X.2007.00359.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 1994;35:224-30. http://dx.doi.org/10.1136/gut.35.2.224.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1002/ibd.20778.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1097/00054725-200411000-00012.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1002/ibd.20047.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Mediators Infl  amm 2009; 512695. http://dx.doi.org/10.1155/2009/512695.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1111/j.1365-2036.2005.02417.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Infl  amm Bowel Dis 2006;12:258-62. http://dx.doi.org/10.1097/01.MIB.0000215093.62245.b9.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gastroente-rology 2002;122:1242-7. http://dx.doi.org/10.1053/gast.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1097/01.MIB.0000182872.76434.8c.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
J Pediatr Gastroenterol Nutr 2012;55:429-35. http://dx.doi.org/10.1097/MPG.0b013e318256b516.67.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1002/ibd.20368.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gastroenterology 2005;128:2020-8. http://dx.doi.org/10.1053/j.gastro.2005.03.046.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1002/ibd.20831.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Scand J Gastroenterol 1987;22:41-52. http://dx.doi.org/10.3109/00365528709089774.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1136/gut.2005.082909.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1002/ibd.20892.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 1998;42:788-91. http://dx.doi.org/10.1136/gut.42.6.788.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Am J Gastroenterol 2006;101:645-52. http://dx.doi.org/10.1111/j.1572-0241.2006.00468.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 2004;53:1117-22. http://dx.doi.org/10.1136/gut.2003.030734.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 2000;47:487-96. http://dx.doi.org/10.1136/gut.47.4.487.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1111/j.1572-0241.2007.01652.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Biochemia Medica 2013;23(1):28–42  http://dx.doi.org/10.11613/BM.2013.006 42Tesija Kuna A. Serological markers in IBD 79.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gastroenterology 2004;126:414-24. http://dx.doi.org/10.1053/j.gastro.2003.11.015.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 2007;56:1394-403. http://dx.doi.org/10.1136/gut.2006.108043.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1111/j.1572-0241.2006.00456.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Clin Gastroen-terol Hepatol 2008;6:1105-11. http://dx.doi.org/10.1016/j.cgh.2008.04.032.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Eur J Gastroenterol He-patol 2005;17:73-7. http://dx.doi.org/10.1097/00042737-200501000-00015.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 1993;34:46-50. http://dx.doi.org/10.1136/gut.34.1.46.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Journal of Crohn’s and Colitis 2008;2:114-22. http://dx.doi.org/10.1016/j.crohns.2007.10.001.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Digestion 1994;55:34-9. http://dx.doi.org/10.1159/000201120.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Mayo Clin Proc 1996;71:431-6. http://dx.doi.org/10.4065/71.5.431.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Am J Gastroenterol 2010;105:1811-9. http://dx.doi.org/10.1038/ajg.2010.95.89.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1016/j.gassur.2006.02.004.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Dis Colon Rectum 2008;51:100-8. http://dx.doi.org/10.1007/s10350-007-9158-3.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 2001;49:671-7. http://dx.doi.org/10.1136/gut.49.5.671.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1111/j.1572-0241.2002.05689.x.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Am J Gastroente- rol 1998;93:1306-10. http://dx.doi.org/10.1111/j.1572-0241 .1998.00415.x.,OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Scand J Gastroenterol 2001;36:196-201. http://dx.doi.org/10.1080/003655201750065960.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
Gut 2005;54:1232-6. http://dx.doi.org/10.1136/gut.2004.060228.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
World J Gastroenterology 2008;14:5115-24. http://dx.doi.org/10.3748/wjg.14.5115.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
http://dx.doi.org/10.1002/ibd.20031.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/biochem_med-23-1-28-6.PMC3900099.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/dd/dhps-6-001.PMC3900312.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug, Healthcare and Patient Safety 2014:6 1–6Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  1Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S5657 4improving medication management   after a hospitalization with pharmacist   home visits and electronic personal   health records: an observational study Stephen Jon Kogut1 elaina goldstein1 camille charbonneau1 anita Jackson1 gail Patry2 1Department of Pharmacy   Practice, college of Pharmacy,    University of rhode island,    Kingston, 2Healthcentric advisors,    Providence, ri, USa correspondence: Stephen Jon Kogut   Department of Pharmacy Practice,   college of Pharmacy, University of   rhode island, 7 greenhouse road,   Kingston, ri 02881, USa   Tel +1 401 874 5370   Fax +1 401 874 2741   email k ogut@ uri.eduBackground:  Substantial opportunity exists to improve medication management in the period  following a hospital discharge.",Non-OADS,/arxiv_data1/oa_pdf/f4/dd/dhps-6-001.PMC3900312.pdf
"Identified using the Medication Discrepancy Tool for multiple events, Care  Transitions Program® (http://www.caretransitions.org /).",Non-OADS,/arxiv_data1/oa_pdf/f4/dd/dhps-6-001.PMC3900312.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug­healthcare­and­patient­safety­journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/f4/dd/dhps-6-001.PMC3900312.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/dd/dhps-6-001.PMC3900312.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/55/ijnrd-7-039.PMC3900313.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 39–48International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  39RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S3789 2Microvascular pericytes in healthy   and diseased kidneys Szu-Yu Pan1,2 Yu-Ting Chang3 Shuei-Liong Lin1,3 1Renal Division, Department of  Internal Medicine, National Taiwan  University Hospital, Taipei, Taiwan;   2Department of Internal Medicine,   National Taiwan University Hospital,   Yun-Lin Branch, Yun-Lin, Taiwan;   3Graduate Institute of Physiology,   College of Medicine, National Taiwan  University, Taipei, Taiwan Correspondence: Shuei-Liong Lin   Graduate Institute of Physiology, No 1,  Jen-Ai Road Section 1, Taipei, 100, Taiwan   Tel +886 2 2312 3456 ext 88235   Fax +886 2 2396 4350   email linsl@ntu.edu.t wAbstract:  Pericytes are interstitial mesenchymal cells found in many major organs.",Non-OADS,/arxiv_data1/oa_pdf/46/55/ijnrd-7-039.PMC3900313.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/46/55/ijnrd-7-039.PMC3900313.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/55/ijnrd-7-039.PMC3900313.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/6f/ijnrd-7-035.PMC3900314.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 35–38International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  35Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJNRD.S5094 8Bilateral renal artery thrombosis in inherited  thrombophilia: a rare cause of acute kidney injury Kate s Wiles1 Laura Hastings1 Vasantha Muthu  Muthuppalaniappan1 Muhammad Hanif2 sumith abeygunasekara1 1Department of Medicine,   2Department of Radiology, Mid essex   Hospital services NHs trust,   Chelmsford, UK Correspondence: sumith abeygunasekara   Department of Nephrology   Mid essex Hospital services NHs trust  Chelmsford, UK CM1 7et   tel +44 1245 514 414   email sumith.abeygunasekara@meht.nhs.u kAbstract:  We describe the case of a 47-year-old man who developed significant acute, and  subsequently chronic, kidney injury due to bilateral renal infarction.",Non-OADS,/arxiv_data1/oa_pdf/b2/6f/ijnrd-7-035.PMC3900314.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/b2/6f/ijnrd-7-035.PMC3900314.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/6f/ijnrd-7-035.PMC3900314.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/06/dmso-7-015.PMC3900315.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 15–24Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  15Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S3875 3Drug treatment of type 2 diabetes mellitus   in patients for whom metformin is contraindicated Brian K irons1 Molly G Minze2 1Department of Pharmacy Practice,   T exas T ech University Health Sciences  Center School of Pharmacy, Lubbock,   2Department of Pharmacy Practice,   T exas T ech University Health Sciences  Center School of Pharmacy, Abilene,   TX, USA Correspondence: Brian K irons   Texas Tech University Health Sciences  Center 3601 4th St, Lubbock, TX 79430,  USA  Tel +1 806 743 4200   Fax +1 806 743 4209   email brian.irons@ttuhsc.ed uAbstract:  Metformin is considered an initial drug of choice for type 2 diabetes mellitus by  leading recommendations.",Non-OADS,/arxiv_data1/oa_pdf/9b/06/dmso-7-015.PMC3900315.pdf
Available from: http://www.idf.org/global-guideline-type-2-diabetes- 2012.,Non-OADS,/arxiv_data1/oa_pdf/9b/06/dmso-7-015.PMC3900315.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/9b/06/dmso-7-015.PMC3900315.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/06/dmso-7-015.PMC3900315.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/ 2008/020357s031,021202s01 6lbl.pdf.",Non-OADS,/arxiv_data1/oa_pdf/9b/06/dmso-7-015.PMC3900315.pdf
"Available  from: http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/ con1376454233492.pd f. Accessed September 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/9b/06/dmso-7-015.PMC3900315.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/cd/cia-9-209.PMC3900316.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 209–218Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  209OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5571 9resistance exercise performance variability   at submaximal intensities in older   and younger adults gregory J grosicki1 Michael e Miller2 Anthony P Marsh1 1Department of health and  exercise science, Wake Forest  University, Winston-salem, nC, UsA;   2Department of Biostatistical sciences,   Division of Public health sciences,   Wake Forest University school of  Medicine, Winston-salem, nC, UsA Correspondence: Anthony P Marsh   Wake Forest University, Department  of health and exercise science, PO Box  7868, Winston-salem, nC 27109, UsA   Tel +1 336 758 4643   Fax +1 336 758 4680   email marshap@wfu.ed uAbstract:  We assessed the variability in the number of repetitions completed at submaximal  loads in three resistance tasks in older (N =32, 16 female, 74.3 ±5.4 years) and younger (N =16,  8 female, 22.8 ±1.8 years) men and women.",Non-OADS,/arxiv_data1/oa_pdf/a4/cd/cia-9-209.PMC3900316.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a4/cd/cia-9-209.PMC3900316.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/cd/cia-9-209.PMC3900316.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/6b/dddt-8-165.PMC3900317.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 165–173Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  165Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5155 9changes in surface expression of N-methyl-   D-aspartate receptors in the striatum   in a rat model of Parkinson’s disease Jing gan1 chen Qi1 li-Min Mao2 Zhenguo liu1 1Department of neurology,   Xinhua hospital, shanghai Jiao   Tong University school of Medicine,  shanghai, People’s republic of china;  2Department of Basic Medical science,  University of Missouri-Kansas city  school of Medicine, Kansas city,   MO, Usa correspondence: Zhenguo liu   Department of neurology,   Xinhua hospital, shanghai Jiao   Tong University school of Medicine,   1665 Kongjiang road, shanghai, 200092,   People’s republic of china   Tel +86 21 2507 7501   email z henguoliu2004@aliyun.com.c nBackground:  N-methyl- d-aspartate (NMDA) receptors play a central role in glutamatergic  synaptic transmission in the mammalian brain and are linked to the pathophysiology and  symptomatology of Parkinson’ s disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/43/6b/dddt-8-165.PMC3900317.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/43/6b/dddt-8-165.PMC3900317.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/6b/dddt-8-165.PMC3900317.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/ca/tcrm-10-061.PMC3900329.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 61–67Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  61ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5198 5Risk factors for mortality in asian Taiwanese   patients with methanol poisoning Chen-Yen lee1,* eileen Kevyn Chang1,* Ja-liang lin1 Cheng-hao Weng1 shen-Yang lee1 Kuo-Chang Juan1 huang-Yu Yang1 Chemin lin2 shwu-hua lee2 i-Kwan Wang3 Tzung-hai Yen1 1Department of n ephrology and  Division of Clinical T oxicology,   2Department of Psychiatry, Chang  gung Memorial hospital and Chang  gung University, Taipei, Taiwan;   3Department of nephrology, China  Medical University hospital and China  Medical University, Taichung, Taiwan *These authors contributed equally to  this work Correspondence: Tzung-hai Yen   Department of nephrology, Chang gung   Memorial hospital, 199 Tung hwa   north Road, Taipei 105, Taiwan   Tel +886 3 328 1200 ext 8181   Fax +886 3 328 2173   email m19570@adm.cgmh.org.t wIntroduction:  Methanol poisoning continues to be a serious public health issue in Taiwan,  but very little work has been done to study the outcomes of methanol toxicity in the Asian  population.",Non-OADS,/arxiv_data1/oa_pdf/64/ca/tcrm-10-061.PMC3900329.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/64/ca/tcrm-10-061.PMC3900329.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/ca/tcrm-10-061.PMC3900329.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/16/jpr-7-065.PMC3900330.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 65–70Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  65ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S5323 4intravenous acetaminophen is superior   to ketamine for postoperative pain after  abdominal hysterectomy: results of a prospective,  randomized, double-blind, multicenter clinical trial hamid Reza Faiz1 Poupak Rahimzadeh1 Ognjen Visnjevac2 Behzad Behzadi1 Mohammad Reza ghodraty1 nader D nader2 1iran University of Medical sciences,   T ehran, iran; 2Va Western n Y  healthcare system, University at  Buffalo, Buffalo, nY, Usa correspondence: nader D nader   Va Western nY healthcare system,  University at Buffalo, 3495 Bailey avenue,  Room 202c, Buffalo, nY 14215, Usa   Tel +1 716 862 8707   cell +1 716 341 2715   email nnader@buffalo.ed uBackground:  In recent years, intravenously (IV) administered acetaminophen has become one  of the most common perioperative analgesics.",Non-OADS,/arxiv_data1/oa_pdf/23/16/jpr-7-065.PMC3900330.pdf
Available  from: http://www.irct.ir/searchresult.php?i d=11319&number =1.,OADS,/arxiv_data1/oa_pdf/23/16/jpr-7-065.PMC3900330.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/23/16/jpr-7-065.PMC3900330.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/16/jpr-7-065.PMC3900330.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/fc/ndt-10-131.PMC3900331.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 131–133Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  131LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5897 0Poor versus good sleepers in patients   under treatment for sleep-related breathing   disorders: better is not good enough Christian Veauthier1,2 1Hanse-Klinikum, Department   of Neurology, Stralsund, Germany;    2Department of Neurology, Centre  Hospitalier de Belfort-Montbéliard  (CHBM), Montbéliard, France Correspondence: Christian Veauthier   Centre Hospitalier de Belfort-   Montbéliard (CHBM), Department of   Neurology , 2 rue du Dr Flamand,   25211 Montbéliard, France   T el +33 6 8075 6030   Fax +49 3212 28 28 668   email cveauthier@web.d eDear editor Recently we published a retrospective study in this journal which reported the signifi - cant relationship between nocturnal awakening, respectively high arousal index, and  fatigue in 410 patients with sleep disorders admitted to our sleep laboratory.1 In this study we noticed that Pittsburgh Sleep Quality Index (PSQI) mean values2  were lower in patients who have been treated for sleep-related breathing disorders  (SRBD) compared with either treatment-naïve SRBD patients, or with patients with  periodic limb movement disorder (PLMD), restless legs syndrome (RLS), or  insomnia.",Non-OADS,/arxiv_data1/oa_pdf/f4/fc/ndt-10-131.PMC3900331.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f4/fc/ndt-10-131.PMC3900331.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/fc/ndt-10-131.PMC3900331.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/ca/ndt-10-123.PMC3900332.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 123–130Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  123OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5602 0Mental health and burnout in primary   and secondary school teachers in the remote   mountain areas of guangdong Province   in the People’s republic of china lulu Zhang1 Jingping Zhao1 huaqing Xiao3 hongbo Zheng2 Yaonan Xiao3 Miaoyang chen3 Dingling chen3 1Mental health institute of the  second Xiangya hospital, Key  laboratory of Psychiatry and  Mental health of hunan Province,   central south University, changsha,   hunan, 2Department of Psychiatry,   guangzhou Brain hospital, affiliated  hospital of guangzhou Medical  University, guangzhou, guangdong,   3Department of Psychiatry, luoding  Dagang hospital, luoding, guangdong,   People’s republic of china correspondence: Jingping Zhao   139 Middle renming road,   2nd Xiangya hospital of central south   University, changsha, hunan 410011,   People’s republic of china   email zhaojingpingcsu@163.co mBackground:  A growing number of studies have shown that education is a work context in  which professionals (teachers) seem likely to suffer from burnout that may be associated with  low levels of mental health.",Non-OADS,/arxiv_data1/oa_pdf/07/ca/ndt-10-123.PMC3900332.pdf
Available from: http://www.getcited.org/pub/10263820 6.,Non-OADS,/arxiv_data1/oa_pdf/07/ca/ndt-10-123.PMC3900332.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/07/ca/ndt-10-123.PMC3900332.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/ca/ndt-10-123.PMC3900332.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/bd/ndt-10-089.PMC3900333.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 89–96Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  89OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5682 7Measuring quality of sleep and autonomic nervous  function in healthy Japanese women Miki sato1 Yuko Yasuhara2 T etsuya Tanioka2 Yukie iwasa2 Masafumi Miyake3 T oshiyuki Yasui2 Masahito T omotake2 haruo Kobayashi4 rozzano c locsin5 1Department of Nursing, Faculty  of Nursing, shikoku University,   2Department of Nursing, institute of  health Biosciences, The University  of T okushima graduate school,   3T okushima Prefectural Minami health  care center, T okushima, 4Faculty of  Medical Welfare, Kawasaki University  of Medical Welfare, Kurashiki, Japan;   5christine e lynn college of Nursing,   Florida atlantic University, Boca  raton, Fl, Usa correspondence: Miki sato   Department of Nursing, Faculty of  Nursing, shikoku University, 123-1,   aza, ebisuno, Furukawa, Ojin-cho,  Tokushima 771-1192, Japan   Tel +81 8 8665 9237   Fax +81 8 8665 8037   email msato@shikoku-u.ac.j pAbstract:  The purpose of this study was to determine the relationship between quality of sleep  and autonomic nervous functioning in healthy adult Japanese women using three measures,  namely, the Pittsburgh Sleep Quality Index (PSQI) for subjective assessment of sleep quality,  actigraphy for objective assessment of sleep, and heart rate variability using high frequency  and low frequency domains.",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/ndt-10-089.PMC3900333.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/ndt-10-089.PMC3900333.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/bd/ndt-10-089.PMC3900333.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/e4/opth-8-255.PMC3900334.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 255–261Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  255Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5648 4Endothelial distance after phakic iris-fixated   intraocular lens implantation: a new   safety reference Tiago Bravo Ferreira Joana Portelinha egas Moniz hospital, lisbon, Portugal Correspondence: Tiago Bravo Ferreira   egas Moniz hospital, 126 rua da   Junqueira, lisbon 1301-049, Portugal   email tiagoferreira@netcabo.p tPurpose:  To evaluate the distance between the endothelial surface of the cornea to the anterior  edge of an Artiflex® phakic intraocular lens (IOL) implant to improve the safety profile of this  implant.",Non-OADS,/arxiv_data1/oa_pdf/4f/e4/opth-8-255.PMC3900334.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4f/e4/opth-8-255.PMC3900334.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/e4/opth-8-255.PMC3900334.pdf
©2013 by Anais Brasileiros de DermatologiaCONTINUING MEDICAL EDUCATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20132233 Abstract: Giant congenital melanocytic nevus is usually defined as a melanocytic lesion present at birth that will reach a diameter ≥ 20 cm in adulthood.,Non-OADS,/arxiv_data1/oa_pdf/d8/13/abd-88-06-0863.PMC3900335.pdf
©2013 by Anais Brasileiros de DermatologiaCONTINUING MEDICAL EDUCATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20132323 Abstract: Patch tests were introduced as a diagnostic tool in the late nineteenth century.,Non-OADS,/arxiv_data1/oa_pdf/b3/11/abd-88-06-0879.PMC3900336.pdf
"Avaialable from: http://www.contactderm.org/i4a/pages/index.cfm?pageid=3277De Benedetto A, Kubo A, Beck LA.",Non-OADS,/arxiv_data1/oa_pdf/b3/11/abd-88-06-0879.PMC3900336.pdf
"1PhD – Doctor – Hospital Garcia de Orta – Almada, Portugal   ©2013 by Anais Brasileiros de DermatologiaINVESTIGATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20132296 Abstract: BACKGROUND : Ingrown nails are a very common problem.",Non-OADS,/arxiv_data1/oa_pdf/3b/66/abd-88-06-0889.PMC3900337.pdf
s Assessing depression and anxiety in the caregivers of  pediatric patients with chronic skin disorders * Avaliação da depressão e ansiedade em cuidadores de pacientes pediátricos  com dermatoses crônicas DOI: http://dx.doi.org/10.1590/abd1806-4841.20131915 Abstract: BACKGROUND : The literature has shown that the presence of emotional disturbances in caregivers of children with skin diseases affects the course and treatment of the disease.,Non-OADS,/arxiv_data1/oa_pdf/77/4a/abd-88-06-0894.PMC3900338.pdf
"Available form: 27. http://www.searo.who.int/N/Section1243/Section1310/Section1343/Section1344/Section1353_5279.htm.Taner E, Coşar B, Burhanoğlu S, Calikoğlu E, Onder M, Arikan Z. Depression and anxiety 28. in patients with Behçet's disease compared with that in patients with psoriasis.",Non-OADS,/arxiv_data1/oa_pdf/77/4a/abd-88-06-0894.PMC3900338.pdf
2013;88(6):900-5. s Randomized clinical efficacy of superficial peeling with 85% lactic acid versus 70% glycolic acid* Estudo randomizado da eficácia clínica dos peelings superficiais de ácido  láctico 85% versus ácido glicólico 70% Paula Souza Prestes1Márcia Motta Maia de Oliveira2Gislaine Ricci Leonardi3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20131888 Abstract: BACKGROUND : Peeling is a procedure which aims to accelerate the process of skin exfoliation.,Non-OADS,/arxiv_data1/oa_pdf/a5/35/abd-88-06-0900.PMC3900339.pdf
"2013;88(6):907-12.907s Incidence of acne vulgaris in young adult users of  protein-calorie supplements in the city of João Pessoa – PB* Incidência de acne vulgar em adultos jovens usuários de suplementos  protéico-calóricos na cidade de João Pessoa – PB  Thaís de Carvalho Pontes1Gilson Mauro Costa Fernandes Filho1 Arthur de Sousa Pereira Trindade1Jader Freire Sobral Filho2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132024 Abstract: BACKGROUND : Based on personal observations of dermatologists, nutritionists and patients, a new problem emerges in the gyms: development and exacerbation of acne in users of whey protein, which is a protein derived from cow's milk.Whey Protein extract contains growth factors that may be related to acne.",Non-OADS,/arxiv_data1/oa_pdf/23/a4/abd-88-06-0907.PMC3900340.pdf
"2013;88(6):913-6.913s Obesity and dyslipidemia in patients with psoriasis treated at a dermatologic clinic in Manaus* Obesidade e dislipidemia em pacientes com psoríase atendidos num  ambulatório de dermatologia de Manaus Mônica Santos1Hannah Monteiro Fonseca2Alex Panizza Jalkh3 Gabriela Piraice Gomes2Andrea de Souza Cavalcante4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132090 Abstract: BACKGROUND : Psoriasis is a chronic inflammatory disease of multifactorial etiology, with participation of genetic, autoimmune and environmental factors.",Non-OADS,/arxiv_data1/oa_pdf/e4/a3/abd-88-06-0913.PMC3900341.pdf
"2013;88(6):918-23. s Serology with ML Flow test in health professionals from three different states of Brazil* Sorologia com o teste ML Flow em profissionais de saúde em  três diferentes estados do Brasil Karla Lucena Sampaio Calado1Mônica Maria Ferreira Magnanini2 Rodrigo Scaliante de Moura3Maria Eugenia Noviski Gallo4 Samira Bührer-Sékula5Maria Leide Wand-Del-Rey de Oliveira6 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132139 Abstract: BACKGROUND : In highly endemic countries, transmission and sub-clinical infection of leprosy are likely and the disease manifests itself in individuals without any known close contact with a leprosy patient.",Non-OADS,/arxiv_data1/oa_pdf/4d/83/abd-88-06-0918.PMC3900342.pdf
"Disponível em: http://con-selho.saude.gov.br/resolucoes/reso_9Gomide M, Grossetti M. Rede social e desempenho de programas de saúde: uma pro- 22. posta investigativa.",OADS,/arxiv_data1/oa_pdf/4d/83/abd-88-06-0918.PMC3900342.pdf
"Disponível em:http://www.ibge.gov.br/home/estatistica/indicadores/trabalhoerendimento/pme_nova/retrospectiva2003_2010.pdf González-Abreu E, Pon JA, Hernádez P , Rodriguez J, Mendoza E, Hernández M,  et al.",OADS,/arxiv_data1/oa_pdf/4d/83/abd-88-06-0918.PMC3900342.pdf
"Disponível em: http://dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinannet/hanseníase/bases/hansbrnet.defOskam L, Slim E, Bührer-Sékula S. Serology: Recent Developments, Strenghts, 28.",Non-OADS,/arxiv_data1/oa_pdf/4d/83/abd-88-06-0918.PMC3900342.pdf
"Disponível em: http://www.ibge.gov.br/home/presidencia/noticias/noticia_visualiza.php?id_noticia=1937&id_pagina=1Sjöwall C, Kastbom A, Almroth G, Wetterö J, Skogh T. Beware of antibodies to dietary 33. proteins in ""antigen-specific"" immunoassays!",Non-OADS,/arxiv_data1/oa_pdf/4d/83/abd-88-06-0918.PMC3900342.pdf
"925s Tattoos on 18-year-old male adolescents - Characteristics and associated factors* Tatuagens em Adolescentes Masculinos de 18 anos -  Características e fatores associados José Froner Bicca1Rodrigo Pereira Duquia2 Juliano de Avelar Breunig3Paulo Ricardo Martins de Souza4 Hiram Larangeira de Almeida Jr.5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132192 Abstract: BACKGROUND : Prevalence of tattoos is around 10-26% in men and 10-22% in women, and can involve negative effects such as: regret, removal attempts, physical and biological changes of the skin and association with some viral diseases.O BJECTIVE : to determine the prevalence, characteristics and factors associated with tattoos in recruiters joining the military.",Non-OADS,/arxiv_data1/oa_pdf/b8/fc/abd-88-06-0925.PMC3900343.pdf
s930INVESTIGATION Triple nanoemulsion potentiates the effects of topical  treatments with microencapsulated retinol and modulates biological processes related to skin aging* Tripla nanoemulsão potencializa os efeitos do tratamento tópico com retinol  microencapsulado e modula processos biológicos relacionados  ao envelhecimento da pele   Alessandro Afornali1Rodrigo de Vecchi1Rodrigo Makowiecky Stuart2 Gustavo Dieamant3Luciana Lima de Oliveira4Carla Abdo Brohem5 Israel Henrique Stokfisz Feferman6Lincoln Helder Zambaldi Fabrício7Márcio Lorencini8 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132208 Abstract: BACKGROUND : The sum of environmental and genetic factors affects the appearance and function of the skin as it ages.,Non-OADS,/arxiv_data1/oa_pdf/b3/13/abd-88-06-0930.PMC3900344.pdf
"2013;88(6):937-44. s937REVIEW Treatment of superficial mycoses: review - part II* Atualização terapêutica das micoses superficiais: artigo de revisão parte II Maria Fernanda Reis Gavazzoni Dias1Fred Bernardes-Filho2 Maria Victória Pinto Quaresma-Santos2Adriana Gutstein da Fonseca Amorim3 Regina Casz Schechtman4David Rubem Azulay5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132018 Abstract: Superficial fungal infections of the hair, skin and nails are a major cause of morbidity in the world.",Non-OADS,/arxiv_data1/oa_pdf/ab/3b/abd-88-06-0937.PMC3900345.pdf
2013;88(6):945-53. s945REVIEW Atopic dermatitis and vitamin D: facts and controversies* Dermatite atópica e vitamina D: fatos e controvérsias Kleyton de Carvalho Mesquita1Ana Carolina de Souza Machado Igreja2 Izelda Maria Carvalho Costa3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132660 Abstract: Patients with atopic dermatitis have genetically determined risk factors that affect the barrier function of the skin and immune responses that interact with environmental factors.,Non-OADS,/arxiv_data1/oa_pdf/57/c5/abd-88-06-0945.PMC3900346.pdf
"Avaialable from: http://www.uptodate.comArabi A, El Rassi R, El-Hajj Fuleihan G. Hypovitaminosis D in developing countries- 8. prevalence, risk factors and outcomes.",Non-OADS,/arxiv_data1/oa_pdf/57/c5/abd-88-06-0945.PMC3900346.pdf
2013;88(6):954-60. sREVIEW954 Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology* Micose fungoide hipocromiante: uma revisão de seus aspectos  clínicos e fisiopatológicos  DOI: http://dx.doi.org/10.1590/abd1806-4841.20132336 Abstract: Several distinct clinical forms of mycosis fungoides have been described.,Non-OADS,/arxiv_data1/oa_pdf/69/8f/abd-88-06-0954.PMC3900347.pdf
2013;88(6):961-5. s961REVIEW Bullous pemphigoid in a 3-month-old infant: case report and literature review of this dermatosis in childhood* Penfigoide bolhoso em lactente de 3 meses: relato de caso e revisão de  literatura da dermatose na infância Eugenio Galdino de Mendonça Reis-Filho1Tainah de Almeida Silva2 Luiza Helena de Lima Aguirre3Carmelia Matos Santiago Reis4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132378 Abstract: Bullous pemphigoid is an autoimmune subepidermal blistering dermatosis that is uncommon in child- hood.,Non-OADS,/arxiv_data1/oa_pdf/5f/12/abd-88-06-0961.PMC3900348.pdf
"2013;88(6):966-8. sDERMATOPATHOLOGY966 Scanning electron microscopy of a blister roof in  dystrophic epidermolysis bullosa* Microscopia eletrônica de varredura do teto de uma bolha  de epidermólise bolhosa distrófica Hiram Larangeira de Almeida Jr.1Luciane Monteiro2Ricardo Marques e Silva3 Nara Moreira Rocha4Hans Scheffer5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20131743 Abstract: In dystrophic epidermolysis bullosa the genetic defect of anchoring fibrils leads to cleavage beneath the basement membrane, with its consequent loss.",Non-OADS,/arxiv_data1/oa_pdf/22/7b/abd-88-06-0966.PMC3900349.pdf
969sCASEREPORT Ectopic cutaneous schistosomiasis - Case report* Esquistossomose cutânea ectópica - Relato de caso  Kathia Monielly Tenorio Nunes1Alberto Eduardo Cox Cardoso2 Fabio de Souza Guedes Pereira3Luiz Henrique Carvalho Batista4 Ricardo Luiz Simoes Houly5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132848 Abstract: Schistosomiasis mansoni is a systemic disease caused by a helminth of the schistosoma genus.,Non-OADS,/arxiv_data1/oa_pdf/08/fa/abd-88-06-0969.PMC3900350.pdf
2013;88(6):973-6.973sCASEREPORT Cutaneous lesions and finger clubbing uncovering  hypocomplementemic urticarial vasculitis and  hepatitis C with mixed cryoglobulinemia* Lesões cutâneas e baqueteamento digital reveladores de vasculite urticariforme hipocomplementêmica e hepatite C com crioglobulinêmia mista  Teresa Pinto-Almeida1Mónica Caetano1Rosário Alves1Manuela Selores1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132776 Abstract: Urticarial vasculitis is a rare clinicopathologic entity characterized by urticarial lesions that persist for more than 24 hours and histologic features of leukocytoclastic vasculitis.,Non-OADS,/arxiv_data1/oa_pdf/78/96/abd-88-06-0973.PMC3900351.pdf
2013;88(6):977-8.977sCASEREPORT Generalized Lichen Nitidus in a boy with  Niemann-Pick disease type B* Líquen nítido generalizado em paciente com doença de Niemann-Pick tipo B  Vera Barreto Teixeira1Inês Coutinho1José Carlos Cardoso2Óscar Tellhechea3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132829 Abstract: Generalized lichen nitidus is an uncommon chronic inflammatory dermatosis with very characteristic histological findings.,Non-OADS,/arxiv_data1/oa_pdf/89/97/abd-88-06-0977.PMC3900352.pdf
"2013;88(6):979-81.979sCASEREPORT De Sanctis-Cacchione Syndrome in a  female infant - Case report* Síndrome de De Sanctis-Cacchione em lactente do  sexo feminino - Relato de caso  Amadeus Lima Rocha Caldas1Mecciene Mendes Rodrigues2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132844 Abstract: The De Sanctis-Cacchione Syndrome is the rarest and most severe kind of xeroderma pigmentosum, characterized by microcephaly, hypogonadism, neurological disorders, mental and growth retardation, with veryfew cases published.",Non-OADS,/arxiv_data1/oa_pdf/b1/37/abd-88-06-0979.PMC3900353.pdf
982sCASEREPORT Bannayan-Riley-Ruvalcaba syndrome with deforming  lipomatous hamartomas in infant - Case report* Síndrome de Bannayan-Riley-Ruvalcaba com hamartomas lipomatosos  deformantes em lactente - Relato de caso Gabriela Maria Abreu Gontijo1Clóvis Antonio Lopes Pinto2Silvia Regina Rogatto3 Isabela Werneck da Cunha2Samuel Aguiar Junior4Célia Antônia Xavier de Moraes Alves5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132730 Abstract: Bannayan-Riley-Ruvalcaba Syndrome is a rare condition caused by mutations in the PTEN gene.,Non-OADS,/arxiv_data1/oa_pdf/ea/79/abd-88-06-0982.PMC3900354.pdf
There was nohospitalization history for anaphylaxis and drug  986sIMAGING IN DERMATOLOGY Dermatoscopic findings of urticaria pigmentosa* Achados dermatoscópicos na urticária pigmentosa Marcela Duarte Benez Miller1Natália Solon Nery2Alexandre Carlos Gripp3 Juan Piñeiro Maceira4Gisele Moro do Nascimento5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132217 Abstract: Mastocytosis is a rare disease characterized by proliferation and accumulation of mast cells in various organs.,Non-OADS,/arxiv_data1/oa_pdf/cd/82/abd-88-06-0986.PMC3900355.pdf
2013;88(6):989-91.989sIMAGING IN DERMATOLOGY Amelanotic metastatic cutaneous melanoma* Melanoma metastático amelanótico cutâneo  Marcela Sena Teixeira Mendes1Mariana Carvalho Costa2Ciro Martins Gomes3 Lisley Calixto de Araújo1Gustavo Henrique Soares Takano4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132206 Abstract: Dermatoscopy of melanocytic lesions has guided the decision of when or not to biopsy a lesion.,Non-OADS,/arxiv_data1/oa_pdf/8c/9a/abd-88-06-0989.PMC3900356.pdf
992sIMAGING IN TROPICAL DERMATOLOGY Leishmaniasis and AIDS coinfection* Coinfecção leishmaniose e AIDS  Adriana Hozannah1Monica Santos2Anette Chrusciak-Talhari3Carolina Talhari4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132191 Abstract: Cutaneous leishmaniasis and HIV coinfection has been reported in Brazil since the initial description of AIDS in the country.,Non-OADS,/arxiv_data1/oa_pdf/82/1b/abd-88-06-0992.PMC3900357.pdf
"No organisms were  994sIMAGING IN TROPICAL DERMATOLOGY Sarcoid-like paracoccidioidomycosis presenting  with perineural granuloma* Paracoccidioidomicose sarcoídica com granuloma perineural  Silvia Ferreira Rodrigues Müller1Mario Fernando Ribeiro de Miranda2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132309 Abstract: Paracoccidioidomycosis presenting as a sarcoid-like plaque may be misdiagnosed as leprosy, especially when shared endemic areas are concerned.",Non-OADS,/arxiv_data1/oa_pdf/42/1b/abd-88-06-0994.PMC3900358.pdf
"1-3In 1961, Hirsch and Helwig were the first to use the term CS to describeDOI: http://dx.doi.org/10.1590/abd1806-4841.20132515 FIGURE 1: volu- minous nodularlesion with asmooth erythe-matous surfacewith telangiec-tasias F IGURE 2: cuboidal cells agglomerates with basophilic round nucleus and eosinophilic cytoplasm (Fig.",Non-OADS,/arxiv_data1/oa_pdf/43/d6/abd-88-06-0997.PMC3900359.pdf
"DOI: http://dx.doi.org/10.1590/abd1806-4841.20132772 FIGURE 1:  Smooth-surfa-ced hyperchro-mic nodule,movable in thedeep layers,located on theright cubitalfossa F IGURE 2:  Hematoxiline-eosin stainedfragment, his-topathologicalexam showingdense prolifera-tion of cellswith a wideeosinophiliccytoplasm, cen-tral nuclei, andslightly conspi-cuous nucleoli.Immunohistochemistry posi-tive for proteinS100 e CD68 S-100 CD68Revista6Vol88ingles_Layout 1  1/2/14  11:39 AM  Página 1005",Non-OADS,/arxiv_data1/oa_pdf/dd/69/abd-88-06-1005.PMC3900361.pdf
"FIGURE 1: Cutaneous hyperpigmentation, cutaneous  xerosis and angiomasFIGURE 3: Proximal leuko-nychia on thehandsF IGURE 2: Facial lipoatrophy andangiomaDOI: http://dx.doi.org/10.1590/abd1806-4841.20132266 DISCUSSION POEMS Syndrome or Crow-Fukase Syndrome, Takatsuki Myeloma Syndrome, OsteocleroticMyeloma Syndrome.",Non-OADS,/arxiv_data1/oa_pdf/bf/62/abd-88-06-1009.PMC3900362.pdf
"4,5DOI: http://dx.doi.org/10.1590/abd1806-4841.20132178 FIGURE 1: A: Generalized lipoatrophy leading to an athletic appea- rance.",Non-OADS,/arxiv_data1/oa_pdf/87/68/abd-88-06-1011.PMC3900363.pdf
2013;88(6):1015-8.Patch test standard series recommended by the Brazilian Contact Dermatitis Study Group during the 2006-2011 period* Bateria de testes padrão preconizada pelo Grupo Brasileiro de Estudos em Dermatite de Contato: período de 2006 a 2011 Ida Alzira Gomes Duarte1Greta Merie Tanaka2Nathalie Mie Suzuki3 Rosana Lazzarini4Andressa Sato de Aquino Lopes5Beatrice Mussio Fornazier Volpini5 Paulo Carrara de Castro6 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132374 Abstract: A retrospective study was carried out between 2006-2011.,Non-OADS,/arxiv_data1/oa_pdf/1d/fd/abd-88-06-1015.PMC3900364.pdf
2013;88(6):1019-21.Endonyx toenail onychomycosis caused by Trichophyton rubrum: treatment with photodynamic therapy  based on methylene blue dye* Onicomicose endonix podal por Trichophyton rubrum: tratamento  por terapia fotodinâmica com corante azul de metileno   Linton Wallis Figueiredo Souza1Simone Vilas Trancoso Souza2 Ana Cristina de Carvalho Botelho3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132180 Abstract: This study shows the effectiveness of photodynamic therapy based on methylene blue dye for the treat- ment of endonyx toenail onychomycosis.,Non-OADS,/arxiv_data1/oa_pdf/14/95/abd-88-06-1019.PMC3900365.pdf
"©2013 by Anais Brasileiros de Dermatologia s1022COMMUNICATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20132327 Abstract: Brittle Nails Syndrome is characterized by fragility of the nail plate, affecting 27% of women.",Non-OADS,/arxiv_data1/oa_pdf/86/52/abd-88-06-1022.PMC3900366.pdf
"©2013 by Anais Brasileiros de Dermatologia s1026COMMUNICATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20132219 Abstract: 94 children and 25 adolescents, 42% male and 58% female, aged predominantly between six and ten years old (40%) were studied at the Martagão Gesteira Childcare and Pediatrics Institute (Rio de Janeiro FederalUniversity) between 2005 and 2011.",Non-OADS,/arxiv_data1/oa_pdf/b8/b7/abd-88-06-1026.PMC3900367.pdf
"©2013 by Anais Brasileiros de Dermatologia s1029SPECIAL DOI: http://dx.doi.org/10.1590/abd1806-4841.20132653 Abstract: Psoriasis is a polygenic, inflammatory and progressive disease, characterized by an abnormal differentiation and hyperprolifera tion of ker- atinocytes, associated with impaired immunologic activation and systemic disorders, while psoriatic arthritis is a chronic infl ammatory articular disease.",Non-OADS,/arxiv_data1/oa_pdf/d9/01/abd-88-06-1029.PMC3900368.pdf
"1 A cutaneous abscess is a localized collection of pus present in the dermis and subcutaneous tissue,usually from streptococcal or staphylococcal etiolo-Fred Bernardes Filho1Andreia Oliveira Alves2Gustavo Martins3 Letícia Soares Sasso4Carolina Mendonça Gama5Gardênia Borges Cenci6 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132864 Abstract: Cutaneous abscess is a localized collection of pus in the dermis and subcutaneous tissue usually caused by trauma.",Non-OADS,/arxiv_data1/oa_pdf/ad/f4/abd-88-06-1036.PMC3900369.pdf
"sICONOGRAPHY Drug-induced acne and rose pearl: similarities* Acne medicamentosa e a pérola rosa: semelhanças Rubens Pontello Junior 1Rogerio Nabor Kondo 21039 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132586 Abstract: Drug-induced acne is a common skin condition whose classic symptoms can be similar to a rose pearl, as in the case of a male patient presenting with this condition after excessive use of a cream containing corticos-teroids.Keywords: Acneiform eruptions; Drug eruptions; Skin diseases Resumo: A acne medicamentosa é uma dermatose comum, que pode apresentar no seu quadro clássico seme- lhanças à pérola rosa, como no caso apresentado de um paciente do sexo masculino cujo quadro surgiu após usointempestivo de creme contendo corticoesteróide.Palavras-chave: Dermatopatias; Erupção por droga; Erupções acneiformes Drug-induced acne, or drug-induced acneiform eruption, is an adverse effect of a series of systemicdrugs, such as corticosteroids, lithium, vitamin B12,thyroid hormones, halogen compounds (iodine,bromine, fluorine, and chlorine), antibiotics (tetracy-cline and streptomycin), antituberculosis drugs(INH), lithium carbonate, antiepileptic drugs (pheno-barbital and hydantoin derivatives), cyclosporin A,antimycotics, gold salts, isotretinoin, clofazimine, epi-dermal growth factor receptor inhibitors (cetuximab,gefitinib, and erlotinib), and interferon-beta.",Non-OADS,/arxiv_data1/oa_pdf/3d/34/abd-88-06-1039.PMC3900370.pdf
"DTI Analysis All DTI analyses were performed with the 3DSlicersoftware package (http://slicer.org, Surgical Planning Laboratory, Brigham and Women ’s Hospital, Boston, MA).",OADS,/arxiv_data1/oa_pdf/ca/be/728.PMC3900542.pdf
False discovery rates formetabolomic and lipidomic data sets were calculated us-ing Q-value software (http://genomics.princeton.edu/storeylab/qvalue/) (26).,OADS,/arxiv_data1/oa_pdf/99/63/688.PMC3900545.pdf
Sequences were aligned with a multiple sequence alignment program(http://www.genome.jp /tools/clustalw/).,OADS,/arxiv_data1/oa_pdf/72/14/596.PMC3900547.pdf
Water was acidi ﬁed by adding HCl as described on the JAX website (http://jaxmice.jax.org/genetichealth/health_program.html; http://craniofacial.jax.org/new_standard_protocols.html).,Non-OADS,/arxiv_data1/oa_pdf/96/58/632.PMC3900548.pdf
The ANOVA analysis forthe robust multichip average normalized data sets wascompleted by the commercial Partek Genomic Suitemicroarray data analysis software (http://www.partek.com/partekgs/).,OADS,/arxiv_data1/oa_pdf/b1/66/715.PMC3900551.pdf
This is an open- access article distributed under the terms  of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/05/e9/thnov04p0119.PMC3900797.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/3a/thnov04p0134.PMC3900798.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d3/dd/thnov04p0142.PMC3900799.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/43/e4/thnov04p0154.PMC3900800.pdf
This is an open- access article distributed under th e terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/71/f7/thnov04p0163.PMC3900801.pdf
This  is an open -access  article  distributed  under  the terms  of the Creative  Commons  License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/58/36/thnov04p0175.PMC3900802.pdf
World  Health  Statistics  2008.    http://www.who.int/whosis/whostat/2008/en/index.html   3.,OADS,/arxiv_data1/oa_pdf/58/36/thnov04p0175.PMC3900802.pdf
This  is an open -access  article  distributed  under  the terms  of the Creative  Commons  License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fe/59/thnov04p0201.PMC3900803.pdf
Image  analysis  and  processing  were performed using  the ImageJ  software   (http://rsb.info.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/fe/59/thnov04p0201.PMC3900803.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1d/d5/thnov04p0215.PMC3900804.pdf
"Mouse MPSS database was based on  the 84 samples from 31 different mouse organs from the Mouse Transcriptome Project (trans -NIH with  Lynx/So lexa MPSS™  technology,  http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/1d/d5/thnov04p0215.PMC3900804.pdf
Relative quantification of plasma protein bin d- ing to each antibody f eature was determined by  curve -fitting using OSPRAI software  (http://www.bioinformatics.org/osprai/index.html)  and a one -to-one interaction model.,OADS,/arxiv_data1/oa_pdf/1d/d5/thnov04p0215.PMC3900804.pdf
We chose representative protein s e- quences to 29 liver- specific targets from the Mouse  Genome Informatics database  (http://www.informatics.jax.org/mgihome/nomen).,OADS,/arxiv_data1/oa_pdf/1d/d5/thnov04p0215.PMC3900804.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3884 | DOI: 10.1038/srep03884 6",Non-OADS,/arxiv_data1/oa_pdf/cb/60/srep03884.PMC3900920.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3851 | DOI: 10.1038/srep03851 7",Non-OADS,/arxiv_data1/oa_pdf/35/9b/srep03851.PMC3900921.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/73/f7/srep03883.PMC3900923.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3883 | DOI: 10.1038/srep03883 6",Non-OADS,/arxiv_data1/oa_pdf/73/f7/srep03883.PMC3900923.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3880 | DOI: 10.1038/srep03880 7",Non-OADS,/arxiv_data1/oa_pdf/87/3e/srep03880.PMC3900924.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/a4/srep03849.PMC3900925.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3849 | DOI: 10.1038/srep03849 9",Non-OADS,/arxiv_data1/oa_pdf/92/a4/srep03849.PMC3900925.pdf
"These multiple levels of analysis can now be exploited, following the sequencing of the tomato genome12(http://solgenomics.net/), to enable a step-change in our ability to utilise the metabolic diversity and natural genetic variation of wild relatives for improving crop quality through metabo- lomics-assisted breeding13–15.",Non-OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
"To analyze individual metabolite perturbations throughout the metabolome, the putative metabolites, ascertained from the PlantCyc database, in combination with those confirmed through targeted metabolite profiling, were tabulated to show fold changesin molecular features relative to the M82 (Supplementary DatasetS1, ftp://ftp.solgenomics.net/projects/uk_metabolomics/Solanum_ pennellii/) and categorized into over 600 pathways (Supplementary Dataset S2, ftp://ftp.solgenomics.net/projects/uk_metabolomics/Solanum_pennellii/).",OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
"Representation in Cytoscape (http://www.cytoscape.org/) revealed metabolite changes exclusive to an IL, or those common to several ILs (Supplementary Figure S4, A–C), whilst chromosome maps, illustrating compounds that increase or decreasetwo fold relative to M82, are shown in Supplementary Figure S5, A– L. An overriding feature of the data is that no IL contains a perturba- tion in a single pathway or metabolite.",OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
"These networks have beenconstructed for individual genotypes and collectively across thepopulation, using biochemical pathways in the Kyoto Encyclopediaof Genes and Genomes (KEGG) database (http://www.genome.jp/kegg/).",OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
"lycopersicum (M82) x S. pennellii IL population, obtained from the Tomato Genetics Resource Center (http://tgrc.ucdavis.edu/ pennellii_ils.aspx), was grown in glasshouse conditions (16 h day length, day temp 20uC, night temp 18 uC) over two seasons.",Non-OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
Heat maps were produced in MatLab v. (http://www.mathworks.co.uk/index.html) and used to show the fold-change for each variable in every IL comparedto the M82 comparator.,OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
An in-house Excel macro was used to compile files compatible with Cytoscape software (http://www.cytoscape.org/).,OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
http://faostat.fao.org/ (2013).,Non-OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
"We also thank Dr Lukas Mueller, Boyce Thompson Institute for Plant Research, New York, for placing supplementary data onto the SolGenomics (http://solgenomics.net/) ftp internet site.",Non-OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3859 | DOI: 10.1038/srep03859 8",Non-OADS,/arxiv_data1/oa_pdf/33/03/srep03859.PMC3900926.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/99/e9/srep03862.PMC3900929.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3862 | DOI: 10.1038/srep03862 7",Non-OADS,/arxiv_data1/oa_pdf/99/e9/srep03862.PMC3900929.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d0/30/srep03855.PMC3900930.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3855 | DOI: 10.1038/srep03855 6",Non-OADS,/arxiv_data1/oa_pdf/d0/30/srep03855.PMC3900930.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3853 | DOI: 10.1038/srep03853 8",Non-OADS,/arxiv_data1/oa_pdf/af/2e/srep03853.PMC3900931.pdf
The CpG islands in ARRDC3 promoter were analyzed by online tool (http://www.cpgislands.com) with default settings (ObsCpG/ExpCpG: 0.6; minimum average percentage of CpG: 50%; minimum length of reported CpG island: 200 bp).,OADS,/arxiv_data1/oa_pdf/8b/8b/srep03846.PMC3900932.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8b/8b/srep03846.PMC3900932.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3846 | DOI: 10.1038/srep03846 7",Non-OADS,/arxiv_data1/oa_pdf/8b/8b/srep03846.PMC3900932.pdf
"For the Venn diagram, we used the following databases: TargetScanHman6.0 (http://www.targetscan.org/vert_60/), microRNA.org (http://www.microrna.org/microrna/getMirnaForm.do), Pictar (http://pictar.mdc-berlin.",OADS,/arxiv_data1/oa_pdf/3d/80/srep03852.PMC3900933.pdf
"de/), RNA hybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/submission.",OADS,/arxiv_data1/oa_pdf/3d/80/srep03852.PMC3900933.pdf
html) and miRBase (http://www.mirbase.org/).,OADS,/arxiv_data1/oa_pdf/3d/80/srep03852.PMC3900933.pdf
"The metabolic pathway map used was the Analysis of Networks containing Experimental Data (VANTED, http://vanted.ipk-gatersleben.de/)51.",OADS,/arxiv_data1/oa_pdf/3d/80/srep03852.PMC3900933.pdf
"Estimation of ELAVL2 as a target gene of miR-520d-5p .Based on the predicted target genes of miR-520d-5p (MIMAT0002855: cuacaaagggaagcccuuuc) according to various databases (miRBase; http://www.mirbase.org, DIANA-MICROT; http:// diana.cslab.ece.ntua.gr/DianaTools/, miRDB; http://mirdb.org, RNA22-HAS; http:// cm.jefferson.edu/rna22v1.0, TargetMiner; http://www.isical.ac.in/ ,bioinfo_miu, mircoRNA.org; http://www.microrna.org/microrna and TargetScan-VERT; http:// www.targetscan.org/cgi-bin/targetscan/vert_50) and after confirming gene downregulation by RT-PCR, we examined gene expression in cells transfected with four types of siRNAs against ELAVL2 (siELAVL2-HLF; see the lentiviral vector construct section) and compared this with gene expression in 520d-HLF cells.",OADS,/arxiv_data1/oa_pdf/3d/80/srep03852.PMC3900933.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/80/srep03852.PMC3900933.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3852 | DOI: 10.1038/srep03852 14",Non-OADS,/arxiv_data1/oa_pdf/3d/80/srep03852.PMC3900933.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/94/94/srep03856.PMC3900993.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3856 | DOI: 10.1038/srep03856 5",Non-OADS,/arxiv_data1/oa_pdf/94/94/srep03856.PMC3900993.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/58/2f/srep03863.PMC3900994.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3863 | DOI: 10.1038/srep03863 6",Non-OADS,/arxiv_data1/oa_pdf/58/2f/srep03863.PMC3900994.pdf
"European reference material ERM FD122, BAM Federal Institute for Materials Research and Testing, Section: 1.3 Strukturanalytik, Germany, http://www.bam.",Non-OADS,/arxiv_data1/oa_pdf/4f/bf/srep03857.PMC3900995.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4f/bf/srep03857.PMC3900995.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3857 | DOI: 10.1038/srep03857 5",Non-OADS,/arxiv_data1/oa_pdf/4f/bf/srep03857.PMC3900995.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/97/4a/srep03882.PMC3900997.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3882 | DOI: 10.1038/srep03882 6",Non-OADS,/arxiv_data1/oa_pdf/97/4a/srep03882.PMC3900997.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a8/b6/srep03854.PMC3900998.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3854 | DOI: 10.1038/srep03854 10",Non-OADS,/arxiv_data1/oa_pdf/a8/b6/srep03854.PMC3900998.pdf
been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO Series accession number GSE53319 (http://www.ncbi.nlm.nih.gov/geo/query/acc.,OADS,/arxiv_data1/oa_pdf/69/a6/srep03843.PMC3900999.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/69/a6/srep03843.PMC3900999.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3843 | DOI: 10.1038/srep03843 8",Non-OADS,/arxiv_data1/oa_pdf/69/a6/srep03843.PMC3900999.pdf
URL:http://2010.igem.org/wiki/index.,OADS,/arxiv_data1/oa_pdf/0f/28/srep03759.PMC3901000.pdf
(Archived by WebCite Hat http://www.webcitation.org/ 6Lw2xwyyD).,OADS,/arxiv_data1/oa_pdf/0f/28/srep03759.PMC3901000.pdf
URL:http://parts.igem.org/Part:pSB1C3?title 5Part:pSB1C3.,Non-OADS,/arxiv_data1/oa_pdf/0f/28/srep03759.PMC3901000.pdf
(Archived by WebCite Hat http://www.webcitation.org/6Lw3Vr2iw).,OADS,/arxiv_data1/oa_pdf/0f/28/srep03759.PMC3901000.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3759 | DOI: 10.1038/srep03759 11",Non-OADS,/arxiv_data1/oa_pdf/0f/28/srep03759.PMC3901000.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/63/sft145.PMC3901039.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/a5/sft138.PMC3901040.pdf
"Weekly Epidemiological Record, PPV23 position state- ment 2008. http://www.who.int/wer/2008/wer8342.pdf (28 September 2013, date last accessed) 5.",Non-OADS,/arxiv_data1/oa_pdf/90/a5/sft138.PMC3901040.pdf
"Department of Health, Seasonal in ﬂuenza vaccine uptake records, 2013. https://www.gov.uk/government/publications/ seasonal-in ﬂuenza-vaccine-uptake-and-vaccine-supply (28 September 2013, date last accessed) 9.",Non-OADS,/arxiv_data1/oa_pdf/90/a5/sft138.PMC3901040.pdf
"Department of Health, Seasonal pneumococcal vaccine uptake records, 2012. http://webarchive.nationalarchives.",Non-OADS,/arxiv_data1/oa_pdf/90/a5/sft138.PMC3901040.pdf
"gov.uk/20130107105354/http://immunisation.dh.gov.uk/ppv- uptake-report-2012 (28 September 2013, date last accessed) 10.",Non-OADS,/arxiv_data1/oa_pdf/90/a5/sft138.PMC3901040.pdf
"UK, 2013. http://cks.nice.org.uk/i mmunizations-seasonal-in ﬂuenza#!",Non-OADS,/arxiv_data1/oa_pdf/90/a5/sft138.PMC3901040.pdf
"Department of Health, Flu vaccination uptake records 2009/2010: http://webarchive.nationalarchives.gov.uk/20130107105354/http:// www.dh.gov.uk/prod_consum_dh/ groups/dh_digitalassets/@dh/ @en/@ps/documents/digitalasset/dh_118645.pdf (28 September 2013, date last accessed) 14.",Non-OADS,/arxiv_data1/oa_pdf/90/a5/sft138.PMC3901040.pdf
"Department of Health, Flu vaccination uptake records 2010/2011: http://webarchive.nationalarchives.gov.uk/20130107105354/ http://www.dh.gov.uk/prod_cons um_dh/groups/dh_digitalassets/ documents/digitalasset/dh_127111.pdf (28 September 2013, date last accessed) Received for publication: 9.6.13; Accepted in revised form: 25.10.1332 S.M.S.",Non-OADS,/arxiv_data1/oa_pdf/90/a5/sft138.PMC3901040.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3858 | DOI: 10.1038/srep03858 7",Non-OADS,/arxiv_data1/oa_pdf/57/1c/srep03858.PMC3901061.pdf
http://www.tarceva.com/patient/ .,Non-OADS,/arxiv_data1/oa_pdf/c2/ea/cro-0006-0602.PMC3901587.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/41/ndt-10-047.PMC3901735.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 47–54Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  47OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5233 81h-Magnetic resonance spectroscopy study   of stimulant medication effect on brain   metabolites in French canadian children   with attention deficit hyperactivity disorder leila Benamor1,2 1Department of Psychiatry sainte- Justine hospital, Montreal, Quebec,   canada; 2Department of Psychiatry,   University of Montreal, Montreal,   Quebec, canada correspondence: leila Benamor   sainte Justine hospital,   Department of Psychiatry,   3175 cote-sainte catherine,   Montreal (Quebec),   canada h3T1c5.",Non-OADS,/arxiv_data1/oa_pdf/98/41/ndt-10-047.PMC3901735.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/98/41/ndt-10-047.PMC3901735.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/41/ndt-10-047.PMC3901735.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/48/ijn-9-559.PMC3901736.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/61/48/ijn-9-559.PMC3901736.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/48/ijn-9-559.PMC3901736.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/ppa-8-093.PMC3901737.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 93–99Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  93OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5515 6Preferences of patients and health professionals  for route and frequency of administration   of biologic agents in the treatment   of rheumatoid arthritis T uan Khai huynh1,2 Ann Østergaard3 charlotte egsmose3 Ole rintek Madsen3 1Department of rheumatology,   copenhagen University hospital  Frederiksberg, Frederiksberg,   Denmark; 2Department of  rheumatology, copenhagen University  hospital hillerød, hillerød, Denmark;   3Department of rheumatology/ c,   copenhagen University hospital  gentofte, hellerup, Denmark correspondence: Ole rintek Madsen   Department of rheumatology/c,  copenhagen University hospital  gentofte, copenhagen, Denmark   Tel +45 39 77 8382   Fax +45 39 77 7619   email rintek@dadlnet.d kObjectives:  To examine the preferences of rheumatoid arthritis (RA) patients and health  professionals (HPs) for the route and frequency of administration of biologic drugs.",Non-OADS,/arxiv_data1/oa_pdf/59/f0/ppa-8-093.PMC3901737.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/59/f0/ppa-8-093.PMC3901737.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/ppa-8-093.PMC3901737.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/d8/ijn-9-575.PMC3901738.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 575–588International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  575OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5475 0Tissue inhibitor of matrix metalloproteinases-1  loaded poly(lactic-co-glycolic acid) nanoparticles  for delivery across the blood–brain barrier Mayank chaturvedi1 Yves Molino2 Bojja sreedhar3 Michel Khrestchatisky4 leszek Kaczmarek1 1laboratory of Neurobiology,    Nencki Institute, Warsaw, Poland;   2Vect-horus, Marseille, France;    3Indian Institute of chemical  T echnology, hyderabad, India;    4aix-Marseille Université, cNrs,   NIcN, UM r7259, Marseille, France correspondence: Mayank chaturvedi;  leszek Kaczmarek   laboratory of Neurobiology, Nencki  Institute, 3 Pasteur street, Warsaw  02-093, Poland   email m.chaturvedi@nencki.gov.p l;  l.kaczmarek@nencki.gov.p lAim:  The aim of this study was to develop poly(lactic-co-glycolic acid) (PLGA) nanoparticles  (NPs) for delivery of a protein – tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) – across  the blood–brain barrier (BBB) to inhibit deleterious matrix metalloproteinases (MMPs).",Non-OADS,/arxiv_data1/oa_pdf/e2/d8/ijn-9-575.PMC3901738.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e2/d8/ijn-9-575.PMC3901738.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/d8/ijn-9-575.PMC3901738.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/56/ijn-9-561.PMC3901739.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 561–574International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  561OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5356 3steric environment around acetylcholine head  groups of bolaamphiphilic nanovesicles influences  the release rate of encapsulated compounds avital stern1 Matteo guidotti2 eleonora shaubi1 Mary Popov3 charles linder4 eliahu heldman3 sarina grinberg1 1Department of chemistry,   Ben-gurion University of the Negev,  Beer-sheva, Israel; 2Istituto di  scienze e Tecnologie Molecolari- cNr, Milano, Italy; 3Department  of clinical Biochemistry and  Pharmacology, Ben- gurion  University of the Negev, Beer- sheva,  Israel; 4Zuckerberg Water Institute  and Department of Biotechnology  engineering, Ben- gurion University  of the Negev, Beer-sheva, Israel correspondence: sarina grinberg   Department of chemistry, Ben-gurion   University of the Negev, PO Box 653,   Beer-sheva 84105, Israel   Tel +972 8 646 1944   Fax +972 8 647 2969   email sarina@bgu.ac.i l    eliahu heldman   Department of clinical Biochemistry   and Pharmacology, Ben-gurion   University of the Negev, PO Box 653,   Beer-sheva 84105, Israel   Tel +972 8 647 7675   Fax +972 8 647 2969   email heldmane@bgu.ac.i lAbstract:  Two bolaamphiphilic compounds with identical acetylcholine (ACh) head groups, but  with different lengths of an alkyl chain pendant adjacent to the head group, as well as differences  between their hydrophobic skeleton, were investigated for their ability to self-assemble into  vesicles that release their encapsulated content upon hydrolysis of their head groups by acetyl - cholinesterase (AChE).",Non-OADS,/arxiv_data1/oa_pdf/d6/56/ijn-9-561.PMC3901739.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d6/56/ijn-9-561.PMC3901739.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/56/ijn-9-561.PMC3901739.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/72/ijwh-6-075.PMC3901740.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 75–82International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  75OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5460 9Intimate partner violence (physical and sexual)   and sexually transmitted infection: results   from nepal Demographic Health survey 2011 liladhar Dhakal gabriele Berg-Beckhoff arja r aro Unit of Health Promotion research,   University of southern Denmark,   esbjerg, Denmark correspondence: liladhar Dhakal   Unit of Health Promotion research,  University of southern Denmark,  esbjerg, Denmark   Tel +977 984 535 8623   email liladhardhakal@gmail.co mIntroduction:  Violence against women perpetrated by their intimate partners is a social  problem  with adverse health consequences.",Non-OADS,/arxiv_data1/oa_pdf/c4/72/ijwh-6-075.PMC3901740.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c4/72/ijwh-6-075.PMC3901740.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/72/ijwh-6-075.PMC3901740.pdf
Available from: https://www.measuredhs.com/data/ dataset/Nepal_Standard-DHS_2011.cfm?flag=1.,OADS,/arxiv_data1/oa_pdf/c4/72/ijwh-6-075.PMC3901740.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/60/cia-9-219.PMC3901741.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 219–225Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  219OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5605 8sustained effect of resistance training   on blood pressure and hand grip strength   following a detraining period in elderly   hypertensive women: a pilot study Dahan da Cunha  nascimento1,5,8 ramires Alsamir Tibana1,8 Franklin M Benik2 Keila elizabeth Fontana3 Frederico ribeiro neto8 Frederico santos de  santana5,8 leopoldo santos-n eto4 renato André sousa  silva1,5,6 Alessandro Oliveira silva1,7 Darlan lopes Farias1,7 sandor Balsamo4,5,8 Jonato Prestes1 1Postgraduate Program in Physical education,   Catholic University of Brasilia, Brasilia, Brazil;   2Department of Kinesiology and sports studies  graduate Program, eastern Illinois University,   Charleston, Il, UsA; 3Faculty of Physical education,   University of Brasilia, Brasilia, Brazil; 4graduate  Program in Medical sciences of the University of  Brasilia, school of Medicine and rheumatology  service, University hospital of Brasilia (hUB),   Brasilia, Brazil; 5Department of Physical education,   University Center euro American University  Center, Brasilia, Brazil; 6Center of excellence in  Medicine of exercise (CeM ex), Brasilia, Brazil;   7Center University of Brasilia (Un ICeUB), Brasilia,   Brazil; 8strength Training and health research  group (geP eeFs), Brasilia, Brazil Correspondence: Dahan da Cunha   nascimento   Postgraduate Program in Physical  education, Catholic University of Brasilia,  Qs 07 lote 01, Bloco g,   71966-700, Brasilia, Brazil   email dahanc@hotmail.comIntroduction:  Hypertension is the most prevalent modifiable risk factor with a high prevalence  among older adults.",Non-OADS,/arxiv_data1/oa_pdf/36/60/cia-9-219.PMC3901741.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/36/60/cia-9-219.PMC3901741.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/60/cia-9-219.PMC3901741.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/70/jpr-7-071.PMC3901742.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 71–79Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  71Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S3661 9Herpes simplex virus-based nerve targeting   gene therapy in pain management James R Goss David Krisky James wechuck Darren wolfe PeriphaGen inc, Pittsburgh, PA, USA Correspondence: James R Goss   PeriphaGen inc, 2100 wharton Street,  Suite 701, Pittsburgh,   PA 15203, USA   Tel +1 412 488 0348 ext 103   Fax +1 412 488 0349   email james.goss@periphagen.co mAbstract:  Chronic pain represents a major medical burden not only in terms of suffering but  also in terms of economic costs.",Non-OADS,/arxiv_data1/oa_pdf/5c/70/jpr-7-071.PMC3901742.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/5c/70/jpr-7-071.PMC3901742.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/70/jpr-7-071.PMC3901742.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/9c/copd-9-099.PMC3901775.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 99–105International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  99OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5146 7Factors associated with a prolonged length   of stay after acute exacerbation of chronic  obstructive pulmonary disease (aeCOPD) Ying Wang1–3 Knut stavem1–3 Fredrik a Dahl1 sjur humerfelt4 T orbjørn haugen1,5 1health services research Unit,   2Department of Pulmonary Medicine,   akershus University hospital, 3Faculty  of Medicine, University of Oslo,   lørenskog, norway; 4Department of  Pulmonary Medicine, Oslo University  hospital, aker, 5Clinic for allergy and  airway Diseases, Oslo, norway Correspondence: Ying Wang   health services research Unit,   akershus University hospital,   PO Box 95, n-1478 lørenskog, norway   Tel +47 679 68 708,   Fax +47 67 98 99 00   email ying.wang@ahus.n oBackground:  Early identification of patients with a prolonged stay due to acute exacerbation  of chronic obstructive pulmonary disease (COPD) may reduce risk of adverse event and treat - ment costs.",Non-OADS,/arxiv_data1/oa_pdf/c9/9c/copd-9-099.PMC3901775.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c9/9c/copd-9-099.PMC3901775.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/9c/copd-9-099.PMC3901775.pdf
Available from: http://apps.who.int/  classifications/icd10/browse/2010/en .,OADS,/arxiv_data1/oa_pdf/c9/9c/copd-9-099.PMC3901775.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/f0/ppa-8-101.PMC3901776.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 101–105Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  101OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5692 2nationwide survey to evaluate medical utilization  by patients with inguinal hernia and the risk   of developing varicocele in Taiwan Wen-liang liu1,* Yu-An chen2 Yu-Wei lai3,4,* Thomas Y hsueh3,4 shiou-sheng chen3,4 Allen W chiu4 1Taipei Databank for Public health  Analysis, institute of clinical research  and T eaching, Taipei city hospital,   2institute of Preventive Medicine,   national Taiwan University, 3Division  of Urology, Taipei city hospital renai  Branch, 4Department of Urology,   school of Medicine and shu-Tien  Urological institute, national Yang- Ming University, Taipei, Taiwan *These authors are joint first authors correspondence: shiou-sheng chen   Division of Urology, Taipei city   hospital renai Branch, 10 renai street,  section 4, Taipei 106, Taiwan   Tel +88 62 2709 3600 ext 3631   Fax +88 62 2704 5064   email eric.yoyo@msa.hinet.ne tBackground:  The purpose of this study was to analyze age, geographical and seasonal variations  in medical service utilization by patients with inguinal hernia in Taiwan, and the influence of  herniorrhaphy on development of ipsilateral varicocele in male patients.",Non-OADS,/arxiv_data1/oa_pdf/cf/f0/ppa-8-101.PMC3901776.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/cf/f0/ppa-8-101.PMC3901776.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/f0/ppa-8-101.PMC3901776.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/e8/vhrm-10-045.PMC3901777.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 45–48Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  45LetteRopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/VHRM.S5752 9Dabigatran and myocardial infarction:   a foggy scenario Daniele Pontillo1 Nicolino Patruno2 1Division of Cardiology, Hospital  Complex Belcolle, Pavilion  Montefiascone Montefiascone, Italy;   2Division of Cardiology, San Giuseppe  Hospital, Albano Laziale (RM), Italy Correspondence: Daniele Pontillo   Division of Cardiology, Hospital Complex  Belcolle, Pavilion Montefiascone  Montefiascone (VT), 01027, Italy   email daniele.pontillo@gmail.co mDear editor The pooled analysis from Clemens et al1 furnishes an up-to-date contribution on the  scenario of the risk of myocardial infarction (MI) of patients on dabigatran in any  disease setting, formulating a “non-guilty” sentence in favor of dabigatran in terms  of net clinical beneﬁt, even though the authors did ﬁnd an absolute increase in MIs.",Non-OADS,/arxiv_data1/oa_pdf/76/e8/vhrm-10-045.PMC3901777.pdf
"Recently  the FDA has proposed a study that will use data from the  FDA Mini-Sentinel Distributed Database (MSDD) includ - ing nearly 100 million patients to assess systematically the  rates of bleeding and thromboembolic outcomes associated  with the use of dabigatran and warfarin for patients with  atrial ﬁbrillation, and that will furnish additional informa - tion regarding MIs ( http://mini-sentinel.org/assessments/ medical_events/details.aspx?ID=21 9).",Non-OADS,/arxiv_data1/oa_pdf/76/e8/vhrm-10-045.PMC3901777.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/76/e8/vhrm-10-045.PMC3901777.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/e8/vhrm-10-045.PMC3901777.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/10/nss-6-019.PMC3901778.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpNature and Science of Sleep 2014:6 19–26Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  19Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S4475 0Kleine-Levin syndrome: a review Mitchell G Miglis Christian Guilleminault Stanford University Sleep Medicine  Division, Stanford Outpatient Medical  Center, Redwood City, CA, USA Correspondence: Christian Guilleminault   Stanford University Sleep Medicine  Division, Stanford Outpatient   Medical Center, 450 Broadway,   Redwood City 94063, CA, USA   Tel +1 650 723 6601   email cguil@stanford.ed uAbstract:  Kleine-Levin syndrome is a recurrent hypersomnia associated with symptoms of  hyperphagia, hypersexuality, and cognitive impairment.",Non-OADS,/arxiv_data1/oa_pdf/c7/10/nss-6-019.PMC3901778.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/c7/10/nss-6-019.PMC3901778.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/10/nss-6-019.PMC3901778.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/dd/ndt-10-135.PMC3901779.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 135–140Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  135Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4978 4Giant thrombosed intracavernous carotid   artery aneurysm presenting as T olosa–Hunt   syndrome in a patient harboring a new   pathogenic neurofibromatosis type 1 mutation:   a case report and review of the literature renata Conforti1 Mario Cirillo2 Valeria Marrone1 rosario Galasso1 Guglielmo Capaldo3 T eresa Giugliano4 assunta scuotto1 Giulio piluso4 Mariarosa aB Melone3,5 1Neuroradiology Unit, Department  of Clinical and experimental  Medicine and surgery, 2radiology  Unit, Department of Medical,   surgical, Neurological, Metabolic  and aging sciences, 3Division of  Neurology, Department of Clinical  and experimental Medicine and  surgery, 4Department of Biochemistry,   Biophysics and General pathology,   school of Medicine, second University  of Naples, Naples, Italy; 5Institute  of protein Biochemistry, National  research Council, Naples, Italy Correspondence: Mariarosa aB Melone   Division of Neurology, Department   of Clinical and experimental Medicine   and surgery, school of Medicine,   second University of Naples,   Is 8, ed 10, 5 Via sergio pansini,   Naples 80131, Italy   Tel +39 081 566 6810   Fax +39 081 566 6805   email marina.melone@unina2.i tAbstract:  Neurofibromatosis type 1 (NF1) is a relatively common single-gene disorder, and  is caused by heterozygous mutations in the NF1 gene that result in a loss of activity or in a  nonfunctional neurofibromin protein.",Non-OADS,/arxiv_data1/oa_pdf/b6/dd/ndt-10-135.PMC3901779.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b6/dd/ndt-10-135.PMC3901779.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/dd/ndt-10-135.PMC3901779.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/7e/ijn-9-539.PMC3901780.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 539–548International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  539OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4961 6Formulation development and optimization   of palm kernel oil esters-based nanoemulsions  containing sodium diclofenac Malahat rezaee1 Mahiran Basri1,2 raja Noor Zaliha raja  abdul rahman3 abu Bakar salleh3 Naz chaibakhsh4 roghayeh abedi Karjiban2 1Institute of Bioscience, 2Faculty of  science, 3Faculty of Biotechnology and  Biomolecular science, Universiti Putra  Malaysia, serdang, selangor, Malaysia;   4Faculty of science, University of  guilan, rasht, Iran correspondence: Mahiran Basri   Department of chemistry, Faculty of  science, Universiti Putra Malaysia, 43400  UPM serdang, selangor, Malaysia   Tel +603 894 6 7266   Fax +603 894 6 6997   email mahiran@science.upm.edu.m yAbstract:  Response surface methodology was employed to study the effect of formulation  composition variables, water content (60%–80%, w/w) and oil and surfactant (O/S) ratio  (0.17–1.33), as well as high-shear emulsification conditions, mixing rate (300–3,000 rpm) and  mixing time (5–30 minutes) on the properties of sodium diclofenac-loaded palm kernel oil  esters-nanoemulsions.",Non-OADS,/arxiv_data1/oa_pdf/f7/7e/ijn-9-539.PMC3901780.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f7/7e/ijn-9-539.PMC3901780.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/7e/ijn-9-539.PMC3901780.pdf
"Letter from the Editor ro nald Ellis1,* and Eva M. ri edmann2 1se nior Vice President r&d  and ch ief te chnology offi cer; na sVax, Ltd.; ne ss Ziona, is rael; 2Acquisitions Editor; Landes Bioscience; Vienna, Austria *Correspondence to: Ronald Ellis; Email: rellis@landesbioscience.com Submitted: 5/22/12; Accepted: 5/22/12http://dx.doi.org/10.4161/hv.25575",Non-OADS,/arxiv_data1/oa_pdf/7a/5e/hvi-9-1185.PMC3901804.pdf
lancet 2013; 381:1926-32; PMiD:  23643111; http://dx.doi.org/10.1016/s0140- 6736(13)60938-12.,OADS,/arxiv_data1/oa_pdf/64/80/hvi-9-1187.PMC3901805.pdf
Hum Vaccin i mmunother 2013;  9:950-6; http://dx.doi.org/10.4161/hv.24939,Non-OADS,/arxiv_data1/oa_pdf/64/80/hvi-9-1187.PMC3901805.pdf
"clin i nfect Dis 2013; 57:197-204; PMiD:  23580737; http://dx.doi.org/10.1093/cid/cit222 2. salmon DA, et al.",OADS,/arxiv_data1/oa_pdf/64/80/hvi-9-1187.PMC3901805.pdf
2013;4:1590;  PMiD:23481398; http://dx.doi.org/10.1038/ncomms2594sanofi Pasteur MsD‘s pediatric vaccine  Hexyon/Hexacima has recently been approved  by the e uropean c ommission.,Non-OADS,/arxiv_data1/oa_pdf/64/80/hvi-9-1187.PMC3901805.pdf
Proc Natl Acad s ci UsA 2013;  110:9036-41; PMiD:23650354; http://dx.doi.org/10.1073/ pnas.1219159110,OADS,/arxiv_data1/oa_pdf/64/80/hvi-9-1187.PMC3901805.pdf
"Human Vaccines & Immunotherapeutics 9:6, 1228–1233; June 2013; © 2013 Landes Bioscience Case RepoR t 1228 Human Vaccines & Immunotherapeutics Volume 9 Issue 6*Correspondence to: Tetsuya Nakatsura; Email: tnakatsu@east.ncc.go.jp Submitted: 11/05/12; Revised: 01/25/13; Accepted: 03/02/13http://dx.doi.org/10.4161/hv.24179Introduction Cancer vaccine targeting hepatocellular carcinoma (HCC)   tumor antigens have been tested in clinical trials.1,2 However,  cancer vaccines using tumor-antigen-derived peptides have not  demonstrated adequate antitumor efficacy in clinical trials for advanced HCC.",Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Clin Cancer Res 2006; 12:2817-25; PMID:16675576;  http://dx.doi.org/10.1158/1078-0432.CCR-05-2856.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
J Hepatol 2006; 45:868- 78; PMID:17046096; http://dx.doi.org/10.1016/j.jhep.2006.09.004.,OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Biochem Biophys Res Commun  2003; 306:16-25; PMID:12788060; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Gastroenterology 2003; 125:89-97; PMID:12851874;  http://dx.doi.org/10.1016/S0016-5085(03)00689-9.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Cancer Sci 2009; 100:1403-7;  PMID:19496787; http://dx.doi.org/10.1111/j.1349- 7006.2009.01206.x.8.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Clin Cancer Res 2004; 10:8630-40; PMID:15623647;  http://dx.doi.org/10.1158/1078-0432.CCR-04-1177.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Clin Cancer Res 2006; 12:2689-97;  PMID:16675560; http://dx.doi.org/10.1158/1078- 0432.CCR-05-2267.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Cancer Res  2005; 65:6245-54; PMID:16024626; http://dx.doi.org/10.1158/0008-5472.CAN-04-4244.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Cancer Immunol Immunother 2004; 53:249-55;  PMID:14704832; http://dx.doi.org/10.1007/s00262- 003-0473-9.13.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Cancer Sci  2011; 102:918-25; PMID:21281401; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Nat Med  2004; 10:909-15; PMID:15340416; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
Oncoimmunology 2012; 1:1448- 50; PMID:23243625; http://dx.doi.org/10.4161/ onci.21351.,Non-OADS,/arxiv_data1/oa_pdf/a7/9d/hvi-9-1228.PMC3901810.pdf
"Human Vaccines & Immunotherapeutics 9:6, 1234–1236; June 2013; © 2013 Landes Bioscience Commentary 1234 Human Vaccines & Immunotherapeutics Volume 9 Issue 6Keywords:  major histocompatibility  complex class I, cytotoxic T lymphocyte,  cancer immunotherapy, tumor antigen, antigen-derived peptide Abbreviations:  CTL, cytotoxic T lym - phocyte; MHC, major histocompatibility  complex; IFN-γ , interferon- γ; ELISPOT,  enzyme-linked immunospot; HLA, human leukocyte antigen; APC, antigen-presenting cell; TCR, T cell receptor Submitted: 01/31/13Accepted: 02/13/13http://dx.doi.org/10.4161/hv.23990 *Correspondence to: Tetsuya Nakatsura;   Email: tnakatsu@east.ncc.go.jpOne of the problems in antigen-spe - cific cancer immunotherapy is the  low density of the tumor antigen-derived  peptide endogenously presented on tumor cell surface major histocompati - bility complex class I molecules.",Non-OADS,/arxiv_data1/oa_pdf/4d/b6/hvi-9-1234.PMC3901811.pdf
Cancer Sci 2011; 102:918-25; PMID:21281401;  http://dx.doi.org/10.1111/j.1349-7006.2011.01896.x.,Non-OADS,/arxiv_data1/oa_pdf/4d/b6/hvi-9-1234.PMC3901811.pdf
Cancer Immunol Immunother 2012; In  press; PMID:23143746; http://dx.doi.org/10.1007/ s00262-012-1366-6.,Non-OADS,/arxiv_data1/oa_pdf/4d/b6/hvi-9-1234.PMC3901811.pdf
BMC Cancer  2011; 11:454; PMID:22014037; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/b6/hvi-9-1234.PMC3901811.pdf
Pathol Int 2012; 62:303-8;  PMID:22524657; http://dx.doi.org/10.1111/j.1440- 1827.2012.02789.x.Disclosure of Potential Conflicts of Interest No potential conflicts of interest were  disclosed.,OADS,/arxiv_data1/oa_pdf/4d/b6/hvi-9-1234.PMC3901811.pdf
Curr  Opin Immunol 2004; 16:644-50; PMID:15342012;  http://dx.doi.org/10.1016/j.coi.2004.07.015.,OADS,/arxiv_data1/oa_pdf/4d/b6/hvi-9-1234.PMC3901811.pdf
Eur  J Immunol 2010; 40:899-910; PMID:20039301;  http://dx.doi.org/10.1002/eji.200939857.compared with cancer cells (unpublished  data).,OADS,/arxiv_data1/oa_pdf/4d/b6/hvi-9-1234.PMC3901811.pdf
"Hence there is a high level of anxiety concerning the possibility for epidemic disease caused by virulent clones or sporadic disease, which can occur  *Correspondence to: Johan Holst; Email: johan.holst@fhi.no Submitted: 11/30/12; Revised: 02/15/13; Accepted: 02/27/13http://dx.doi.org/10.4161/hv.24129The utility of wild-type outer membrane vesicle (wtOMV)  vaccines against serogroup B (MenB) meningococcal disease has been explored since the 1970s.",Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Exp Med 1913; 17:553-76; PMID:19867668; http://dx.doi.org/10.1084/jem.17.5.553.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Lancet 1999; 353:941-2; PMID:10459897; http://dx.doi.org/10.1016/S0140-6736(98)00279-7.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
FEMS  Microbiol Rev 2007; 31:3-14; PMID:17233633; http://dx.doi.org/10.1111/j.1574-6976.2006.00051.x.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Lancet 2007; 369:2196-210; PMID:17604802; http://dx.doi.org/10.1016/S0140-6736(07)61016-2.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Med Microbiol 2008; 57:1313-21; PMID:18927406; http://dx.doi.org/10.1099/jmm.0.47599-0.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Handb Clin Neurol 2010; 95:417-33; PMID:19892131; http://dx.doi.org/10.1016/S0072-9752(08)02128-3.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Eur J Clin Microbiol Infect Dis 1998; 17:690-4; PMID:9865981; http://dx.doi.org/10.1007/s100960050162.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2001; 19:1327-46; PMID:11163654; http://dx.doi.org/10.1016/S0264-410X(00)00333-9.14.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
N Engl J Med 2006; 355:1466-73; PMID:17021322; http://dx.doi.org/10.1056/NEJMcp063561.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Exp Med 1969; 129:1307-26; PMID:4977280; http://dx.doi.org/10.1084/jem.129.6.1307.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Exp Med 1969; 129:1367-84; PMID:4977283; http://dx.doi.org/10.1084/jem.129.6.1367.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
N Engl J Med 2010; 362:1511-20; PMID:20410516; http://dx.doi.org/10.1056/NEJMra0906357.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Expert Rev Vaccines 2009; 8:729-45; PMID:19485754; http://dx.doi.org/10.1586/erv.09.30.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Hum Vaccin 2011; 7:170-82; PMID:21178398; http://dx.doi.org/10.4161/hv.7.2.13717.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Infect Drug Resist 2011; 4:137-47; PMID:21904459; http://dx.doi.org/10.2147/IDR.S12716.24.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Arch Pediatr Adolesc Med 2005; 159:907-13; PMID:16203934; http://dx.doi.org/10.1001/archpedi.159.10.907.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Health Aff (Millwood) 2011; 30:1049-57; PMID:21653956; http://dx.doi.org/10.1377/hlthaff.2011.0328.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
N Engl J Med 2001; 344:1378-88; PMID:11333996; http://dx.doi.org/10.1056/NEJM200105033441807.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Infect Dis 1972; 126:514-21; PMID:4197754; http://dx.doi.org/10.1093/infdis/126.5.514.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2004; 22:1087-96; PMID:15003635; http://dx.doi.org/10.1016/j.vaccine.2003.10.005.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Clin Infect Dis 2010; 50(Suppl 2):S54-65; PMID:20144017; http://dx.doi.org/10.1086/648966.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Lancet Infect Dis 2010; 10:112-24; PMID:20113980; http://dx.doi.org/10.1016/S1473-3099(09)70324-X.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2009; 27(Suppl 2):B3-12; PMID:19481313; http://dx.doi.org/10.1016/j.vac-cine.2009.04.071.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Clin Infect Dis 2009; 49:597-605; PMID:19622040; http://dx.doi.org/10.1086/603552.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2005; 23:2191-6; PMID:15755593; http://dx.doi.org/10.1016/j.vaccine.2005.01.063.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2007; 25:3075-9; PMID:17289223; http://dx.doi.org/10.1016/j.vac-cine.2007.01.023.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Pediatr Infect Dis J 2007; 26:345-50; PMID:17414400; http://dx.doi.org/10.1097/01.inf.0000258697.05341.2c.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Expert Rev Vaccines 2004; 3:77-87; PMID:14761245; http://dx.doi.org/10.1586/14760584.3.1.77.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2005; 23:2222-7; PMID:15755600; http://dx.doi.org/10.1016/j.vaccine.2005.01.051.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2006; 24:5093-107; PMID:16838413; http://dx.doi.org/10.1016/j.vaccine.2006.03.091.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2005; 23:2218-21; PMID:15755599; http://dx.doi.org/10.1016/j.vac-cine.2005.01.070.48.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
JAMA 1999; 281:1520-7; PMID:10227322; http://dx.doi.org/10.1001/jama.281.16.1520.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
JAMA 1999; 281:1541-3; PMID:10227326; http://dx.doi.org/10.1001/jama.281.16.1541.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Infect Dis 1998; 177:497-500; PMID:9466547; http://dx.doi.org/10.1086/517385.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2005; 23:2197-201; PMID:15755594; http://dx.doi.org/10.1016/j.vaccine.2005.01.061.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2008; 26:5899-904; PMID:18804134; http://dx.doi.org/10.1016/j.vaccine.2008.08.062.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Clin Vaccine Immunol 2006; 13:486-91; PMID:16603616; http://dx.doi.org/10.1128/CVI.13.4.486-491.2006.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2006; 24:1395-400; PMID:16242221; http://dx.doi.org/10.1016/j.vaccine.2005.09.043.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Int J Epidemiol 2009; 38:413-8; PMID:18988650; http://dx.doi.org/10.1093/ije/dyn228.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Arch Dis Child 2009; 94:745-51; PMID:18838420; http://dx.doi.org/10.1136/adc.2007.132571.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 1996; 14:1001-8; PMID:8873395; http://dx.doi.org/10.1016/0264-410X(96)00020-5.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 1999; 17:2612-9; PMID:10418910; http://dx.doi.org/10.1016/S0264-410X(99)00044-4.33.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2005; 23:2202-5; PMID:15755595; http://dx.doi.org/10.1016/j.vac-cine.2005.01.058.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2007; 25:2537-8; PMID:16460845; http://dx.doi.org/10.1016/j.vac-cine.2005.12.059.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Antonie Van Leeuwenhoek 1987; 53:403-11; PMID:3130779; http://dx.doi.org/10.1007/BF00415494.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Infect Dis 1978; 137:728-39; PMID:77885; http://dx.doi.org/10.1093/infdis/137.6.728.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Exp Med 1978; 147:629-44; PMID:416164; http://dx.doi.org/10.1084/jem.147.3.629.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Lancet 1991; 338:1093-6; PMID:1682541; http://dx.doi.org/10.1016/0140-6736(91)91961-S. 44.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2003; 21:734-7; PMID:12531351; http://dx.doi.org/10.1016/S0264-410X(02)00591-1.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Clin Vaccine Immunol 2006; 13:790-6; PMID:16829617; http://dx.doi.org/10.1128/CVI.00047-06.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Infect Dis 1998; 177:683-91; PMID:9498448; http://dx.doi.org/10.1086/514232.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2010; 28:6086-93; PMID:20619376; http://dx.doi.org/10.1016/j.vaccine.2010.06.083.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Paediatr Child Health 2012; 48:193-201; PMID:21996021; http://dx.doi.org/10.1111/j.1440-1754.2010.01969.x.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Lancet Infect Dis 2011; 11:455-63; PMID:21489881; http://dx.doi.org/10.1016/S1473-3099(11)70027-5.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2012; 30:5059-62; PMID:22658929; http://dx.doi.org/10.1016/j.vaccine.2012.05.051.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Infect Dis 2008; 198:262-70; PMID:18505380; http://dx.doi.org/10.1086/589308.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
PLoS Negl T rop Dis 2011; 5:e1302; PMID:21909444; http://dx.doi.org/10.1371/journal.pntd.0001302.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Infect Immun 2005; 73:4070-80; PMID:15972495; http://dx.doi.org/10.1128/IAI.73.7.4070-4080.2005.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2011; 29:1413-20; PMID:21199704; http://dx.doi.org/10.1016/j.vaccine.2010.12.039.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2012; 30:712-21; PMID:22138211; http://dx.doi.org/10.1016/j.vac-cine.2011.11.084.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Clin Vaccine Immunol 2012; 19:659-65; PMID:22461527; http://dx.doi.org/10.1128/CVI.00070-12.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Hum Vaccin 2011; 7:886-90; PMID:21785281; http://dx.doi.org/10.4161/hv.7.8.16086.88.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Expert Opin Biol Ther 2011; 11:969-85; PMID:21615224; http://dx.doi.org/10.1517/14712598.2011.585965.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Expert Rev Vaccines 2011; 10:575-88; PMID:21604979; http://dx.doi.org/10.1586/erv.11.32.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Clin Pract 2012; 9:101-17; http://dx.doi.org/10.2217/cpr.11.128.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Expert Opin Biol Ther 2011; 11:969-85; PMID:21615224; http://dx.doi.org/10.1517/14712598.2011.585965.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
N Engl J Med 2011; 364:2293-304; PMID:21675889; http://dx.doi.org/10.1056/NEJMoa1003812.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2009; 27:2794-803; PMID:19428890; http://dx.doi.org/10.1016/j.vaccine.2009.02.098.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
J Infect Dis 2009; 200:379-89; PMID:19534597; http://dx.doi.org/10.1086/600141.74.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Am J Epidemiol 2007; 166:817-23; PMID:17615088; http://dx.doi.org/10.1093/aje/kwm147.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2011; 29:7100-6; PMID:21803101; http://dx.doi.org/10.1016/j.vaccine.2011.06.120.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Pediatr Infect Dis J 2009; 28:385-90; PMID:19384263; http://dx.doi.org/10.1097/INF .0b013e318195205e.,OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2008; 26:2746-52; PMID:18430496; http://dx.doi.org/10.1016/j.vaccine.2008.03.017.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Hum Vaccin 2007; 3:196-204; PMID:17660718; http://dx.doi.org/10.4161/hv.3.5.4458.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2012; 30(Suppl 2):B57-62; PMID:22607900; http://dx.doi.org/10.1016/j.vac-cine.2011.12.093.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Arch Dis Child 2009; 94:224-6; PMID:18650242; http://dx.doi.org/10.1136/adc.2007.125195.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2008; 26:739-42; PMID:18187240; http://dx.doi.org/10.1016/j.vac-cine.2007.12.001.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
Vaccine 2007; 25:3080-4; PMID:17287053; http://dx.doi.org/10.1016/j.vac-cine.2007.01.022.,Non-OADS,/arxiv_data1/oa_pdf/4f/b0/hvi-9-1241.PMC3901813.pdf
"Human Vaccines & Immunotherapeutics 9:6, 1254–1262; June 2013; © 2013 Landes Bioscience ReseaR cH papeR 1254 Human Vaccines & Immunotherapeutics Volume 9 Issue 6*Correspondence to: Geert Leroux-Roels; Email: geert.lerouxroels@ugent.be Submitted: 10/31/12; Revised: 02/06/13; Accepted: 02/19/13http://dx.doi.org/10.4161/hv.24043Introduction Herpes simplex virus (HSV) types 1 (HSV-1) and 2 (HSV-2)  cause genital herpes.",Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
Bull World Health Organ  2008; 86:805-12; PMID:18949218; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
J Infect Dis 2002; 186(Suppl 1):S3-28;  PMID:12353183; http://dx.doi.org/10.1086/343739.,OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
N Engl J Med 2004; 350:11- 20; PMID:14702423; http://dx.doi.org/10.1056/ NEJMoa035144.,OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
Clin Infect Dis 2005; 40:1271-81;  PMID:15825029; http://dx.doi.org/10.1086/429240.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
N Engl J Med 2012; 366:34-43; PMID:22216840;  http://dx.doi.org/10.1056/NEJMoa1103151.12.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
Arch Virol 1997; 142:1659-71; PMID:9672626;  http://dx.doi.org/10.1007/s007050050187.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
J Med Virol 1989; 27:59- 65; PMID:2466100; http://dx.doi.org/10.1002/ jmv.1890270113.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
J Virol 2000; 74:7196- 203; PMID:10906173; http://dx.doi.org/10.1128/ JVI.74.16.7196-7203.2000.21.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
J Virol 2006; 80:5509-15; PMID:16699031; http://dx.doi.org/10.1128/ JVI.02659-05.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
J Virol  2011; 85:3461-72; PMID:21270160; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
Clin Vaccine Immunol  2008; 15:1638-43; PMID:18784341; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
Future Virol 2012; 7:371-8; PMID:22701511; http://dx.doi.org/10.2217/ fvl.12.22.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
J Immunol Methods  1987; 103:189-94; PMID:3668258; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
Vaccine 1994; 12:812-8; PMID:7975860;  http://dx.doi.org/10.1016/0264-410X(94)90290-9.,Non-OADS,/arxiv_data1/oa_pdf/dc/22/hvi-9-1254.PMC3901814.pdf
"www.landesbioscience.com Human Vaccines & Immunotherapeutics 1263Human Vaccines & Immunotherapeutics 9:6, 1263–1267; June 2013; © 2013 Landes Bioscience Commentary Commentary Keywords:  RSV, vaccination strategy,  immunology, maternal immunization,  infant immunization, risk groups,  seasonality Submitted: 02/08/13Accepted: 02/25/13http://dx.doi.org/10.4161/hv.24096 *Correspondence to: Patricia Kaaijk; Email: patricia.",Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Adv Ther 2011; 28:91-109; PMID:21318606; http://dx.doi.org/10.1007/s12325-010-0100-z.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Open Microbiol J 2011; 5:144-54;  PMID:22262987; http://dx.doi.org/10.2174/187428 5801105010144.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
N Engl J Med 2009; 360:588-98; PMID:19196675; http://dx.doi.org/10.1056/NEJMoa0804877.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Pediatrics 2004; 114:e437- 44; PMID:15466069; http://dx.doi.org/10.1542/ peds.2004-0049.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Gen Virol 1985; 66:2111-24; PMID:2413163; http://dx.doi.org/10.1099/0022-1317-66-10-2111.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Clin  Microbiol Rev 2000; 13:1-15; PMID:10627488;  http://dx.doi.org/10.1128/CMR.13.1.1-15.2000.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Infect Dis 1991; 163:693-8; PMID:2010624; http://dx.doi.org/10.1093/ infdis/163.4.693.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Pediatr Infect Dis J 2003;  22(Suppl):S94-9; PMID:12671459; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Am J Epidemiol 2012; 176:794-802; PMID:23059788; http://dx.doi.org/10.1093/aje/ k ws257.immune response.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Virus Res 2011; 162:80- 99; PMID:21963675; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Open Microbiol J 2011; 5:135-43; PMID:22262986;  http://dx.doi.org/10.2174/1874285801105010135.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
JAMA 2003; 289:179-86;  PMID:12517228; http://dx.doi.org/10.1001/jama.289.2.179.may be unprotected during the most vul - nerable early months after birth.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Med Virol 1981; 7:263- 71; PMID:7038043; http://dx.doi.org/10.1002/ jmv.1890070403.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Pediatr 2009; 154:296-8; PMID:19150677; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Med Virol 1997; 52:97- 104; PMID:9131465; http://dx.doi.org/10.1002/ (SICI)1096-9071(199705)52:1<97::AID- JMV16>3.0.CO;2-Y.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Infect Dis  2008; 198:1007-15; PMID:18702606; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Med Virol 1986; 20:79-87; PMID:3760842; http://dx.doi.org/10.1002/jmv.1890200110.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Pediatr Infect Dis J 2003; 22:563-4; PMID:12828155; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
"Am J Obstet Gynecol 2011;  204:146, e1-7; PMID:20965490; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Clin Infect Dis 2011; 52:157-62; PMID:21288837;  http://dx.doi.org/10.1093/cid/ciq001.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Clin Ther  2010; 32:1479-95; PMID:20728761; http://dx.doi.org/10.1016/j.clinthera.2010.07.017.31.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Vaccine 2003; 21:2448-60; PMID:12744878; http://dx.doi.org/10.1016/S0264-410X(03)00098-7.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Infect Dis 2001; 184:1456-60; PMID:11709789;  http://dx.doi.org/10.1086/324426.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Infect Dis 2008; 198:1317-26; PMID:18855558;  http://dx.doi.org/10.1086/592168.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Vaccine 2009; 27:5913-9; PMID:19651171; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Expert Rev Vaccines 2011; 10:1415-33; PMID:21988307; http://dx.doi.org/10.1586/ erv.11.120.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Future Microbiol 2010; 5:585-602;  PMID:20353300; http://dx.doi.org/10.2217/ fmb.10.22.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Virol J 2010; 7:114; PMID:20525213;  http://dx.doi.org/10.1186/1743-422X-7-114.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Vaccine 2003; 21:3647-52; PMID:12922094; http://dx.doi.org/10.1016/S0264-410X(03)00426-2.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Virol 2000; 74:9317-21; PMID:10982380; http://dx.doi.org/10.1128/ JVI.74.19.9317-9321.2000.19.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Biologics 2008; 2:433-9;  PMID:19707374; http://dx.doi.org/10.2147/BTT.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Vaccine 2003; 21:3479-82;  PMID:12850364; http://dx.doi.org/10.1016/S0264- 410X(03)00355-4.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Immunol 2010; 185:6489-98; PMID:20971927;  http://dx.doi.org/10.4049/jimmunol.1002645.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
J Pediatr 1980; 96:179-86;  PMID:6243354; http://dx.doi.org/10.1016/S0022- 3476(80)80799-2.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Vaccine 2007; 25:7372-8; PMID:17868959; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
Pediatr Infect Dis J 2009; 28:655-8; PMID:19483659; http://dx.doi.org/10.1097/ INF.0b013e318199c3b1.,OADS,/arxiv_data1/oa_pdf/5f/58/hvi-9-1263.PMC3901815.pdf
"Human Vaccines & Immunotherapeutics 9:6, 1308–1315; June 2013; © 2013 Landes Bioscience ReseaR cH papeR 1308 Human Vaccines & Immunotherapeutics Volume 9 Issue 6*Correspondence to: Li-Min Huang; Email: lmhuang@ntu.edu.tw Submitted: 11/29/12; Revised: 02/06/13; Accepted: 02/18/13http://dx.doi.org/10.4161/hv.24035Introduction Measles, mumps, rubella and varicella are viral diseases associ - ated with significant morbidity and mortality in children and  sometimes linked with potentially life-threatening complica - tions.1-4 Effective vaccination strategies coupled with sustained  high vaccination coverage can reduce the risk of transmission of such highly infectious viruses.",Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Pediatr Infect Dis J 2007; 26:632-8; PMID:17596807;  http://dx.doi.org/10.1097/INF .0b013e3180616c8f.7.,OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Vaccine 2009; 27:6504-11;  PMID:19665608; http://dx.doi.org/10.1016/j.vac- cine.2009.07.076.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Arch Dis Child 2008; 93:845-50; PMID:18456699;  http://dx.doi.org/10.1136/adc.2007.126243.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Pediatrics 2011; 128:214- 20; PMID:21788222; http://dx.doi.org/10.1542/ peds.2010-3385.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Med Hyg  (Geneve) 2010; 82:40-4; http://dx.doi.org/10.4269/ajtmh.2010.09-0302.11.,OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
BMC Infect Dis 2011; 11:352;  PMID:22176638; http://dx.doi.org/10.1186/1471- 2334-11-352.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Vaccine 2011; 29:2756-60;  PMID:21315697; http://dx.doi.org/10.1016/j.vac- cine.2011.01.092.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
J Formos Med Assoc  2009; 108:267-9; PMID:19369172; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Pediatrics 2011; 128:630- 2; PMID:21873692; http://dx.doi.org/10.1542/ peds.2011-1968.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
N Engl J Med 1992; 327:1122- 7; PMID:1528207; http://dx.doi.org/10.1056/ NEJM199210153271603.,OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Clin Infect Dis  2009; 48:849-55; PMID:19239351; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Vaccine 2009; 27:4656-61;  PMID:19520201; http://dx.doi.org/10.1016/j.vac- cine.2009.05.056.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Pediatrics 2010; 126:e1- 8; PMID:20587679; http://dx.doi.org/10.1542/ peds.2010-0665.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Pediatr Infect Dis J 2012; 31:e133-40; PMID:22622699; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Pediatr Infect Dis  J 2004; 23:379-89; PMID:15131459; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Vaccine 2002; 21:281-9; PMID:12450703;  http://dx.doi.org/10.1016/S0264-410X(02)00459-0.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Pediatr Infect  Dis J 2006; 25:12-8; PMID:16395096; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Pediatr Infect Dis J 2008; 27:724- 30; PMID:18600190; http://dx.doi.org/10.1097/ INF .0b013e318170bb22.,OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
Vaccine 2011; 29:3842-9;  PMID:21382484; http://dx.doi.org/10.1016/j.vac- cine.2011.02.067.,Non-OADS,/arxiv_data1/oa_pdf/83/93/hvi-9-1308.PMC3901822.pdf
"The objective of our review was to provide an overview of the epidemiology of meningococcal  disease in North America during the last half century and portray how it has evolved over time, particularly in response to the differ - ent vaccination strategies employed by the US and Canada, rather than focus on the contemporary situation in each country.Reply letter car men Baccarini,1,* and rew ter nouth,2 Heather Wieffer2 and an drew Vyse3 1Glaxo sm ithKline Vaccines; King of pr ussia, pa  Us a; 2Heron Evidence de velopment Ltd; Luton, UK; 3Glaxo sm ithKline Vaccines; Wavre, Belgium Keywords: Literature review, Neisseria meningitidis, North America, epidemiology, meningococcal disease *Correspondence to: Carmen Baccarini; carmen.i.baccarini@gsk.com Submitted: 02/15/13; Accepted: 02/23/13http://dx.doi.org/10.4161/hv.24087Reply to: Bettinger JA, Scheifele DW, Halperin SA, Vaudry W, Le Saux N. Response to the changing epidemiology of meningococcal disease in North America 1945—2010.",Non-OADS,/arxiv_data1/oa_pdf/e5/92/hvi-9-1325.PMC3901825.pdf
Human Vaccines & Immunotherapeutics 2013; 9:1323 - 1324; PMID: 23454840; http://dx.doi.org/10.4161/hv.24009Reference 1.,Non-OADS,/arxiv_data1/oa_pdf/e5/92/hvi-9-1325.PMC3901825.pdf
Hum Vaccin Immunother 2013; 9:1323 - 1324; PMID: 23454840; http://dx.doi.org/10.4161/hv.24009,Non-OADS,/arxiv_data1/oa_pdf/e5/92/hvi-9-1325.PMC3901825.pdf
"Ms Joanne Yarwood addressed prenatal immunization and Keywords:  immunization, vaccine,   vaccination, immunity Submitted: 05/26/13Accepted: 05/26/13http://dx.doi.org/10.4161/hv.25257 *Correspondence to: David Baxter;   Email: baxter@nhs.net; and Martin J. Guppy;  Email: guppy@btinternet.com",Non-OADS,/arxiv_data1/oa_pdf/60/88/hvi-9-1358.PMC3901830.pdf
"Human Vaccines & Immunotherapeutics 9:6, 1360–1363; June 2013; © 2013 Landes Bioscience SpecIaL  FocuS  ReVIew 1360 Human Vaccines & Immunotherapeutics Volume 9 Issue 6Correspondence to: David Baxter; Email: baxter@nhs.net Submitted: 04/15/13; Accepted: 04/15/13http://dx.doi.org/10.4161/hv.25525For the 2010/11 influenza season the prenatal vaccination  program was extended to all women in e ngland and w ales  irrespective of gestational age—this was a considerable  shift in practice for both pregnant women and healthcare  providers where the emphasis previously had been only on targeted vaccination for pregnant women with adverse risk factors for influenza infection.",Non-OADS,/arxiv_data1/oa_pdf/74/10/hvi-9-1360.PMC3901831.pdf
Available from URL: http://www.nice.org.uk/ nicemedia/pdf/CG062NICEguideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/74/10/hvi-9-1360.PMC3901831.pdf
Am J Obstet  Gynecol 2012; 207(Suppl):S75-7;  pMID:22920064 ;  http://dx.doi.org/10.1016/j.ajog.2012.06.0785.,Non-OADS,/arxiv_data1/oa_pdf/74/10/hvi-9-1360.PMC3901831.pdf
Vaccine   2012 ; 30:5661 -5; pMID:22781306 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/10/hvi-9-1360.PMC3901831.pdf
Aust N Z J Obstet Gynaecol 2012 ;  52:334-41; p MID:22486173 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/10/hvi-9-1360.PMC3901831.pdf
Am J Obstet  Gynecol  2012 ; 207(Suppl ):S67-74; pMID:22920063 ;  http://dx.doi.org/10.1016/j.ajog.2012.06.0778.,Non-OADS,/arxiv_data1/oa_pdf/74/10/hvi-9-1360.PMC3901831.pdf
Gene Ontology Classifications in the MGI  (http://www.informatics.jax.org/) suggest that FANK1 has DNA binding activity and is involved  in DNA - dependent transcription.,Non-OADS,/arxiv_data1/oa_pdf/c4/ae/AJA-16-124.PMC3901870.pdf
Available from: http://www.epa.gov/opptintr/existingchemicals/pubs/ tscainventory/basic.html.,OADS,/arxiv_data1/oa_pdf/ae/05/AJA-16-23.PMC3901877.pdf
Available from: http://ec.europa.eu/environment/chemicals/reach/pdf/2007_02_ reach_in_brief.pdf [Last accessed on 2013 Jul 17].,Non-OADS,/arxiv_data1/oa_pdf/ae/05/AJA-16-23.PMC3901877.pdf
Available from: http://ec.europa.eu/environment/chemicals/ reach/reach_intro.htm.,Non-OADS,/arxiv_data1/oa_pdf/ae/05/AJA-16-23.PMC3901877.pdf
Available from: http://www.cdph.ca.gov/programs/hesis/ Documents/introtoxsubstances.pdf [Last accessed on 2013 Aug 15].,OADS,/arxiv_data1/oa_pdf/ae/05/AJA-16-23.PMC3901877.pdf
p. 296  Available from: http://www.who.int/mediacentre/news/releases/2013/hormone_ disrupting_20130219/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/2d/17/AJA-16-60.PMC3901883.pdf
Available from: http://www.federal reserve.,Non-OADS,/arxiv_data1/oa_pdf/2d/17/AJA-16-60.PMC3901883.pdf
Available from: http://www.who.int/ceh/publications/endocrine_disrupters_child/ en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/2d/17/AJA-16-60.PMC3901883.pdf
Available from: http://search.oecd.org/ officialdocuments/displaydocumentpdf/?cote=env/jm/mono (2012) 22 and  doclanguage=en.,OADS,/arxiv_data1/oa_pdf/2d/17/AJA-16-60.PMC3901883.pdf
"ACKNOWLEDGMENTS DA is grateful to ICI Plc and MAFF (Ministry of Agriculture Fisheries and  Food) for the animal studies she conducted in the 1980s and 1990s and  more recently to the European Union Integrated Project New Generis,  6th Framework Programme, Priority 5: food Quality and Safety, contract  FOOD-CT -2005-016320 (http://www.newgeneris.org), for the mother, father  and baby triad study.",Non-OADS,/arxiv_data1/oa_pdf/16/11/AJA-16-81.PMC3901885.pdf
"JAK-STAT 2013; 2:e25666; http://dx.doi.org/10.4161/jkst.25666Introduction The signal transducer and activator of transcription (STAT)  proteins are a family of transcription factors which have been  shown to be involved in many cellular functions including tumorigenesis, apoptosis, cell proliferation, development, and autophagy.",OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
T rends  Cell Biol 1998; 8:97-8; PMID:9695817; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
J  Biol Chem 2010; 285:28715-22; PMID:20592027; http://dx.doi.org/10.1074/jbc.M110.133355 4.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
EMBO J 1998; 17:5321-33; PMID:9736611;  http://dx.doi.org/10.1093/emboj/17.18.5321 8.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Science 1995; 269:81-3; PMID:7541555;  http://dx.doi.org/10.1126/science.754155511.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Immunity 2012; 36:503-14; PMID:22520844;  http://dx.doi.org/10.1016/j.immuni.2012.03.013 12.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Int J Cardiol 1997; 58:95-117;  PMID:9049675; http://dx.doi.org/10.1016/S0167-5273(96)02854-9 13.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Nat Med 2011; 17:1391- 401; PMID:22064429; http://dx.doi.org/10.1038/nm.2507 14.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Basic Res Cardiol 2010; 105:771-85;  PMID:20960209; http://dx.doi.org/10.1007/s00395- 010-0124-1 15.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Am  J Physiol Heart Circ Physiol 2006; 290:H2024-34;  PMID:16399872; http://dx.doi.org/10.1152/ajp- heart.00683.2005 43.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Antioxid Redox Signal  2012; 17:794-802; PMID:22077334; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Mol Cell  2009; 33:505-16; PMID:19250911; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
EMBO  J 2011; 30:1195-208; PMID:21358617; http://dx.doi.org/10.1038/emboj.2011.49 48.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
J Biol Chem 2013; 288:915- 26; PMID:23152496; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Heart Fail Rev 2012; In press;  PMID:23188163; http://dx.doi.org/10.1007/s10741- 012-9367-2 50.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Cardiovasc  Res 2004; 63:611-6; PMID:15306216; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Circulation 2001; 104:253- 6; PMID:11457740; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Am J Med 1991; 91(3C):79S-85S; PMID:1928216; http://dx.doi.org/10.1016/0002- 9343(91)90288-9 30.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
J Clin Invest 1985; 76:1713- 9; PMID:4056048; http://dx.doi.org/10.1172/ JCI112160 31.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Science 2009; 323:793-7;  PMID:19131594; http://dx.doi.org/10.1126/sci- ence.1164551 33.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Autophagy 2011; 7:279- 96; PMID:21189453; http://dx.doi.org/10.4161/ auto.7.3.14487 34.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
J Biol Chem  2008; 283:22847-57; PMID:18524774; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
J Biol Chem 2007; 282:24131-45; PMID:17580304; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Mol Cell 2012; 48:329-42;  PMID:23022382; http://dx.doi.org/10.1016/j.mol- cel.2012.08.024 38.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Cell Death Differ 2002; 9:1140-6; PMID:12232802;  http://dx.doi.org/10.1038/sj.cdd.4401082 17.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
J Biol Chem 2000; 275:10002- 8; PMID:10744676; http://dx.doi.org/10.1074/ jbc.275.14.10002 18.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
FASEB J  2006; 20:2115-7; PMID:16935931; http://dx.doi.org/10.1096/fj.06-6188fje 19.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
J Cell Mol Med 2012; 16:386-93;  PMID:21447043; http://dx.doi.org/10.1111/j.1582- 4934.2011.01323.x 20.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
J Cell Biol 2002; 157:455- 68; PMID:11980920; http://dx.doi.org/10.1083/ jcb.200109094 24.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Autophagy 2009; 5:720-2; PMID:19395874;  http://dx.doi.org/10.4161/auto.5.5.8625 25.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
EMBO Rep 2009; 10:285-92; PMID:19180116; http://dx.doi.org/10.1038/embor.2008.246 26.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
EMBO J 2000; 19:5720- 8; PMID:11060023; http://dx.doi.org/10.1093/ emboj/19.21.5720 27.,Non-OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
J Cell Biol  1999; 147:435-46; PMID:10525546; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
Circ Res  2012; 111:1208-21; PMID:23065344; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/67/jkst-2-e25666.PMC3902047.pdf
"OncoImmunology 2013; 2:e26853; http://dx.doi.org/10.4161/onci.26853Targeting inflammatory cytokines-androgen  receptor (AR) signaling with ASC-J9® to better  battle prostate cancer progression Kouji Izumi1,2 and Chawnshang Chang1,3,* 1Departments of Pathology, u rology, r adiation Oncology, and The w ilmot Cancer Center; u niversity of r ochester Medical Center; r ochester, N y usa ;   2Department of Integrative Cancer Therapy and u rology; Kanazawa u niversity; Kanazawa, Japan;   3sex h ormone r esearch Center; China Medical u niversity and h ospital; Taichung, Taiwan Keywords:  inflammatory cytokines, androgen receptor, prostate cancer, macrophage, tumorigenesis, metastasis Inflammatory cytokines and chemokines released by macrophages in the prostate cancer microenvironment may  signal via the androgen receptor ( ar) to influence tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/85/d0/onci-2-e26853.PMC3902114.pdf
CA Cancer J Clin 2013; 63:11-30;  PMID:23335087 ; http://dx.doi.org/10.3322/ caac.21166 2.,Non-OADS,/arxiv_data1/oa_pdf/85/d0/onci-2-e26853.PMC3902114.pdf
Proc Natl Acad Sci U S A 2008; 105:12182- 7; PMID:18723679 ; http://dx.doi.org/10.1073/ pnas.0804700105 3.,OADS,/arxiv_data1/oa_pdf/85/d0/onci-2-e26853.PMC3902114.pdf
J Clin Invest 2009; 119:3739-51;  PMID:19907077 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/d0/onci-2-e26853.PMC3902114.pdf
EMBO Mol Med  2013; 5:1383-401;  PMID:23982944 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/d0/onci-2-e26853.PMC3902114.pdf
Lancet 2000; 355:1491-8;  PMID:10801170 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/d0/onci-2-e26853.PMC3902114.pdf
N Engl J Med 2012; 367:1187-97; PMID:22894553 ;  http://dx.doi.org/10.1056/NEJMoa12075069.,OADS,/arxiv_data1/oa_pdf/85/d0/onci-2-e26853.PMC3902114.pdf
Cell Death Dis 2013; 4:e764; PMID:23928703 ;  http://dx.doi.org/10.1038/cddis.2013.270 10.,Non-OADS,/arxiv_data1/oa_pdf/85/d0/onci-2-e26853.PMC3902114.pdf
Am J Pathol 2013; 182:1942- 9; PMID:23570837 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/d0/onci-2-e26853.PMC3902114.pdf
"OncoImmunology 2013; 2:e26937; http://dx.doi.org/10.4161/onci.26937Attacking malignant cells that survive therapy Exploiting immunogenic modulation James w  hodge*, a nna Kwilas, a ndressa a rdiani, and s ofia r  Gameiro Laboratory of Tumor Immunology and Biology; Center for Cancer r esearch; National Cancer Institute; National Institutes of h ealth; Bethesda, MD usa Keywords:  antigen-processing machinery, calreticulin, CTL-mediated lysis, immu - nogenic modulation, immunotherapy, therapeutic cancer vaccine we have recently defined “immunogenic modulation,” a mechanism whereby malignant cells that survive anticancer  therapy, due to sublethal delivery or development of treatment resistance, become nonetheless more sensitive to killing  by cytotoxic T lymphocytes.",Non-OADS,/arxiv_data1/oa_pdf/75/1c/onci-2-e26937.PMC3902115.pdf
Semin Oncol 2012; 39:323- 39; PMID:22595055 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/75/1c/onci-2-e26937.PMC3902115.pdf
Annu Rev Immunol 2013 ; 31:51-72;  PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008 3.,Non-OADS,/arxiv_data1/oa_pdf/75/1c/onci-2-e26937.PMC3902115.pdf
Cancer Immunol Immunother  2011 ;  60:1227 -42; PMID:21544650 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/1c/onci-2-e26937.PMC3902115.pdf
PLoS One   2013 ; 8:e70417 ; PMID:23894654 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/1c/onci-2-e26937.PMC3902115.pdf
Int J Cancer 2013 ; 133:624- 36; PMID:23364915 ; http://dx.doi.org/10.1002/ ijc.28070 7.,Non-OADS,/arxiv_data1/oa_pdf/75/1c/onci-2-e26937.PMC3902115.pdf
J Exp Med 2006 ; 203:1259 - 71; PMID:16636135 ; http://dx.doi.org/10.1084/ jem.20052494,Non-OADS,/arxiv_data1/oa_pdf/75/1c/onci-2-e26937.PMC3902115.pdf
Immunol Invest  2006 ;  35:485-503; PMID:16916763 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/1c/onci-2-e26937.PMC3902115.pdf
"OncoImmunology 2013; 2:e27058;http://dx.doi.org/10.4161/onci.27058Combining low-dose or metronomic  chemotherapy with anticancer vaccines A therapeutic opportunity for lymphomas Heng Sheng Sow and Stephen r  Mattarollo* The University of Queensland Diamantina Institute; The University of Queensland; Translational r esearch Institute; Brisbane, australia Keywords:  anticancer vaccines, immunotherapy, metronomic chemotherapy, low-dose chemotherapy, lymphoma Abbreviations: CTL, cytotoxic T lymphocytes; DC, dendritic cell; NHL, non-Hodgkin’s lymphoma;   MDSC, myeloid-derived suppressor cell; MTD, maximal tolerated dose; THBS1, thrombospondin 1; Treg, regulatory T cell;  VEGF, vascular endothelial growth factor Therapeutic vaccination is regarded as a promising strat - egy against multiple hematological malignancies including  lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Lancet 2012; 380:848-57;  PMID:22835603 ; http://dx.doi.org/10.1016/ S0140-6736(12)60605-9 2.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Blood Rev 2005; 19:165-78;  PMID:15748964 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Blood  2005; 106:3725-32;  PMID:16123223 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Ann Hematol 2012; 91:561- 70; PMID:22200972 ; http://dx.doi.org/10.1007/ s00277-011-1361-6 5.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Nat Rev Cancer 2005; 5:516-25; PMID :15965493 ;  http://dx.doi.org/10.1038/nrc1650 6.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Lancet Oncol 2001; 2:733- 40; PMID :11902515 ; http://dx.doi.org/10.1016/ S1470-2045(01)00587-3 7.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Immunol Immunother 2008; 57:1579-87;  PMID:18369619 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Br J Haematol 2002; 119:417-24;  PMID:12406080 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Br J Cancer  2010; 102:115-23;  PMID:19997099 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Res 2011; 71:768-78; PMID:21156650 ;  http://dx.doi.org/10.1158/0008-5472.CAN-10-278814.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Res  2010; 70:855-8;  PMID:20086177 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
J Clin Invest 2010; 120:1111-24;  PMID:20234093 ; http://dx.doi.org/10.1172/ JCI40269 16.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Br J Dermatol 2000; 143:313-9;  PMID:10951138 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Sci 2007; 98:1969-76; PMID:17922852 ;  http://dx.doi.org/10.1111/j.1349-7006.2007.00632.x 20.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Int J Cancer 2006; 119:1630-7; PMID:16646079 ; http://dx.doi.org/10.1002/ ijc.22019 21.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
"Prostate Cancer Prostatic Dis 2005; 8:274-9; PMID:15897917 ; http://dx.doi.org/10.1038/ sj.pcan.4500798 22. van der Most RG, Currie AJ, Cleaver AL, Salmons  J, Nowak AK, Mahendran S, Larma I, Prosser A,  Robinson BWS, Smyth MJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
PLoS One  2009; 4:e6982;  PMID :19746156 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Oncogene 2008; 27:5932- 43; PMID:18836474 ; http://dx.doi.org/10.1038/ onc.2008.267 24.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Br J Haematol 1999; 104:144-51; PMID:10027727 ;  http://dx.doi.org/10.1046/j.1365-2141.1999.01129.x 25.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
the journal of the  American Society of Gene Therapy 2013; 21:895- 903; http://dx.doi.org/10.1038/mt.2013.1426.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Blood 2012; 119:1479- 89; PMID:22167753 ; http://dx.doi.org/10.1182/ blood-2011-07-370841 27.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Nature 2002; 419:734-8;  PMID:12384702 ; http://dx.doi.org/10.1038/ nature01112 28.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
J Invest Dermatol  2013; 133:499-508;  PMID:22951720 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Blood 2009; 113:3503-11;  PMID:19098271 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Int Immunopharmacol  2005; 5:1057-67;  PMID :15829421 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cytokine 2008; 42:128- 36; PMID:18280748 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Clin Cancer Res  2007; 13:644-53;  PMID:17255288 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cell 2000; 101:455- 8; PMID:10850488 ; http://dx.doi.org/10.1016/ S0092-8674(00)80856-9,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Science 2008; 322:271-5; PMID:18845758 ;  http://dx.doi.org/10.1126/science.1160062 39.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Eur J Immunol 2010; 40:1011- 21; PMID:20127675 ; http://dx.doi.org/10.1002/ eji.200939513 40.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
J Exp Med  2005; 202:1075-85;  PMID:16230475 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Blood 2008; 111:5359- 70; PMID:18305220 ; http://dx.doi.org/10.1182/ blood-2007-08-105395 43.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cell Mol Immunol 2012; 9:482-8; PMID:23000689 ; http://dx.doi.org/10.1038/ cmi.2012.34 44.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Immunol Immunother  2010; 59:769-77;  PMID:19940990 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Nat Immunol  2013; 14:211-20;  PMID:23354483 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Int Immunopharmacol 2011; 11:802-7;  PMID:21237299 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
J Leukoc Biol 2011; 89:311- 7; PMID:21106641 ; http://dx.doi.org/10.1189/ jlb.031016251.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
J Transl Med 2013; 11:16; PMID:23320561 ;  http://dx.doi.org/10.1186/1479-5876-11-16 52.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Res 2008; 68:5439-49;  PMID:18593947 ; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6621 53.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
J Immunol 2012; 189:5602- 11; PMID:23152559 ; http://dx.doi.org/10.4049/ jimmunol.1201018 54.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
J Oncol 2010;  2010:201026;  PMID:20490273 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Blood 2011; 117:872-81; PMID:21063024 ;  http://dx.doi.org/10.1182/blood-2010-05-283820 56.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Int Immunopharmacol  2009; 9:900-9;  PMID:19336265 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Res 2010; 70:3052-61;  PMID:20388795 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-3690 59.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Immunol Immunother 2013; 62:383- 91; PMID:22926062 ; http://dx.doi.org/10.1007/ s00262-012-1343-0 60.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Immunity 2013; 38:729- 41; PMID:23562161 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Res 2004; 64:1570-4;  PMID:14996710 ; http://dx.doi.org/10.1158/0008- 5472.CAN-03-3126 64.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Proc Natl Acad Sci U S A 2003; 100:12917-22;  PMID:14561896 ; http://dx.doi.org/10.1073/ pnas.2135406100 65.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Ann Oncol 2013; 24:2310-6;  PMID:23666914 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Int J Exp Pathol 2010; 91:10-6;  PMID:20096070 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Ann Oncol 2000;  11:857-60;  PMID:10997814 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Clin Cancer Res  2006; 12:3092-8;  PMID:16707607 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Immunol Immunother  2007; 56:641-8;  PMID:16960692 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Blood 2009; 113:18- 27; PMID:18809757 ; http://dx.doi.org/10.1182/ blood-2008-06-165654,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
J Clin Oncol 2011; 29:2787-94; PMID:21632504 ; http://dx.doi.org/10.1200/ JCO.2010.33.3005 75.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Cancer Res 2005; 65:5958-64;  PMID:15994975 ; http://dx.doi.org/10.1158/0008- 5472.CAN-05-0406 76.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Blood 2012; 120:3019- 29; PMID:22932803 ; http://dx.doi.org/10.1182/ blood-2012-04-426643 78.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
J Clin Oncol 2009; 27:5911-8; PMID:19805669 ; http://dx.doi.org/10.1200/ JCO.2009.23.349479.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Int J Breast Cancer 2011;  2011:710292;  PMID:22295231 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
Oncoimmunology  2013; 2:e22664;  PMID:23482679 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/6d/onci-2-e27058.PMC3902116.pdf
"OncoImmunology 2013; 2:e26620; http://dx.doi.org/10.4161/onci.26620Modifying tumor-associated macrophages An important adjunct to immunotherapy Zvi G Fridlender1,2,* and s teven M a lbelda2 1Institute of Pulmonary Medicine; h adassah- hebrew u niversity Medical Center; Jerusalem, Israel;   2Thoracic Oncology r esearch Laboratory; u niversity of Pennsylvania; Philadelphia, P a usa Keywords:  tumor associated macrophages, immunotherapy, lung cancer, DMXAA, vaccines The therapeutic success of immunotherapy requires specific alterations of the tumor microenvironment and/or the  inhibition of tumor-elicited immunosuppression.",Non-OADS,/arxiv_data1/oa_pdf/7a/45/onci-2-e26620.PMC3902117.pdf
CA Cancer J Clin 2012; 62:309- 35; PMID:22576456 ; http://dx.doi.org/10.3322/ caac.20132 2.,Non-OADS,/arxiv_data1/oa_pdf/7a/45/onci-2-e26620.PMC3902117.pdf
N Engl J Med 2008 ;  358:2704 -15; PMID:18565863 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7a/45/onci-2-e26620.PMC3902117.pdf
Expert Opin Ther Targets 2007 ;  11:1219 -29; PMID:17845147 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7a/45/onci-2-e26620.PMC3902117.pdf
Cancer Res 2005 ; 65:11752 -61;  PMID:16357188 ; http://dx.doi.org/10.1158/0008- 5472.CAN-05-1658 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/45/onci-2-e26620.PMC3902117.pdf
Br J Cancer  2013 ; 108:1288 -97; PMID:23481183 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7a/45/onci-2-e26620.PMC3902117.pdf
Br J Cancer 2012 ;  106:1134 -47; PMID :22415295 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7a/45/onci-2-e26620.PMC3902117.pdf
J Clin Oncol 2011 ; 29:2965 -71; PMID:21709202 ;  http://dx.doi.org/10.1200/JCO.2011.35.0660 9.,Non-OADS,/arxiv_data1/oa_pdf/7a/45/onci-2-e26620.PMC3902117.pdf
J Immunol   2013 ; 190:5216 -25; PMID:23585680 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7a/45/onci-2-e26620.PMC3902117.pdf
"OncoImmunology 2013; 2:e26617; http://dx.doi.org/10.4161/onci.26617Role of TH17 cytokines in the control   of colorectal cancer Veronica De Simone, Francesco Pallone, Giovanni Monteleone, and Carmine Stolfi* Department of Systems Medicine; University of Tor Vergata; r ome, Italy Keywords:  anti-cytokine therapy, colitis-associated colon cancer, IL-17A, IL-17F, IL-21, IL-22, inflammation,   NFκB, STAT3, TH17 cells Immune/inflammatory cells infiltrate almost all human  solid tumors and affect all stages of carcinogenesis as they  produce different cytokine subsets.",Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
CA Cancer J Clin  2009; 59:366-78;  PMID:19897840 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cancer   2001 ; 91:854-62; PMID:11241255 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Oncoimmunology   2012 ; 1:717-25; PMID:22934263 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Int J Mol Sci  2012 ; 13:11071 -84; PMID:23109839 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Science  2006 ; 313:1960 - 4; PMID:17008531 ; http://dx.doi.org/10.1126/ science.1129139 8.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Nat Rev Cancer 2012 ; 12:298- 306; PMID:22419253 ; http://dx.doi.org/10.1038/ nrc3245 9.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cancer Res 2011 ; 71:5601 -5; PMID:21846822 ;  http://dx.doi.org/10.1158/0008-5472.CAN-11-1316 10.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cell 2006 ; 126:1121 -33;  PMID:16990136 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cytokine Growth Factor Rev 2010 ; 21:393-401;  PMID:20947410 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cytokine Growth Factor Rev 2010 ; 21:365-79;  PMID:20870448 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Annu Rev Immunol 2008 ; 26:57- 79; PMID:17953510 ; http://dx.doi.org/10.1146/ annurev.immunol.26.021607.090316 16.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
N Engl J Med 2009 ; 361:888- 98; PMID:19710487 ; http://dx.doi.org/10.1056/ NEJMra0707449 17.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Immunity  2008 ; 28:29- 39; PMID:18164222 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Nat Immunol  2008 ; 9:1297 - 306; PMID:18849990 ; http://dx.doi.org/10.1038/ ni.1663 19.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Nat Immunol  2007 ; 8:967-74;  PMID :17581537 ; http://dx.doi.org/10.1038/ni148820.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Nature  2008 ; 454:350- 2; PMID:18469800 ; http://dx.doi.org/10.1038/ nature07021 21.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Nat Immunol  2007 ; 8:942-9;  PMID:17676045 ; http://dx.doi.org/10.1038/ni1496 22.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Nat Immunol  2010 ; 11:674-80; PMID:20644573 ;  http://dx.doi.org/10.1038/ni.1899 23.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Curr  Opin Immunol  2009 ; 21:274-80; PMID:19524429 ;  http://dx.doi.org/10.1016/j.coi.2009.05.021 24.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Immunol Rev  2008 ;  223:87-113; PMID:18613831 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Oncoimmunology  2012 ; 1:1438 - 9; PMID:23243621 ; http://dx.doi.org/10.4161/ onci.21245 26.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Carcinogenesis  2011 ; 32:643-9; PMID:21304053 ;  http://dx.doi.org/10.1093/carcin/bgr019 27.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Biochem Biophys Res Commun  2011 ; 407:348- 54; PMID:21396350 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Sci Transl Med 2012 ; 4:ra159 ;  PMID:23241743 ; http://dx.doi.org/10.1126/ scitranslmed.3004566,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
J Exp Med 2011 ; 208:2279 -90; PMID:21987656 ;  http://dx.doi.org/10.1084/jem.20111106 30.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
PLoS One   2012 ; 7:e34959 ; PMID:22509371 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
BMC Cancer 2013 ; 13:59; PMID:23379788 ;  http://dx.doi.org/10.1186/1471-2407-13-59 32.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Scand J Gastroenterol  2012 ; 47:1304 -12; PMID:22989213 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cytokine Growth Factor Rev 2003 ; 14:155-74;  PMID:12651226 ; http://dx.doi.org/10.1016/ S1359-6101(03)00002-9 35.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Blood  2003 ; 101:2620 -7; PMID:12411307 ;  http://dx.doi.org/10.1182/blood-2002-05-1461 36.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Blood  2009 ; 114:357- 9;  PMID:19289853 ; http://dx.doi.org/10.1182/ blood-2008-09-177360 37.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
"Blood  2010 ; 115:2554 -5,  author reply 2556-7 ; PMID:20339108 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Proc Natl Acad Sci U S A 2010 ;  107:5540 -4; PMID:20212110 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Nat Med  2009 ; 15:1016 - 22; PMID:19701202 ; http://dx.doi.org/10.1038/ nm.2015 40.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Carcinogenesis  2012 ; 33:931-6;  PMID:22354874 ; http://dx.doi.org/10.1093/carcin/ bgs106 41.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cancer Res 2007 ; 67:9721 -30; PMID:17942902 ;  http://dx.doi.org/10.1158/0008-5472.CAN-07-273542.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Trends Pharmacol Sci   2009 ; 30:441-7; PMID:19616319 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Oncoimmunology  2012 ; 1:351- 4; PMID:22737612 ; http://dx.doi.org/10.4161/ onci.19122 46.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Gastroenterology  2005 ; 128:687- 94; PMID:15765404 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Gastroenterology   2008 ; 134:1038 -48; PMID:18395085 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Gut 2011 ; 60:1678 -86;  PMID:21948944 ; http://dx.doi.org/10.1136/ gutjnl-2011-300612 49.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
J Biol  Chem  2002 ; 277:33676 -82; PMID:12087100 ;  http://dx.doi.org/10.1074/jbc.M204204200 50.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
J Biol  Chem  2007 ; 282:16006 -15; PMID:17438334 ;  http://dx.doi.org/10.1074/jbc.M611040200 51.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Genes Immun  2003 ; 4:204-11;  PMID:12700595 ; http://dx.doi.org/10.1038/ sj.gene.636394754.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Inflamm Bowel Dis 2012 ; 18:1777 - 84; PMID:22359410 ; http://dx.doi.org/10.1002/ ibd.22929 55.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Nature   2012 ; 491:259-63; PMID:23075849 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cancer Causes Control 2010 ; 21:1165 - 70; PMID:20339910 ; http://dx.doi.org/10.1007/ s10552-010-9542-5 58.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Int J Biol Sci 2012 ; 8:1248 -53; PMID:23136553 ;  http://dx.doi.org/10.7150/ijbs.4614 59.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Am J Physiol Regul Integr Comp  Physiol  2008 ; 294:R393 -401; PMID:18056981 ;  http://dx.doi.org/10.1152/ajpregu.00716.2007 61.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cancer Cell   2009 ; 15:103-13; PMID:19185845 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Immunity  2004 ; 21:491-501; PMID :15485627 ;  http://dx.doi.org/10.1016/j.immuni.2004.07.020 63.,OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
Cancer Cell  2013 ; 24:257-71; PMID:23948300 ;  http://dx.doi.org/10.1016/j.ccr.2013.06.017,Non-OADS,/arxiv_data1/oa_pdf/d0/23/onci-2-e26617.PMC3902118.pdf
"OncoImmunology 2013; 2:e26860; http://dx.doi.org/10.4161/onci.26860Harnessing the antitumor potential   of macrophages for cancer immunotherapy Kristen B Long and Gregory L Beatty* abramson Cancer Center; Department of Medicine; Division of Hematology-Oncology; University of Pennsylvania Perelman School of Medicine; Philadelphia, P a US a Keywords:  angiogenesis, cancer; fibrosis, macrophage, phagocytosis, tumoricidal Abbreviations: ANG2, angiopoietin 2; CCl4, carbon tetrachloride; CSF1R, colony stimulating factor 1 receptor;   ECM, extracellular matrix; GM-CSF, granulocyte macrophage colony-stimulating factor; HIF, hypoxia-inducible factor;   IFN, interferon; IL, interleukin; LDL, low density lipoprotein; LRP, LDL-receptor related protein; mAb, monoclonal antibody;  MMP, matrix metalloproteinase; mTOR, mammalian target of rapamycin; NOD, nucleotide-binding oligomerization domain;  PDA, pancreatic ductal adenocarcinoma; SIRP α, signal regulatory protein α ; TLR, toll-like receptor;   TNFα, tumor necrosis factor α ; VEGF, vascular endothelial growth factor Macrophages constitute a dominant fraction of the pop - ulation of immune cells that infiltrate developing tumors.",Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Nat Rev Immunol 2003; 3:23-35; PMID:12511873 ;  http://dx.doi.org/10.1038/nri978 2.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Trends Immunol 2002; 23:549-55; PMID:12401408 ; http://dx.doi.org/10.1016/ S1471-4906(02)02302-5 3.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cell 2011; 144:646-74; PMID:21376230 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cell 2010; 141:39-51; PMID:20371344 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Clin Oncol 2010; 28:4045- 51; PMID:20644090 ; http://dx.doi.org/10.1200/ JCO.2010.27.9992 6.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cancer Cell  2013; 23:277-86;  PMID:23518347 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Science 2011; 331:1612-6; PMID:21436454 ; http://dx.doi.org/10.1126/ science.1198443 8.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Proc Natl Acad Sci U  S A 1981; 78:1680-4; PMID:6940181 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Science 2013; 341:88-91; PMID:23722425 ;  http://dx.doi.org/10.1126/science.1238856 11.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Pathol 2012; 227:17-28; PMID:22262122 ;  http://dx.doi.org/10.1002/path.398912.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Immunol 2012; 189:3168- 77; PMID:22869907 ; http://dx.doi.org/10.4049/ jimmunol.1103817 13.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Clin Oncol 2008; 26:633- 8; PMID:18235123 ; http://dx.doi.org/10.1200/ JCO.2008.14.0095 15.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Clin Dev Immunol 2010; 2010:357591;  PMID:20862387 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Leukoc Biol 2003; 74:277-86; PMID:12885945 ;  http://dx.doi.org/10.1189/jlb.0103026 17.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Clin Cancer Res 2012; 18:858-68; PMID:22147941 ;  http://dx.doi.org/10.1158/1078-0432.CCR-11-2121 18.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Expert Rev Vaccines 2013;  12:493-504;  PMID:23659298 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Immunother 2012; 35:544- 54; PMID:22892451 ; http://dx.doi.org/10.1097/ CJI.0b013e3182661afa 21.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Clin Invest 1987; 79:319-26; PMID:3543052 ;  http://dx.doi.org/10.1172/JCI11281522.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Annu Rev Immunol  1997; 15:323-50;  PMID:9143691 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Exp Med 1991; 173:1047-52; PMID:2022919 ; http://dx.doi.org/10.1084/ jem.173.5.1047 24.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Proc Natl Acad Sci U S A 1986; 83:5233- 7; PMID:3487788 ; http://dx.doi.org/10.1073/ pnas.83.14.5233 26.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Nature 2007; 450:435-9; PMID:17960135 ; http://dx.doi.org/10.1038/ nature06307 27.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cell 2005; 123:321-34; PMID:16239148 ;  http://dx.doi.org/10.1016/j.cell.2005.08.032 29.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Sci Transl Med 2010; 2:63ra94; PMID:21178137 ;  http://dx.doi.org/10.1126/scitranslmed.3001375 30.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Immunol  2012; 189:5457-66;  PMID:23105143 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Exp Med 2001; 193:855-62; PMID:11283158 ; http://dx.doi.org/10.1084/ jem.193.7.855 32.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Science 2000; 288:2051- 4; PMID:10856220 ; http://dx.doi.org/10.1126/ science.288.5473.2051,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cell 2009; 138:286-99; PMID:19632179 ;  http://dx.doi.org/10.1016/j.cell.2009.05.045 35.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cancer Res 2006; 66:11238-46; PMID:17114237 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-1278 38.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Immunol  2009; 183:4705-14;  PMID:19752225 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Clin Cancer Res  2011; 17:5226-32;  PMID :21576085 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cancer Cell 2011; 19:512-26; PMID:21481792 ;  http://dx.doi.org/10.1016/j.ccr.2011.02.005 41.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Proc Natl Acad Sci U S A 2012;  109:17561-6;  PMID:23045683 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cancer Cell  2008; 13:206-20;  PMID:18328425 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Immunol 2011; 187:1970-6; PMID:21765015 ;  http://dx.doi.org/10.4049/jimmunol.110084145.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Clin Cancer Res 2007; 13:4677-85;  PMID:17699845 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Nat Rev Immunol  2011; 11:723-37;  PMID:21997792 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
N Engl J Med 1986; 315:1650- 9; PMID:3537791 ; http://dx.doi.org/10.1056/ NEJM198612253152606 52.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Proc Natl Acad Sci U S A 2012;  109:E3186-95;  PMID:23100531 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Nat Rev Immunol 2013; 13:649-65;  PMID:23969736 ; http://dx.doi.org/10.1038/ nri3499 56.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Proc Natl Acad Sci U S A 1986; 83:4167- 71; PMID:2424019 ; http://dx.doi.org/10.1073/ pnas.83.12.4167 57.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Clin Cancer Res 2006; 12:1906-12;  PMID:16551876 ; http://dx.doi.org/10.1158/1078- 0432.CCR-05-214159.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Science 2009; 324:1457-61;  PMID:19460966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cancer Cell  2012; 21:418-29;  PMID:22439937 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Gut 2013; 62:112-20; PMID:22466618 ;  http://dx.doi.org/10.1136/gutjnl-2012-302529 62.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cancer Cell 2005; 7:469-83; PMID :15894267 ;  http://dx.doi.org/10.1016/j.ccr.2005.04.023 63.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Clin Invest 2006; 116:2587-90;  PMID:17016554 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Nat Rev Cancer 2012; 12:252-64;  PMID:22437870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Nat Med 2013; 19:1264-72; PMID:24056773 ;  http://dx.doi.org/10.1038/nm.3337 67.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cancer Discov 2011; 1:54-67;  PMID:22039576 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Immunol  2011; 187:5062-8;  PMID:22003200 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Biol Chem 2011; 286:1786-94;  PMID:21097505 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Blood 2013;  122:243-52;  PMID:23487026 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
J Immunol 2013; 190:6542- 9; PMID:23667114 ; http://dx.doi.org/10.4049/ jimmunol.1202496 73.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Adv Immunol 2013; 120:163- 84; PMID:24070384 ; http://dx.doi.org/10.1016/ B978-0-12-417028-5.00006-574.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Immunol Rev 2013; 253:12- 24; PMID:23550635 ; http://dx.doi.org/10.1111/ imr.12042 75.,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Immunity 2013; 38:1236-49; PMID:23809164 ;  http://dx.doi.org/10.1016/j.immuni.2013.06.00476.,OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
Cancer Res 2013; 73:2782-94;  PMID:23418320 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-3981,Non-OADS,/arxiv_data1/oa_pdf/56/fc/onci-2-e26860.PMC3902119.pdf
"OncoImmunology 2013; 2:e26621; http://dx.doi.org/10.4161/onci.26621Trial Watch Peptide vaccines in cancer therapy Fernando a randa1,2,3,4,†, erika Vacchelli1,2,3,4,†, alexander e ggermont1, Jerome Galon5,6,7, 8, Catherine Sautès-Fridman6,7,9,   eric Tartour10,11, Laurence Zitvogel1,12, Guido Kroemer2,4,5,10,13,‡,*, and Lorenzo Galluzzi1,4,5,‡,* 1Gustave r oussy; Villejuif, France; 2INSerM, U848; Villejuif, France; 3Université Paris-Sud/Paris XI; Le Kremlin-Bicêtre, France;   4equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de r echerche des Cordeliers; Paris, France;   5Université Paris Descartes/Paris V; Sorbonne Paris Cité; Paris, France; 6Université Pierre et Marie Curie/Paris VI; Paris, France; 7INSerM, U872; Paris, France;   8equipe 15, Centre de r echerche des Cordeliers; Paris, France; 9equipe 13, Centre de r echerche des Cordeliers; Paris, France;   10Pôle de Biologie, Hôpital e uropéen Georges Pompidou, a P-HP; Paris, France; 11INSerM, U970; Paris, France; 12INSerM, U1015; CICBT507; Villejuif, France;   13Metabolomics and Cell Biology Platforms, Gustave r oussy; Villejuif, France.",Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
"Literature Update During the last 13 mo, the results of no less than 22 clinical  studies investigating the therapeutic potential of full length TAAs or peptides thereof in cancer patients have been published in peer-reviewed scientific journals (source http://www.ncbi.nlm.nih.gov/pubmed).",OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
"135 However, the CEO of GemVax and  KAEL Co., the company that is currently developing GV1001, declared that 2 candidate biomarkers were identified that may pre - dict immunological responses to the vaccine as well as increased survival in a subset of patients (source http://online.wsj.com/article/PR-CO-20130603-906288.html).",Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
"On 2013, September 5th, GlaxoSmithKline plc announced that the DERMA study also failed to meet its first co-primary endpoint as recombinant MAGEA3 administered in AS15 did not extend the disease-free survival of patients with Stage IIIB/C resected MAGEA3 + mela - noma as compared with placebo (source http://www.gsk.com/media/press-releases/2013/the-investigational-mage-a3-antigen-specific-cancer-immunotherap.html).",Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
"The status of most of these trials has remained unchanged since, excep - tion made for NCT01232712, NCT00633724, NCT00655785, NCT00711334, NCT00773097, NCT00874588, NCT00887796, NCT00892567, NCT00952692, NCT01003808, NCT01219348, and NCT01673217 (all of which have been completed), as well as of NCT00706992 (which has been terminated) (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
"When this Trial Watch was being redacted (September 2013),  official sources listed 20 clinical trials launched after 2012, September 1st to investigate the safety and therapeutic potential of purified/recombinant TAAs or peptide thereof in cancer patients (Table 1 ) (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Nat Med 2003; 9:269-77; PMID:12612576 ;  http://dx.doi.org/10.1038/nm0303-269 2.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Front Immunol 2012; 3:68; PMID:22566949 ;  http://dx.doi.org/10.3389/fimmu.2012.00068 5.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
N Engl J Med 1980; 303:1263-73;  PMID:6252467 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:1557-76; PMID:23264902 ; http://dx.doi.org/10.4161/ onci.22428 7.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:699-716;  PMID:22934262 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:894-907;   PMID:23162757 ; http://dx.doi.org/10.4161/ onci.20931 9.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e25238;  PMID:24083080 ; http://dx.doi.org/10.4161/ onci.25238 10.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Dev Immunol  2011; 2011:609579;  PMID:22110526 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Annu Rev Immunol 1994; 12:991-1045;  PMID:8011301 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
"Science 2002; 296:301-5; PMID:11951032 ;  http://dx.doi.org/10.1126/science.1071059 14. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cyto - lytic T lymphocytes on a human melanoma.",OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Science 1991; 254:1643-7;  PMID:1840703 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Immunol Today 1993; 14:536-8;  PMID:8274196 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:1111-34;   PMID:23170259 ; http://dx.doi.org/10.4161/ onci.21494 17.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
OncoImmunology 2013; 2:e25771; PMID:23170259 ; http://dx.doi.org/10.4161/ onci.25771 18.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e23803; PMID:23734328 ; http://dx.doi.org/10.4161/ onci.23803 19.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Exp Med 2004; 199:81 5-24;  PMID:15024047 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Blood 2013; 121:2836-44; PMID:23390195 ; http://dx.doi.org/10.1182/ blood-2012-09-452078 21.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Nat Rev Immunol 2007; 7:790- 802; PMID:17853902 ; http://dx.doi.org/10.1038/ nri2173 22.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
N  Engl J Med 2007; 356:1908-10; PMID:17494923 ;  http://dx.doi.org/10.1056/NEJMp078053 23.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Lancet  2009; 374:301-14;  PMID:19586656 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
N Engl J Med 2007; 356:1915- 27; PMID:17494925 ; http://dx.doi.org/10.1056/ NEJMoa061741 25.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
N Engl J Med 2010; 363:411-22; PMID:20818862 ; http://dx.doi.org/10.1056/ NEJMoa100129426.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
OncoImmunology 2013; 2:e26084; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Nat Rev Cancer 2008; 8:351-60; PMID:18418403 ; http://dx.doi.org/10.1038/ nrc2373 32.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology  2013; 2:e24534;  PMID:23894716 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Sci Transl Med 2013; 5:172ra20;  PMID:23408053 ; http://dx.doi.org/10.1126/ scitranslmed.3004888 34.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e24238;   PMID:23762803 ; http://dx.doi.org/10.4161/ onci.24238 35.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:306- 15; PMID:22737606 ; http://dx.doi.org/10.4161/ onci.19549 36.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
OncoImmunology 2013; 2:  e24238; http://dx.doi.org/10.4161/onci.24238 37.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
"Oncoimmunology 2013; 2:e23082; PMID:23525565 ; http://dx.doi.org/10.4161/ onci.23082Acknowledgments Authors are supported by the European Commission  (ArtForce); European Research Council (ERC); Agence  National de la Recherche (ANR); Ligue Nationale contre le Cancer; Fondation pour la Recherche Médicale (FRM); Institut National du Cancer (INCa); Association pour la Recherche sur le Cancer (ARC), LabEx Immuno-Oncologie; Fondation de France; Fondation Bettencourt-Schueller; AXA Chair for Longevity Research; Cancéropôle Ile-de-France, Paris Alliance of Cancer Research Institutes (PACRI) and Cancer Research for Personalized Medicine (CARPEM).",Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e24612;   PMID:23894720 ; http://dx.doi.org/10.4161/ onci.24612 39.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:1323-43; PMID:23243596 ; http://dx.doi.org/10.4161/ onci.22009 40.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res  2013; 19:205-14;  PMID:22872572 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol Immunother 2013; 62:1149-59; PMID:23657629 ; http://dx.doi.org/10.1007/ s00262-013-1435-5 42.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Int J Cancer 2013; 132:1581- 91; PMID:22948952 ; http://dx.doi.org/10.1002/ ijc.27819 43.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Sci 2012; 103:2135- 8; PMID:22957712 ; http://dx.doi.org/10.1111/ cas.12014 45.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Invest New Drugs 2013;  Forthcoming;  PMID:23609828 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Sci 2013; 104:124-9;  PMID:23078230 ; http://dx.doi.org/10.1111/ cas.12046 48.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Int J Cancer 2013;  132:345-54;  PMID:22729530 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol Immunother 2013; 62:1041- 52; PMID:23591981 ; http://dx.doi.org/10.1007/ s00262-013-1415-9 50.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin  Cancer Res 2012; 18:6485-96; PMID:23032742 ;  http://dx.doi.org/10.1158/1078-0432.CCR-12-1516 51.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Transl Med 2012; 10:141;  PMID:22776426 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Transl  Med 2013; 11:97; PMID:23578144 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Br J Cancer 2013; 108:1260-6;  PMID:23470466 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Gastric Cancer 2013; Forthcoming;  PMID:23613128 ; http://dx.doi.org/10.1007/ s10120-013-0258-6 56.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Sci  2013; 104:98-104;  PMID:23020774 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res  2012; 18:6497-508;  PMID:23032745 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Sci 2013;  Forthcoming;  PMID:23829867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Hum Vaccin Immunother 2013;  Forthcoming;  PMID:23466818 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol Immunother  2012; 61:2091-103;  PMID:22565484 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Expert Rev Vaccines 2012; 11:1401-4; PMID:23252384 ; http://dx.doi.org/10.1586/ erv.12.122 63.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Cancer Res Clin Oncol  2013; 139:457-63;  PMID:23160854 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Trends Parasitol 2005; 21:412-4; PMID:16043410 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Adv Drug Deliv Rev 1998; 32:173-86; PMID:10837643 ;  http://dx.doi.org/10.1016/S0169-409X(98)00009-X 66.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Expert Opin Biol Ther 2007; 7:1257-66;  PMID:17696823 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Curr Mol Med  2002; 2:545-56;  PMID:12243247 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e24677;  PMID:23894722 ; http://dx.doi.org/10.4161/ onci.24677 69.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e23493;  PMID:23734310 ; http://dx.doi.org/10.4161/ onci.23493 70.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e23619;   PMID:23734314 ; http://dx.doi.org/10.4161/ onci.23619 71.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:773- 6; PMID:22934279 ; http://dx.doi.org/10.4161/ onci.19729,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology  2013; 2:e24850;  PMID:24073369 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:493-506;  PMID:22754768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798 ; http://dx.doi.org/10.1038/ nrd3626 75.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Immunity 2013; 39:74-88; PMID:23890065 ;  http://dx.doi.org/10.1016/j.immuni.2013.06.014 76.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:179- 88; PMID:22720239 ; http://dx.doi.org/10.4161/ onci.1.2.19026 77.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e23510;  PMID:23687621 ; http://dx.doi.org/10.4161/ onci.23510 78.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology  2012; 1:1409-10;  PMID:23243610 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
EMBO  J 2010; 29:1272-84; PMID:20186124 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Br J Cancer 2011; 104:376- 86; PMID:21063397 ; http://dx.doi.org/10.1038/ sj.bjc.6605990 81.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Res 2007; 67:11601-11; PMID:18089789 ;  http://dx.doi.org/10.1158/0008-5472.CAN-07-3243 82.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res 2008; 14:1701-6;  PMID:18347170 ; http://dx.doi.org/10.1158/1078- 0432.CCR-07-2039 83.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Lancet Oncol 2006; 7:556- 64; PMID:16814207 ; http://dx.doi.org/10.1016/ S1470-2045(06)70732-X 84.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Nature 2012; 488:665-9; PMID:22895187 ; http://dx.doi.org/10.1038/ nature1130885.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Nature 2012; 485:195- 200;  PMID:22575959 ; http://dx.doi.org/10.1038/ nature11019 86.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Breast Cancer Res Treat 2012; 136:419- 27; PMID:23053644 ; http://dx.doi.org/10.1007/ s10549-012-2249-4 88.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res 2006; 12:2689-97;  PMID:16675560 ; http://dx.doi.org/10.1158/1078- 0432.CCR-05-2267 90.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res 2004; 10:8630-40; PMID :15623647 ; http://dx.doi.org/10.1158/1078- 0432.CCR-04-1177 91.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Exp Med 1998; 188:277- 86; PMID:9670040 ; http://dx.doi.org/10.1084/ jem.188.2.277 93.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Immunother  1997; 20:15-25;  PMID:9101410 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
N Engl J Med 1998; 338:153-60; PMID:9428816 ; http://dx.doi.org/10.1056/ NEJM19980115338030396.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res 2006; 12:5841-9;  PMID:17020992 ; http://dx.doi.org/10.1158/1078- 0432.CCR-06-0750 98.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res 2007; 13:5991-4;  PMID:17947459 ; http://dx.doi.org/10.1158/1078- 0432.CCR-07-0686 99.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Blood 2003; 102:571- 6; PMID:12576330 ; http://dx.doi.org/10.1182/ blood-2002-08-2554 100.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Blood 2011; 117:6813-24; PMID:21447831 ;  http://dx.doi.org/10.1182/blood-2010-08-304568 101.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Int J Cancer 2004; 109:385- 92; PMID :14961577 ; http://dx.doi.org/10.1002/ ijc.11721 102.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:670- 86; PMID:22934259 ; http://dx.doi.org/10.4161/ onci.20426 103.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Biomed Biotechnol 2011; 2011:702146;  PMID :21541192 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cell Cycle 2008; 7:1949-55; PMID:18642442 ;  http://dx.doi.org/10.4161/cc.7.13.6222 105.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Future Oncol 2009; 5:941-4; PMID:19792962 ;  http://dx.doi.org/10.2217/fon.09.62 106. van der Burg SH.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Expert Rev Vaccines 2008; 7:1-5; PMID:18251686 ;  http://dx.doi.org/10.1586/14760584.7.1.1 107.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Nat Med  2013; 19:465-72;  PMID:23455713 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Immunol 2013; 190:5588- 99; PMID:23630363 ; http://dx.doi.org/10.4049/ jimmunol.1203216,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Res  2006; 66:7716-23;  PMID:16885374 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
PLoS One  2013; 8:e52940;  PMID:23308126 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e23430;   PMID:23802085 ; http://dx.doi.org/10.4161/ onci.23430 112.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res 2012; 18:6284-95;  PMID:23032748 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res 2011; 17:6847-57; PMID:21918169 ;  http://dx.doi.org/10.1158/1078-0432.CCR-11-1385 114.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Ann Oncol 2012; 23:442-9;  PMID:21873272 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol Immunother  2012 ; 61:157-68 ;  PMID:21858533 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol Immunother  2011; 60:1553-64;  PMID:21681371 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res  2011; 17:4568-80;  PMID :21586625 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J  Dermatol Sci 2011; 62:75-83; PMID:21377838 ;  http://dx.doi.org/10.1016/j.jdermsci.2011.02.001 119.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol  Immunother 2011; 60:809-18; PMID:21365467 ;  http://dx.doi.org/10.1007/s00262-011-0991-9120.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Mol Ther 2011; 19:990-9; PMID:21189474 ; http://dx.doi.org/10.1038/ mt.2010.289 121.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Blood 2011; 117:788-97; PMID:21030558 ;  http://dx.doi.org/10.1182/blood-2010-08-299396 122.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
BMC Cancer  2010; 10:209;  PMID:20478057 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cytotherapy 2010; 12:721-34;  PMID:20429791 ;  http://dx.doi.org/10.3109/14653241003774045 124.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Scand J Immunol 2009; 70:481-9;  PMID:19874553 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Transl  Med 2009; 7:18; PMID:19298672 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J  Immunother 2008; 31:771-80; PMID:18779742 ;  http://dx.doi.org/10.1097/CJI.0b013e3181833818 127.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Clin Oncol  2007; 25:2727-34;  PMID:17602077 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol Immunother 2007; 56:1755-63;  PMID:17464507 ;  http://dx.doi.org/10.1007/s00262-007-0319-y 129.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Br J Cancer 2006; 95:1474-82; PMID:17060934 ; http://dx.doi.org/10.1038/ sj.bjc.6603437130.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncology  2006; 70:306-14;  PMID:17047402 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Res 2006; 66:5910-8; PMID:16740731 ;  http://dx.doi.org/10.1158/0008-5472.CAN-05-3905 132.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol  Immunother 2006; 55:1553-64;  PMID:16491401 ;  http://dx.doi.org/10.1007/s00262-006-0145-7 133.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res  2004; 10:828-39;  PMID:14871958 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Expert Opin Investig Drugs 2009; 18:687-94;  PMID:19388882 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Clin Oncol 2013; 31:2388-95; PMID:23715562 ; http://dx.doi.org/10.1200/ JCO.2012.44.3762 139.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Blood  2009; 114:2888-99;  PMID:19589923 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Science 2006; 314:126-9; PMID:16946036 ; http://dx.doi.org/10.1126/ science.1129003,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol Immunother  2012; 61:1289-97;  PMID:22388712 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e24567; PMID:23802090 ; http://dx.doi.org/10.4161/ onci.24567 144.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:810-21;  PMID:23162748 ;  http://dx.doi.org/10.4161/onci.20447 145.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Histopathology 2010; 57:597-606;  PMID:20955385 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Glycoconj J 2013; 30:227-36; PMID:22878593 ;  http://dx.doi.org/10.1007/s10719-012-9437-7 147.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e23687;  PMID:23483762 ; http://dx.doi.org/10.4161/ onci.23687 148.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Immunol Immunother 2006; 55:469-74; PMID:16133111 ;  http://dx.doi.org/10.1007/s00262-005-0056-z 150.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Virol 2003;  77:11220-31;  PMID:14512570 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cell Immunol  2011; 271:401-12;  PMID:21889130 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cancer Res 2013; 73:4383-94;  PMID:23651636 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
PLoS One 2013; 8:e65678;  PMID:23762409 ; http://dx.doi.org/10.1371/jour - nal.pone.0065678 155.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology  2013; 2:e24436;  PMID:23762809 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:1445-7;  PMID:23243624 ;  http://dx.doi.org/10.4161/onci.21318 157.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res  2005; 11:8055-62;  PMID:16299236 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin Cancer Res  2004; 10:5708-16;  PMID :15355897 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Immunol 2011; 186:1218-27; PMID:21149605 ;  http://dx.doi.org/10.4049/jimmunol.1000808 161.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Blood 2010; 116:2277-85;   PMID:20566893 ; http://dx.doi.org/10.1182/ blood-2010-02-268425 162.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncogene 2013; 32:4331-42; PMID:23085751 ;  http://dx.doi.org/10.1038/onc.2012.469163.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Cell Cycle 2011; 10:2323-30;  PMID:21654193 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Vaccine  2005; 23:5263-70;  PMID:16081189 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Expert Rev Vaccines 2012; 11:721-31; PMID:22873128 ; http://dx.doi.org/10.1586/ erv.12.39 166.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Clin  Cancer Res 2008; 14:169-77; PMID:18172268 ;  http://dx.doi.org/10.1158/1078-0432.CCR-07-1881 167.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Ann Oncol 2008; 19:1657-8; PMID:18647966 ;  http://dx.doi.org/10.1093/annonc/mdn430 168.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
J Clin Oncol 2011; 29:2787-94; PMID:21632504 ; http://dx.doi.org/10.1200/ JCO.2010.33.3005 169.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2012; 1:579-80; PMID:22934249 ; http://dx.doi.org/10.4161/ onci.20730 170.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Immunity 1999; 11:263-70; PMID:10514004 ;  http://dx.doi.org/10.1016/S1074-7613(00)80101-6 171.,OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology  2012; 1:28-37;  PMID:22720209 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
Oncoimmunology 2013; 2:e22789; PMID:23482847 ; http://dx.doi.org/10.4161/ onci.22789,Non-OADS,/arxiv_data1/oa_pdf/20/25/onci-2-e26621.PMC3902120.pdf
"OncoImmunology 2013; 2:e26968; http://dx.doi.org/10.4161/onci.26968CSF1R inhibition delays cervical and mammary  tumor growth in murine models by attenuating  the turnover of tumor-associated macrophages  and enhancing infiltration by CD8+ T cells Debbie C Strachan1,†, Brian r uffell2, yoko Oei1, Mina J Bissell3, Lisa M Coussens2, Nancy Pryer1, and Dylan Daniel1,* 1Novartis Institutes for Biomedical r esearch; e meryville, C a US a; 2Department of Cell and Developmental Biology and Knight Cancer Institute;   Oregon Health and Science University; Portland, O r US a; 3Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, C a USa †Current address: Cellerant Therapeutics; San Carlos, C a US a Keywords:  breast cancer, cervical cancer, CSF1R, M-CSF, tumor-associated macro - phages, tumor immune evasion, tumor immunology, transgenic mouse models Abbreviations: CSF1, colony stimulating factor 1 ; Csf1op, Csf1 -nullizygous mouse; CSF1R, CSF1 receptor; EGF, epidermal growth  factor; HPV-16, human papilloma virus type 16; IL, interleukin; K14, keratin 14; MMTV, mouse mammary tumor virus; PyMT,  polyomavirus middle T antigen; TAM, tumor-associated macrophage Increased numbers of tumor-infiltrating macrophages correlate with poor disease outcome in patients affected by  several types of cancer, including breast and prostate carcinomas.",Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Supplemental Materials Supplemental materials can be found here:   http://www.landesbioscience.com/journals/oncoimmunology/article/26968 /  References 1.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Curr  Opin Immunol 2010; 22:231-7; PMID:20144856 ;  http://dx.doi.org/10.1016/j.coi.2010.01.009 2.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
J Immunol 2010;  185:642-52;  PMID:20530259 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Nat Rev Immunol 2009; 9:259- 70; PMID:19282852 ; http://dx.doi.org/10.1038/ nri2528 4.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
J Pathol  2002; 196:254-65;  PMID:11857487 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Trends Immunol 2002; 23:549-55; PMID:12401408 ; http://dx.doi.org/10.1016/ S1471-4906(02)02302-5 6.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Immunity 2008; 28:477- 87; PMID:18400190 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Annu Rev Immunol 2009; 27:451- 83; PMID:19105661 ; http://dx.doi.org/10.1146/ annurev.immunol.021908.1325328.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cancer Res 2010; 70:5728-39;  PMID:20570887 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-4672 9.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
J Immunol  2012; 189:5457-66;  PMID:23105143 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Nat Rev Immunol  2008; 8:958-69;  PMID:19029990 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cancer Cell 2009; 16:91-102; PMID:19647220 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Nature 2011; 475:222- 5; PMID:21654748 ; http://dx.doi.org/10.1038/ nature10138 13.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
PLoS One 2009; 4:e6562;  PMID:19668347 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cell 2010; 141:39-51; PMID:20371344 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
J Cell Biochem 1992; 50:350-6; PMID:1334964 ; http://dx.doi.org/10.1002/ jcb.240500403 16.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Biol Reprod 1996; 55:310- 7; PMID:8828834 ; http://dx.doi.org/10.1095/ biolreprod55.2.310 17.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Science  2008; 320:807-11;  PMID:18467591 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
J Leukoc Biol 2010; 88:495-505; PMID:20504948 ;  http://dx.doi.org/10.1189/jlb.1209822 20.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
J Mammary Gland Biol Neoplasia 2002; 7:147-62;  PMID:12465600 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Breast Cancer Res Treat 2010; 123:397- 404; PMID:19949854 ; http://dx.doi.org/10.1007/ s10549-009-0654-0 22.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
J Exp Med  2001; 193:727-40;  PMID:11257139 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cancer Discov  2011; 1:54-67;  PMID:22039576 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cancer Cell 2011; 19:512-26; PMID:21481792 ;  http://dx.doi.org/10.1016/j.ccr.2011.02.005 27.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Blood  2009; 114:901-14;  PMID:19383967 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
J Exp Med 1968; 128:415-35;  PMID:5666958 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Proc Natl Acad Sci U S A 2012;  109:2796-801;  PMID:21825174 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cancer Res  2005; 65:5278-83;  PMID:15958574 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cancer Res 2009; 69:9498-506;  PMID:19934330 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-1868 32.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cancer Res 2005; 65:2018-25;  PMID:15753402 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-3444 34.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cancer Cell 2011; 19:541- 55; PMID:21481794 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Cancer Res 2004; 64:7022-9;  PMID:15466195 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-144937.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Nat Med 2013; 19:1264-72; PMID:24056773 ;  http://dx.doi.org/10.1038/nm.3337 39.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Gynecol Oncol  2007; 105:157-65;  PMID:17229459 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Gynecol Oncol  2008; 108:112-20;  PMID:17936343 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Clin Cancer Res 2009;  15:4391-400 ;  PMID:19549768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
BMC Immunol 2010; 11:27;  PMID:20525400 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
Proc Natl Acad Sci U S A 1996; 93:2930- 5; PMID:8610145 ; http://dx.doi.org/10.1073/ pnas.93.7.2930 44.,OADS,/arxiv_data1/oa_pdf/60/59/onci-2-e26968.PMC3902121.pdf
"Received: July 24, 2012    Revised: January 14, 2013 Accepted:  March 5, 2013    Available online: December 16, 2013  Correspondence: Chul Lee, MD, PhD Department of Psychiatry, Seoul St. Mary’s Hospital, The Catholic University  of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Re - public of Korea Tel: +82-2-2258-5443, Fax: +82-2-594-3870, E-mail: cle512@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.307REVIEW ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/32/eb/pi-10-307.PMC3902147.pdf
"Received: December 1, 2012    Revised: February 17, 2013 Accepted:  May 20, 2013    Available online: December 16, 2013  Correspondence: Isil Gogcegoz Gul, MD Uskudar University NP Istanbul Hospital, MD, Saray Mh., 34768 Umraniye,  Istanbul, Turkey Tel: +90 5332076230, Fax: +90 2164741256, E-mail: dr.isilggul@mynet cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.317REVIEW ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/ed/7d/pi-10-317.PMC3902148.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.326 326  Copyright © 2013 Korean Neuropsychiatric Association   ORIGINAL ARTICLE Generalized Anxiety Disorder, Comorbid Major Depression and  Heart Rate Variability: A Case-Control Study in Taiwan  Hsin-An Chang1, Chuan-Chia Chang1, Nian-Sheng Tzeng1,2,   Terry B. J. Kuo3, Ru-Band Lu4, and San-Yuan Huang1  1Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan  2Student Counseling Center, National Defense Medical Center, Taipei, Taiwan  3Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan  4Institute of Behavioral Medicine and Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan Objective aaDecreased heart rate variability (HRV) has been reported in generalized anxiety disorder (GAD), but the results are mixed.",Non-OADS,/arxiv_data1/oa_pdf/71/a4/pi-10-326.PMC3902149.pdf
"2, Nei-Hu District, Taipei,  114, Taiwan, ROCTel: +011-886-2-8792-7220, Fax: +011-886-2-8792-7221 E-mail: chang.ha@msa.hinet.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Generalized anxiety disorder (GAD) is a chronic anxiety  disorder and characterized by fluctuating levels of persistent,  uncontrollable worry associated with fatigue, insomnia, mus - cle tension, poor concentration, and irritability.",Non-OADS,/arxiv_data1/oa_pdf/71/a4/pi-10-326.PMC3902149.pdf
"Received: December 3, 2012    Revised: May 2, 2013 Accepted:  May 3, 2013    Available online: October 16, 2013  Correspondence: Un-Sun Chung, MD, PhD  Department of Psychiatry, Kyungpook National University School of Medi - cine, 200 Dongdeok-ro, Jung-gu, Daegu 700-721, Republic of KoreaTel: +82-53-200-6414, Fax: +82-53-426-5361 E-mail: chungunsun@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.336ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/e5/4c/pi-10-336.PMC3902150.pdf
Available at: http://hikostat.kr/1204.,Non-OADS,/arxiv_data1/oa_pdf/e5/4c/pi-10-336.PMC3902150.pdf
Available at: http://www.hu-manesociety.org/issues/pet_overpopulation/facts/pet_ownership_sta-tistics.html.,Non-OADS,/arxiv_data1/oa_pdf/e5/4c/pi-10-336.PMC3902150.pdf
"Received: October 12, 2012    Revised: February 8, 2013 Accepted:  February 15, 2013    Available online: December 16, 2013  Correspondence: Ki Woong Kim, MD, PhD Department of Neuropsychiatry, Seoul National University Bundang Hospital,  300 Gumi-dong, Bundang-gu, Seongnam 463-707, Republic of Korea Tel: +82-31-787-7439, Fax: +82-31-787-4058, E-mail: kwkimmd@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.346ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/df/34/pi-10-346.PMC3902151.pdf
"Received: November 21, 2012    Revised: February 21, 2013 Accepted:  February 27, 2013    Available online: December 16, 2013  Correspondence: Jong-Ik Park, MD, PhD, LLM Department of Psychiatry, Kangwon National University School of Medicine,  156 Baengnyeong-ro, Chuncheon 200-722, Republic of Korea Tel: +82-33-258-9171, Fax: +82-33-257-4656, E-mail: lugar@kangwon.ac.kr  cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.352ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/9e/9b/pi-10-352.PMC3902152.pdf
"Received:  November 8, 2012    Revised:  January 12, 2013    Accepted:  February 4, 2013    Available online:  December 16, 2013  Correspondence:  Nahathai Wongpakaran, MD, FRCPsychT  Geriatric Psychiatry Unit, Department of Psychiatry, Faculty of Medicine,  Chiang Mai University, 110 Intawaroros Rd., T. Sriphum, A. Muang Chiang  Mai, Kingdom of Thailand 50200 Tel: +6653945422, Fax: +6653945426, E-mail:  nkuntawo@med.cmu.ac.th cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.359ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/03/ab/pi-10-359.PMC3902153.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.365   Copyright © 2013 Korean Neuropsychiatric Association   365ORIGINAL ARTICLE Examining Antecedents and Consequences of Gambling Passion:  The Case of Gambling on Horse Races Choong-Ki Lee1, Ki-Joon Back2, David C. Hodgins3, and Tae Kyung Lee4  1College of Hotel & Tourism, Kyung Hee University, Seoul, Republic of Korea  2Conrad N. Hilton College of Hotel and Restaurant Management, University of Houston, Houston, TX, USA   3Department of Psychology, University of Calgary, Alberta, Canada  4Department of Addiction Psychiatry, Seoul National Hospital, Seoul, Republic of Korea Objective aaThis study investigated the antecedents and consequences of gambling passion using structural equation modeling to ex- amine relationships among gambling motivation, passion, emotion, and behavioral intentions in the horse racing industry.",Non-OADS,/arxiv_data1/oa_pdf/a8/82/pi-10-365.PMC3902154.pdf
"Received: November 8, 2012    Revised: December 22, 2012 Accepted:  January 15, 2013    Available online: December 16, 2013  Correspondence: Tae Kyung Lee, MD, PhD Department of Addiction Psychiatry, Seoul National Hospital, 398 Neungdong- ro, Gwangjin-gu, Seoul 143-711, Republic of Korea Tel: +82-2-2204-0179, Fax: +82-2-2204-0394 E-mail: TKLeeMD@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Like many other jurisdictions, South Korea has legalized  horseracing, casinos, cycle and motorboat racing, a lottery,  and sports betting.",Non-OADS,/arxiv_data1/oa_pdf/a8/82/pi-10-365.PMC3902154.pdf
"Received:  December 13, 2012    Revised:  May 11, 2013 Accepted:  May 14, 2013    Available online:  December 16, 2013  Correspondence:  Y ong Chon Park, MD Department of Psychiatry, Hanyang University Guri Hospital, 153 Gyeong- chun-ro, Guri 471-701, Republic of Korea Tel: +82-31-560-2273, Fax: +82-31-554-2599, E-mail:  hypyc@hanyang.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.373ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/0d/84/pi-10-373.PMC3902155.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.382 382  Copyright © 2013 Korean Neuropsychiatric Association   ORIGINAL ARTICLE Psychiatric Comorbidity and Quality of Life in Patients   with Post-Stroke Emotional Incontinence Dong-Ho Choi1, Bo-Ok Jeong1, Hee-Ju Kang1, Sung-Wan Kim1, Jae-Min Kim1 , Il-Seon Shin1,   Joon-Tae Kim2, Man-Seok Park2, Ki-Hyun Cho2, and Jin-Sang Yoon1 1Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea  2Department of Neurology, Chonnam National University Medical School, Gwangju, Republic of Korea Objective aaWe aimed to investigate the associations of post-stroke emotional incontinence (PSEI) with various psychiatric symptoms  and quality of life independent of potential covariates in survivors of acute stroke.",Non-OADS,/arxiv_data1/oa_pdf/4c/40/pi-10-382.PMC3902156.pdf
"Received: January 28, 2013    Revised: April 1, 2013 Accepted:  April 2, 2013    Available online: October 16, 2013  Correspondence: Jae-Min Kim, MD, PhD Department of Psychiatry, Chonnam National University Medical School, 42  Jebong-ro, Dong-gu, Gwangju 501-746, Republic of Korea Tel: +82-62-220-6143, Fax: +82-62-225-2351 E-mail: jmkim@chonnam.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Emotional lability is a common syndrome of affective dys- regulation caused by many neurological disorders, including  stroke, multiple sclerosis, amyotrophic lateral sclerosis, and tr-aumatic brain injury.",Non-OADS,/arxiv_data1/oa_pdf/4c/40/pi-10-382.PMC3902156.pdf
"Received: December 13, 2012    Revised: January 28, 2013 Accepted:  March 6, 2013    Available online: December 16, 2013  Correspondence: Doug Hyun Han, MD, PhD  Department of Psychiatry, Chung Ang University Hospital, 102 Heukseok-ro,  Dongjak-gu, Seoul 156-755, Republic of Korea Tel: +82-2-6299-3132, Fax: +82-2-6299-1114, E-mail: hduk@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.388ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/3e/07/pi-10-388.PMC3902157.pdf
Corti- cal thickness was measured using FreeSurfer 5.1 (http://surf-er.nmr.mgh.harvard.edu).,OADS,/arxiv_data1/oa_pdf/3e/07/pi-10-388.PMC3902157.pdf
"5737, Fax: +886-6-3028715 E-mail: dibe1011@yahoo.com.tw cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.393ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/15/c2/pi-10-393.PMC3902158.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.399ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/17/da/pi-10-399.PMC3902159.pdf
"Voxel-wise statistical analysis of the fractional anisotropy  data was performed using Tract-Based Spatial Statistics (TBSS) version 1.2, implemented in FMRIB Software Library (FSL version 4.1, Oxford, UK, http://www.fmrib.ox.ac.jk/fsl) according to the standard procedure described in detail.",OADS,/arxiv_data1/oa_pdf/17/da/pi-10-399.PMC3902159.pdf
"Received:  October 24, 2012    Revised:  December 27, 2012 Accepted:  January 16, 2013    Available online:  December 16, 2013  Correspondence:  Chul-Eung Kim, MD, PhD Department of Psychiatry, Inha University College of Medicine, 27 Inhang- ro, Jung-gu, Incheon 400-711, Republic of Korea Tel: +82-32-890-3475, Fax: +82-32-890-3558, E-mail:  kce320@inha.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.407ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/8e/6b/pi-10-407.PMC3902160.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.417   Copyright © 2013 Korean Neuropsychiatric Association   417CASE REPORT  Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive   Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases Yakup Albayrak1  and Kenji Hashimoto2 1Department of Psychiatry, Medical Faculty, Namık Kemal University, Tekirdag, Turkey  2Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan Fluvoxamine is a selective serotonin reuptake inhibitor that is approved for psychiatric disorders such as major depressive episodes and  obsessive-compulsive disorder.",Non-OADS,/arxiv_data1/oa_pdf/ad/91/pi-10-417.PMC3902161.pdf
"Case 2 Mr M, a 41-year-old man, had been diagnosed with schizo -Received: December 11, 2012    Revised: February 5, 2013 Accepted:  March 25, 2013    Available online: October 24, 2013  Correspondence: Y akup Albayrak, MD Department of Psychiatry, Medical Faculty, Namık Kemal University, Namık  Kemal Mahallesi, Kampus Caddesi, Tekirdag, Turkey Tel: +905056355434, Fax: +02822509928, E-mail: dr.fuge@hotmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/91/pi-10-417.PMC3902161.pdf
"Pomorska 251, 92-213 Łódz ´, Poland Tel: +48426757236, Fax: +48426757403  E-mail: dominik.strzelecki@umed.lodz.pl cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.421CASE REPORT",Non-OADS,/arxiv_data1/oa_pdf/89/21/pi-10-421.PMC3902162.pdf
Available at: http://pl.lundbeck.com/pl/PDF/Ebixa%20SA/EBX_Monograph.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/21/pi-10-421.PMC3902162.pdf
"Received: October 2, 2012    Revised: February 7, 2013 Accepted:  February 11, 2013    Available online: December 16, 2013  Correspondence: Ozlem Tanriover, MD Department of Family Medicine, Y editepe University Faculty of Medicine,  Kayisdagi Cad., 26 Agustos Y erlesimi, 34755 Kadikoy-Istanbul, Turkey Tel: +90 533 742 32 00, Fax: +90 216 578 25 75 E-mail: otanriover@yeditepe.edu.tr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.425CASE REPORT",Non-OADS,/arxiv_data1/oa_pdf/07/b3/pi-10-425.PMC3902163.pdf
"Received: February 9, 2013    Revised: February 13, 2013 Accepted:  February 13, 2013    Available online: December 16, 2013  Correspondence: Tae Won Park, MD, PhD  Department of Psychiatry, Chonbuk National University Medical School, 634- 18 Geumam-dong, Jeonju 561-712, Republic of Korea Tel: +82-63-250-2028, Fax: +82-63-275-3157, E-mail: ptaewon@jbnu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.4.428CASE REPORT",Non-OADS,/arxiv_data1/oa_pdf/41/a8/pi-10-428.PMC3902164.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003374).,Non-OADS,/arxiv_data1/oa_pdf/a2/25/bmjopen-2013-003374.PMC3902194.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003536).,Non-OADS,/arxiv_data1/oa_pdf/e0/99/bmjopen-2013-003536.PMC3902195.pdf
Data sharing statement The full protocol is accessible at: http://www.giviti.,OADS,/arxiv_data1/oa_pdf/e0/99/bmjopen-2013-003536.PMC3902195.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003526).,Non-OADS,/arxiv_data1/oa_pdf/57/f9/bmjopen-2013-003526.PMC3902196.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/57/f9/bmjopen-2013-003526.PMC3902196.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003656).,Non-OADS,/arxiv_data1/oa_pdf/4d/75/bmjopen-2013-003656.PMC3902197.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/75/bmjopen-2013-003656.PMC3902197.pdf
http://www.isdscotland.org/Health-Topics/Cancer/Publications (accessed 28 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/4d/75/bmjopen-2013-003656.PMC3902197.pdf
http://guidance.nice.org.uk/CG132 (accessed Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/4d/75/bmjopen-2013-003656.PMC3902197.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003440).,Non-OADS,/arxiv_data1/oa_pdf/b5/94/bmjopen-2013-003440.PMC3902198.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/94/bmjopen-2013-003440.PMC3902198.pdf
http://www.epa.gov/ region09/waste/sfund/prg .,OADS,/arxiv_data1/oa_pdf/ca/87/10661_2013_Article_3472.PMC3902199.pdf
http://www.epa.gov/region6/6pd/rcra_c/ protocol/protocol.htm .,OADS,/arxiv_data1/oa_pdf/ca/87/10661_2013_Article_3472.PMC3902199.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003462).,Non-OADS,/arxiv_data1/oa_pdf/b0/00/bmjopen-2013-003462.PMC3902201.pdf
"2013. http://www.pubs.niaaa.nih.gov/publications/UnderageDrinking/Underage_Fact.pdfTable 5 OR of risky drinking on a usual drinking occasion in the past 6 months Covariate % (SE) OR (95% CI) p Value Gender Male 74.36 (0.31) 7.38 (4.05 to 13.46) 0.000Female 25.63 (0.31) 1 Age 16 26.86 (0.39) 1.26 (0.59 to 2.71) 0.55517 34.38 (0.37) 0.84 (0.40 to 1.74) 0.63718 38.75 (0.31) 1 Supplier Parent 32.5 (0.32) 0.92 (0.49 to 1.74) 0.804Friend 47.5 (0.37) 5.67 (2.54 to12.68) 0.000Other 18.75 (0.39) 1.26 (0.49 to 1.74) 0.557Stranger 1.25 (0.21) 1 Place Own home 22.5 (0.30) 1Another home 18.75 (0.29) 1.13 (0.637 to 2.02) 0.669 Pubs/clubs 43.13 (0.31) 1.99 (1.09 to 3.65) 0.025 Special events 15.63 (0.41) 1.78 (0.80 to 3.96) 0.159 Asante LS, Chun S, Yun M, et al.BMJ Open 2014; 4:e003462.",Non-OADS,/arxiv_data1/oa_pdf/b0/00/bmjopen-2013-003462.PMC3902201.pdf
Korea National Legislation Information Center (http://www.law.go.kr).,Non-OADS,/arxiv_data1/oa_pdf/b0/00/bmjopen-2013-003462.PMC3902201.pdf
2011. http://www.law.go.kr/lsInfoP.do?lsiSeq=121990&efYd=20120916#0000 (accessed 9 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/b0/00/bmjopen-2013-003462.PMC3902201.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003627).,Non-OADS,/arxiv_data1/oa_pdf/fb/e5/bmjopen-2013-003627.PMC3902202.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/19/bmjopen-2013-003517.PMC3902203.pdf
Golf participation in Europe 2011. http://www.kpmg.com/Global/ en/industry/real-estate/Documents/golf-participation-in-europe.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/4d/19/bmjopen-2013-003517.PMC3902203.pdf
2007. http://www.thebsa.org.uk/docs/RecPro/REM.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/4d/19/bmjopen-2013-003517.PMC3902203.pdf
http://www.head-acoustics.de/downloads/eng/application_notes/Golfclubs_06_11e.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/4d/19/bmjopen-2013-003517.PMC3902203.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/09/cmt061.PMC3902211.pdf
This study was supported  by the UK National Prevention Research Initiative ( http://www.npri.,Non-OADS,/arxiv_data1/oa_pdf/c3/09/cmt061.PMC3902211.pdf
"Princeton, NJ: Robert Johnson Wood Foundation, 2010.  http://www.rwjf.org/content/dam/farm/reports/reports/2010/ rwjf54583 .",Non-OADS,/arxiv_data1/oa_pdf/c3/09/cmt061.PMC3902211.pdf
http://www.who.int/healthinfo/global_bur - den_disease/metrics_paf/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/c3/09/cmt061.PMC3902211.pdf
http://www.ic.nhs.uk/ statistics-and-data-collections/health-and-lifestyles-related-surveys/ health-survey-for-england/health-survey-for-england--2010-trend-tables .,Non-OADS,/arxiv_data1/oa_pdf/c3/09/cmt061.PMC3902211.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits  non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/99/cmt063.PMC3902212.pdf
http://www.hscic.gov.uk/catalogue  (accessed on 5 August 2013).2.,Non-OADS,/arxiv_data1/oa_pdf/a7/99/cmt063.PMC3902212.pdf
Safeguarding children and young people: A toolkit  for general practice 2011. http://www.rcgp.org.uk/clinical_and_research/ safeguarding_children_tookit.aspx  (accessed on 14 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/a7/99/cmt063.PMC3902212.pdf
http://www.education.gov.uk/munroreview/index.shtml   (accessed on 14 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/a7/99/cmt063.PMC3902212.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003713).,Non-OADS,/arxiv_data1/oa_pdf/4d/2b/bmjopen-2013-003713.PMC3902303.pdf
"It aspires to enableall funded projects to complete and publish in the pro- gramme ’s own journal HTA, freely available on the pro- gramme ’s website (http://www.hta.ac.uk).",Non-OADS,/arxiv_data1/oa_pdf/4d/2b/bmjopen-2013-003713.PMC3902303.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/2b/bmjopen-2013-003713.PMC3902303.pdf
2011. http://www.un.org/en/ga/ ncdmeeting2011/ 8.,Non-OADS,/arxiv_data1/oa_pdf/45/89/bmjopen-2013-003720.PMC3902305.pdf
2011. http://www.bag.admin.ch/themen/ernaehrung_ bewegung/05190/05294/12869/index.html 11.,Non-OADS,/arxiv_data1/oa_pdf/45/89/bmjopen-2013-003720.PMC3902305.pdf
2006. http://www.heartfoundation.org.au/ SiteCollectionDocuments/Dietary-Electrolytes-CVD-Summary-Evidence.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/45/89/bmjopen-2013-003720.PMC3902305.pdf
http://www.foodstandards.gov.au/_srcfiles/Salt_Intake_5.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/45/89/bmjopen-2013-003720.PMC3902305.pdf
2012. https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/213420/Sodium-Survey-England-2011_Text_to-DH_FINAL1.pdf 40.,Non-OADS,/arxiv_data1/oa_pdf/45/89/bmjopen-2013-003720.PMC3902305.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003690).,Non-OADS,/arxiv_data1/oa_pdf/93/4c/bmjopen-2013-003690.PMC3902306.pdf
http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/93/4c/bmjopen-2013-003690.PMC3902306.pdf
http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/mental-health/news/news/2012/10/depression-in-europe (accessed 20 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/93/4c/bmjopen-2013-003690.PMC3902306.pdf
http://www.who.int/topics/ depression/en/ (accessed 20 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/93/4c/bmjopen-2013-003690.PMC3902306.pdf
"http://www.cochrane-handbook.org, 2011.",OADS,/arxiv_data1/oa_pdf/93/4c/bmjopen-2013-003690.PMC3902306.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003689).,Non-OADS,/arxiv_data1/oa_pdf/f1/45/bmjopen-2013-003689.PMC3902307.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/45/bmjopen-2013-003689.PMC3902307.pdf
http://www12.statcan.ca/census-recensement/2006/dp-pd/hlt/97-558/pages/page.,OADS,/arxiv_data1/oa_pdf/f1/45/bmjopen-2013-003689.PMC3902307.pdf
http://www12.statcan.ca/census-recensement/2006/as-sa/97-558/tables-tableaux-notes-eng.cfm#figures (accessed 23 May 2011).,OADS,/arxiv_data1/oa_pdf/f1/45/bmjopen-2013-003689.PMC3902307.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003667).,Non-OADS,/arxiv_data1/oa_pdf/d7/9d/bmjopen-2013-003667.PMC3902308.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003706).,Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
16. http://www.isdscotland.org/Health-Topics/Hospital-Care/Publications/ 2012-09-25/IP_DC_OP_Procedures_Sep12.xls (accessed 18 Jan2013).,Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
2011. http://userpage.fu-berlin.de/%7Ehealth/faq_gse.pdf (accessed 27 Jan2013).,Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
23. http://www.ipaq.ki.se/downloads.htm (accessed 11 Jan 2013).24.,Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
25. http://www.foodfrequency.org.uk (accessed 11 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
27. http://www.who.int/dietphysicalactivity/en/ (accessed 11 Jan 2013).28.,Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
"Edinburgh: Scottish Government, 2008. http://www.scotland.",Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
"Edinburgh: Scottish Government, 2009. http://www.scotland.gov.uk/Resource/Doc/262905/0078610.pdf (accessed 27 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
31. http://simd.scotland.gov.uk/publication-2012/ (accessed 11 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
41. http://www.healthscotland.com/topics/settings/health/index.,Non-OADS,/arxiv_data1/oa_pdf/31/d8/bmjopen-2013-003706.PMC3902309.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003698).,Non-OADS,/arxiv_data1/oa_pdf/69/81/bmjopen-2013-003698.PMC3902310.pdf
BMC Musculoskelet Disord 2004;5:2. http://www.biomedcentral.com/content/pdf/1471 –2474-5-2.pdf (accessed Sep 2013).,OADS,/arxiv_data1/oa_pdf/69/81/bmjopen-2013-003698.PMC3902310.pdf
The English Indices of deprivation 2004-summary (revised); http://www.brent.gov.uk/tps.nsf/Files/LBBA869/$FILE/sd62bIndicesofDeprivation2004.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/69/81/bmjopen-2013-003698.PMC3902310.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003671).,Non-OADS,/arxiv_data1/oa_pdf/8b/3b/bmjopen-2013-003671.PMC3902312.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8b/3b/bmjopen-2013-003671.PMC3902312.pdf
http://ci5.iarc.fr(accessed 30 Nov 2013) 15.,Non-OADS,/arxiv_data1/oa_pdf/8b/3b/bmjopen-2013-003671.PMC3902312.pdf
http://www.health.gov.au/internet/screening/publishing.nsf/ Content/2DDFA95B20302107CA257 (accessed 30 Nov 2013) 22.,Non-OADS,/arxiv_data1/oa_pdf/8b/3b/bmjopen-2013-003671.PMC3902312.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003670).,Non-OADS,/arxiv_data1/oa_pdf/cb/b6/bmjopen-2013-003670.PMC3902313.pdf
"Vienna, Austria: R Foundation for Statistical Computing, 2011. http://www.R-project.org/ 18.",Non-OADS,/arxiv_data1/oa_pdf/cb/b6/bmjopen-2013-003670.PMC3902313.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003699).,Non-OADS,/arxiv_data1/oa_pdf/61/03/bmjopen-2013-003699.PMC3902314.pdf
http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf 13.,OADS,/arxiv_data1/oa_pdf/61/03/bmjopen-2013-003699.PMC3902314.pdf
http://www.cdc.gov/nchs/data/databriefs/db42.htm 19.,OADS,/arxiv_data1/oa_pdf/61/03/bmjopen-2013-003699.PMC3902314.pdf
http://www.pharmacy.ca.gov/laws_regs/1707_5_proposed_text.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/61/03/bmjopen-2013-003699.PMC3902314.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003845).,Non-OADS,/arxiv_data1/oa_pdf/dd/bc/bmjopen-2013-003845.PMC3902327.pdf
"ISD Scotland, better information, better decisions, better health, http://www.isdscotland.org (accessed 12 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/bmjopen-2013-003845.PMC3902327.pdf
doi:10.1136/bmjopen-2013- 004018 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004018).,Non-OADS,/arxiv_data1/oa_pdf/84/24/bmjopen-2013-004018.PMC3902328.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004066).,Non-OADS,/arxiv_data1/oa_pdf/03/53/bmjopen-2013-004066.PMC3902329.pdf
http://faculty.chass.ncsu.edu/garson/PA765/reliability.htm (accessed 17 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/03/53/bmjopen-2013-004066.PMC3902329.pdf
http://pareonline.net/ pdf/v10n7.pdf 48.,Non-OADS,/arxiv_data1/oa_pdf/03/53/bmjopen-2013-004066.PMC3902329.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004046).,Non-OADS,/arxiv_data1/oa_pdf/af/33/bmjopen-2013-004046.PMC3902330.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/af/33/bmjopen-2013-004046.PMC3902330.pdf
http://www.bbc.co.uk/news/health-20584897 (accessed 4 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/af/33/bmjopen-2013-004046.PMC3902330.pdf
34. http://www.isdscotland.org/Health-Topics/Finance/Costs/Detailed-Tables/ Theatres.asp (accessed 30 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/af/33/bmjopen-2013-004046.PMC3902330.pdf
http://www.westhertshospitals.,Non-OADS,/arxiv_data1/oa_pdf/af/33/bmjopen-2013-004046.PMC3902330.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003874).,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/bmjopen-2013-003874.PMC3902331.pdf
2012. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216855/ CYP-Acutely-Ill.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/bmjopen-2013-003874.PMC3902331.pdf
2007. http://www.nice.org.uk/cg047 11.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/bmjopen-2013-003874.PMC3902331.pdf
2006. http://www.sign.ac.uk/pdf/qrg91.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/bmjopen-2013-003874.PMC3902331.pdf
2007. http://www.nhsalliance.org/publication/view/out-of-hours-clinical-audit-toolkit/ 13.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/bmjopen-2013-003874.PMC3902331.pdf
2012. http://publications.nice.org.uk/quality-standard-for-bacterial-meningitis-and-meningococcal-septicaemia-in-children-and-young-qs19/list-of-quality-statements 16.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/bmjopen-2013-003874.PMC3902331.pdf
2013 [21 Nov 2013]; http://publications.nice.org.uk/ifp160 22.,Non-OADS,/arxiv_data1/oa_pdf/0d/a3/bmjopen-2013-003874.PMC3902331.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-004158).,Non-OADS,/arxiv_data1/oa_pdf/1b/78/bmjopen-2013-004158.PMC3902332.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/d8/bmjopen-2013-003996.PMC3902333.pdf
April 2009. http://www.nice.org.uk/nicemedia/live/12145/43887/43887.pdf (accessed 15 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/4e/d8/bmjopen-2013-003996.PMC3902333.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/4e/d8/bmjopen-2013-003996.PMC3902333.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003873).,Non-OADS,/arxiv_data1/oa_pdf/b3/db/bmjopen-2013-003873.PMC3902334.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004153).,Non-OADS,/arxiv_data1/oa_pdf/26/d3/bmjopen-2013-004153.PMC3902335.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/26/d3/bmjopen-2013-004153.PMC3902335.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004039).,Non-OADS,/arxiv_data1/oa_pdf/96/d4/bmjopen-2013-004039.PMC3902336.pdf
http://www.quality-health.co.uk/images/stories/pdfs/2012CancerReports/2011-12cancerpatientexperiencesurveynationalreport.pdf (last accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/96/d4/bmjopen-2013-004039.PMC3902336.pdf
http://www.bbc.co.uk/news/uk-england-london-19408829(last accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/96/d4/bmjopen-2013-004039.PMC3902336.pdf
SN: 7134. http://dx.doi.org/10.5255/UKDA-SN-7134 –1 (last accessed Nov 2013).,OADS,/arxiv_data1/oa_pdf/96/d4/bmjopen-2013-004039.PMC3902336.pdf
SN: 7034. http://dx.doi.org/10.5255/UKDA-SN-7034 –1 (last accessed Nov 2013).,OADS,/arxiv_data1/oa_pdf/96/d4/bmjopen-2013-004039.PMC3902336.pdf
http://www.hsj.co.uk/news/policy/london-trusts-fare-poorly-in-national-hospital-patient-survey/5057705.article (last accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/96/d4/bmjopen-2013-004039.PMC3902336.pdf
doi:10.1136/bmjopen-2013- 003980 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003980).,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2013-003980.PMC3902347.pdf
"Setting We will recruit participants from a unique website, which is visited by the majority of Moroccan-Dutch adolescents:http://www.marokko.nl.",Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2013-003980.PMC3902347.pdf
This mental health domain of Marokko.nl iscalled http://www.ziekofbezeten.marokko.nl ( ‘ziek of bezeten ’means: being ill or being possessed).,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2013-003980.PMC3902347.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2013-003980.PMC3902347.pdf
"13. http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL& PA=37325&D1=a&D2=0&D3=0&D4=0&D5=0-1,3,137,152,220,237&D6=l&HD=130312-1304&HDR=T&STB=G1,G2,G3,G4,G5 14.",Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2013-003980.PMC3902347.pdf
34. http://www.urbanconnect.nl/index.php?nav=static&pagina=Marokko.nl35.,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2013-003980.PMC3902347.pdf
54. http://www.qualtrics.com55.,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/bmjopen-2013-003980.PMC3902347.pdf
"5. WHO Patient Safety Solutions| volume 1, solution 3 | May 2007. http://www.refworks.com/refgrabit/rw2linkpage.aspx?subscriber=6107&user=1209&_=1344860455630 (accessed 13 Aug2012).6.",Non-OADS,/arxiv_data1/oa_pdf/0c/d0/bmjopen-2013-004268.PMC3902348.pdf
Copyright 1989. http://shortellresearch.berkeley.edu/ICU.htm (accessed 24 Sept 2013).,Non-OADS,/arxiv_data1/oa_pdf/0c/d0/bmjopen-2013-004268.PMC3902348.pdf
January 2009. http://www.who.int/patientsafety/implementation/taxonomy/publications/en/index.html.,OADS,/arxiv_data1/oa_pdf/0c/d0/bmjopen-2013-004268.PMC3902348.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003883).,Non-OADS,/arxiv_data1/oa_pdf/ef/05/bmjopen-2013-003883.PMC3902349.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/05/bmjopen-2013-003883.PMC3902349.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004069).,Non-OADS,/arxiv_data1/oa_pdf/f5/08/bmjopen-2013-004069.PMC3902350.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1. http://www.who.int/en/ (accessed 18 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/f5/08/bmjopen-2013-004069.PMC3902350.pdf
4. http://www.goldcopd.org (accessed 18 Apr 2013).5.,Non-OADS,/arxiv_data1/oa_pdf/f5/08/bmjopen-2013-004069.PMC3902350.pdf
doi:10.1136/bmjopen-2013- 004195 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004195).,Non-OADS,/arxiv_data1/oa_pdf/ce/72/bmjopen-2013-004195.PMC3902351.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/72/bmjopen-2013-004195.PMC3902351.pdf
"Bureau of Health Information, 2011. http://www.bhi.nsw.gov.au/publications/annual_performance_report_series/healthcare_in_focus_2011 (accessed 30 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/ce/72/bmjopen-2013-004195.PMC3902351.pdf
2010. http://www.who.int/violence_injury_prevention/other_ injury/falls/en/index.html (accessed 30 Sept 2013).,Non-OADS,/arxiv_data1/oa_pdf/ce/72/bmjopen-2013-004195.PMC3902351.pdf
http://www.health.wa.gov.au/activity/home/index.cfm(accessed 30 Sep 2013).,OADS,/arxiv_data1/oa_pdf/ce/72/bmjopen-2013-004195.PMC3902351.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004026).,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/bmjopen-2013-004026.PMC3902355.pdf
November 2013. http://www.ons.gov.uk/ons/dcp171778_296157.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/bmjopen-2013-004026.PMC3902355.pdf
http://dx.doi.org/10.1016/0301 –2115(95)02201-H 17.,OADS,/arxiv_data1/oa_pdf/bf/6b/bmjopen-2013-004026.PMC3902355.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003917).,Non-OADS,/arxiv_data1/oa_pdf/80/0e/bmjopen-2013-003917.PMC3902361.pdf
"National routinely collected datasets In Scotland, routinely collected health information and statistics are collated and stored in a national database bythe Information Services Division (ISD), National Health Service (NHS) Scotland (http://www.isdscotland.org/ isd/1.html).",OADS,/arxiv_data1/oa_pdf/80/0e/bmjopen-2013-003917.PMC3902361.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004143).,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/bmjopen-2013-004143.PMC3902362.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/bmjopen-2013-004143.PMC3902362.pdf
http://www.controlled-trials.com/ISRCTN78372190/STREAM 18.,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/bmjopen-2013-004143.PMC3902362.pdf
http://clinicaltrials.gov/ct2/show/ NCT0169153451.,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/bmjopen-2013-004143.PMC3902362.pdf
"Geneva, Switzerland: WHO, 2012. http://www.who.int/tb/challenges/mdr/ greenlightcommittee/Meetingreport2ndgGLCmeeting.pdf 56. WHO.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/bmjopen-2013-004143.PMC3902362.pdf
http://grls.rosminzdrav.ru/ 74.,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/bmjopen-2013-004143.PMC3902362.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004230).,Non-OADS,/arxiv_data1/oa_pdf/b1/70/bmjopen-2013-004230.PMC3902363.pdf
Sociol Res 2004;9. http://www.socresonline.org.uk/9/2/bagnoli.html (accessed 20 Dec 20 2012).,Non-OADS,/arxiv_data1/oa_pdf/b1/70/bmjopen-2013-004230.PMC3902363.pdf
2001. http://www.indiana.edu/~cshm/oral_history_techniques.pdf (accessed Mar 18 2013).,Non-OADS,/arxiv_data1/oa_pdf/b1/70/bmjopen-2013-004230.PMC3902363.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003799).,Non-OADS,/arxiv_data1/oa_pdf/88/aa/bmjopen-2013-003799.PMC3902374.pdf
2010. http://riskfactor.cancer.,Non-OADS,/arxiv_data1/oa_pdf/88/aa/bmjopen-2013-003799.PMC3902374.pdf
doi:10.1136/bmjopen-2013- 004465 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004465).,Non-OADS,/arxiv_data1/oa_pdf/d3/3d/bmjopen-2013-004465.PMC3902375.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/3d/bmjopen-2013-004465.PMC3902375.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004129).,Non-OADS,/arxiv_data1/oa_pdf/16/14/bmjopen-2013-004129.PMC3902376.pdf
Data sharing statement Further data relating to the Research Investments project can be found at http://www.researchinvestments.org or by contactingthe corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/16/14/bmjopen-2013-004129.PMC3902376.pdf
"Berlin, 2013. http://www.life-worldwide.org/assets/uploads/files/ECCMID global Burden abstracts final Nov 2012 3.pdf2.",Non-OADS,/arxiv_data1/oa_pdf/16/14/bmjopen-2013-004129.PMC3902376.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23140942 (accessed 17 Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/16/14/bmjopen-2013-004129.PMC3902376.pdf
http://www.researchinvestments.org/ (accessed 30 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/16/14/bmjopen-2013-004129.PMC3902376.pdf
J Antimicrob Chemother 2013. http://www.ncbi.nlm.nih.gov/pubmed/24038777 (accessed 26 Sep2013).,OADS,/arxiv_data1/oa_pdf/16/14/bmjopen-2013-004129.PMC3902376.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004097).,Non-OADS,/arxiv_data1/oa_pdf/9a/78/bmjopen-2013-004097.PMC3902377.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003985).,Non-OADS,/arxiv_data1/oa_pdf/38/da/bmjopen-2013-003985.PMC3902378.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/38/da/bmjopen-2013-003985.PMC3902378.pdf
http://www.iefp.pt/formacao/CNP/Paginas/CNP.aspx 25.,Non-OADS,/arxiv_data1/oa_pdf/38/da/bmjopen-2013-003985.PMC3902378.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004302).,Non-OADS,/arxiv_data1/oa_pdf/8e/33/bmjopen-2013-004302.PMC3902379.pdf
The websites tb.org and http://www.stoptb.org will be sought for available material.,Non-OADS,/arxiv_data1/oa_pdf/8e/33/bmjopen-2013-004302.PMC3902379.pdf
"Geneva: World Health Organization, 2012. http://www.who.int/tb/publications/global_report/gtbr12_main.pdf (accessed 2 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/8e/33/bmjopen-2013-004302.PMC3902379.pdf
"Geneva: World Health Organization, 2007.http://www.stoptb.org/assets/documents/resources/publications/ acsm/ACSM_Handbook.pdf (accessed 2 Oct 2013).",Non-OADS,/arxiv_data1/oa_pdf/8e/33/bmjopen-2013-004302.PMC3902379.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 14.",OADS,/arxiv_data1/oa_pdf/8e/33/bmjopen-2013-004302.PMC3902379.pdf
"Data Collection Checklist, 2008. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf (accessed 28 Nov 2013).",OADS,/arxiv_data1/oa_pdf/8e/33/bmjopen-2013-004302.PMC3902379.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004210).,Non-OADS,/arxiv_data1/oa_pdf/50/71/bmjopen-2013-004210.PMC3902380.pdf
http://www.aaaqip.com/files/aaaqip-interim-report-new-final-printed-version-23 –06–11.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/31/dc/bmjopen-2013-004094.PMC3902383.pdf
Second Vascular Surgery Database Report 2008. http://www.esvs.,Non-OADS,/arxiv_data1/oa_pdf/31/dc/bmjopen-2013-004094.PMC3902383.pdf
http://www.vascularsociety.org.uk/vascular/wp-content/uploads/2012/11/VSGBI-Mortality-Report.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/31/dc/bmjopen-2013-004094.PMC3902383.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/73/e4/srep03875.PMC3902384.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3875 | DOI: 10.1038/srep03875 8",Non-OADS,/arxiv_data1/oa_pdf/73/e4/srep03875.PMC3902384.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3860 | DOI: 10.1038/srep03860 5",Non-OADS,/arxiv_data1/oa_pdf/ff/a2/srep03860.PMC3902385.pdf
doi:10.1136/bmjopen-2013-004205 ▸Prepublication history and additional material for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004205).,Non-OADS,/arxiv_data1/oa_pdf/b8/d3/bmjopen-2013-004205.PMC3902386.pdf
"Washington, DC: U.S. Department of Defense, 2009. http://www.healthquality.va.gov/mtbi/concussion_mtbi_full_1_0.pdf (accessed18 Jun 2013).Table 4 Generalised linear regression coefficient estimates of four measurements in controls and patients with mTBI at baseline and 6 weeks postinjury Control vs mTBI (baseline) Control vs mTBI (6 weeks) BAI BDI ESS PSQI BAI BDI ESS PSQI mTBI 1.4* 0.567* 0.245* 0.487* 1.026* 2.632* 1.309* 0.557 Age 0.0007 −0.003 −0.007* 0.003 −0.001 −0.035 −0.045* 0.016 Women 0.437* 0.056* 0.137* 0.137* 0.562* 2.945* 1.263* 1.170* *p<0.05.",Non-OADS,/arxiv_data1/oa_pdf/b8/d3/bmjopen-2013-004205.PMC3902386.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d8/df/srep03869.PMC3902387.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3869 | DOI: 10.1038/srep03869 8",Non-OADS,/arxiv_data1/oa_pdf/d8/df/srep03869.PMC3902387.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3867 | DOI: 10.1038/srep03867 7",Non-OADS,/arxiv_data1/oa_pdf/ec/02/srep03867.PMC3902388.pdf
"Web.,http://www.aoml.noaa.gov/hrd/hurdat/Data_Storm.html .Accessed 20 October 2013.",OADS,/arxiv_data1/oa_pdf/17/94/srep03876.PMC3902391.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3876 | DOI: 10.1038/srep03876 7",Non-OADS,/arxiv_data1/oa_pdf/17/94/srep03876.PMC3902391.pdf
"10 slides of each lung were examined by Olympus BX41 micro- scope and images were acquired by Olympus DP72 digital camera, followed by image analysis using ImageJ software (available from http://rsbweb.nih.gov/ij/).",Non-OADS,/arxiv_data1/oa_pdf/90/d7/srep03864.PMC3902392.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3864 | DOI: 10.1038/srep03864 5",Non-OADS,/arxiv_data1/oa_pdf/90/d7/srep03864.PMC3902392.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004283).,Non-OADS,/arxiv_data1/oa_pdf/a7/3f/bmjopen-2013-004283.PMC3902401.pdf
"A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org and http://www.regardssepsis.org Contributors HEW, JMS and GH conceived the study.",Non-OADS,/arxiv_data1/oa_pdf/a7/3f/bmjopen-2013-004283.PMC3902401.pdf
"Helping Patients Who Drink Too Much, a Clinician ’s Guide NIH publication 2015:07- 3769, available at http://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/guide.pdf.",Non-OADS,/arxiv_data1/oa_pdf/a7/3f/bmjopen-2013-004283.PMC3902401.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003919).,Non-OADS,/arxiv_data1/oa_pdf/f1/3c/bmjopen-2013-003919.PMC3902402.pdf
2012. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131639453 10.,Non-OADS,/arxiv_data1/oa_pdf/f1/3c/bmjopen-2013-003919.PMC3902402.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004156).,Non-OADS,/arxiv_data1/oa_pdf/8f/0e/bmjopen-2013-004156.PMC3902403.pdf
doi:10.1136/bmjopen-2013- 004132 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004132).,Non-OADS,/arxiv_data1/oa_pdf/bc/80/bmjopen-2013-004132.PMC3902404.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/af/srep03892.PMC3902405.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3892 | DOI: 10.1038/srep03892 7",Non-OADS,/arxiv_data1/oa_pdf/57/af/srep03892.PMC3902405.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003735).,Non-OADS,/arxiv_data1/oa_pdf/68/9f/bmjopen-2013-003735.PMC3902406.pdf
"101The authors deemed these differences to be suf ﬁcient to warrant the use of national growth curves over the MGRS curves.101 Overall, 20% of the total means were ≥0.5 SD from the ihttp://apps.nccd.cdc.gov/dnpabmi/Calculator.aspx?",OADS,/arxiv_data1/oa_pdf/68/9f/bmjopen-2013-003735.PMC3902406.pdf
2012. http://www.moh.gov.gr/articles/ citizen/anakoinwseis-ndash-egkyklioi/173-bibliario-ygeias-paidioy 81.,Non-OADS,/arxiv_data1/oa_pdf/68/9f/bmjopen-2013-003735.PMC3902406.pdf
Geneva: World HealthOrganization (2006) http://www.who.int/childgrowth/standards/technical_report/en/index.html (accessed August 2013).,Non-OADS,/arxiv_data1/oa_pdf/fa/2e/srep03889.PMC3902432.pdf
http://www.who.int/childgrowth/software/en/ (accessed January2013).,Non-OADS,/arxiv_data1/oa_pdf/fa/2e/srep03889.PMC3902432.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3889 | DOI: 10.1038/srep03889 6",Non-OADS,/arxiv_data1/oa_pdf/fa/2e/srep03889.PMC3902432.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003954).,Non-OADS,/arxiv_data1/oa_pdf/7c/80/bmjopen-2013-003954.PMC3902435.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/80/bmjopen-2013-003954.PMC3902435.pdf
"Korea Centers for Disease Control and Prevention, 2007.http://www.cdc.go.kr/CDC/cms/content/49/12449_view.html 22.",Non-OADS,/arxiv_data1/oa_pdf/7c/80/bmjopen-2013-003954.PMC3902435.pdf
"Secondary Global database on body mass index:BMI classification, 2008. http://www.who.int/bmi/index.jsp?introPage=intro_3.html 23.",OADS,/arxiv_data1/oa_pdf/7c/80/bmjopen-2013-003954.PMC3902435.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3893 | DOI: 10.1038/srep03893 6",Non-OADS,/arxiv_data1/oa_pdf/3d/bb/srep03893.PMC3902437.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003824).,Non-OADS,/arxiv_data1/oa_pdf/f9/82/bmjopen-2013-003824.PMC3902438.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/54/0b/srep03888.PMC3902440.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3888 | DOI: 10.1038/srep03888 7",Non-OADS,/arxiv_data1/oa_pdf/54/0b/srep03888.PMC3902440.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/80/b5/srep03878.PMC3902441.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3878 | DOI: 10.1038/srep03878 8",Non-OADS,/arxiv_data1/oa_pdf/80/b5/srep03878.PMC3902441.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/66/18/srep03890.PMC3902442.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3890 | DOI: 10.1038/srep03890 6",Non-OADS,/arxiv_data1/oa_pdf/66/18/srep03890.PMC3902442.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c6/7d/srep03872.PMC3902446.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3872 | DOI: 10.1038/srep03872 10",Non-OADS,/arxiv_data1/oa_pdf/c6/7d/srep03872.PMC3902446.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004073).,Non-OADS,/arxiv_data1/oa_pdf/fc/7f/bmjopen-2013-004073.PMC3902459.pdf
"METHODS Identification of a new MS natural history dataset The Scienti ﬁc Advisory Group undertook a detailed examination of all the available dataset through litera-ture reviews, expert opinion, discussion with the clinical leads for the RSS and discussion with the Sylvia Lawry Centre for Multiple Sclerosis Research, Germany(http://www.slcmsr.net).",Non-OADS,/arxiv_data1/oa_pdf/fc/7f/bmjopen-2013-004073.PMC3902459.pdf
A list of the centres can be found at http://www.mstrust.org.uk/research/risksharingscheme/.,Non-OADS,/arxiv_data1/oa_pdf/fc/7f/bmjopen-2013-004073.PMC3902459.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fc/7f/bmjopen-2013-004073.PMC3902459.pdf
"A cross-sectional observational study in the UK.Scandinavian Working Papers in Economics, 2000. http://swopec.hhs.se/hastef/papers/hastef0398.pdf (accessed 28 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/fc/7f/bmjopen-2013-004073.PMC3902459.pdf
26. http://www.bcstats.gov.bc.ca/StatisticsBySubjct/Census.aspx Specifically the 1986 Census.,OADS,/arxiv_data1/oa_pdf/fc/7f/bmjopen-2013-004073.PMC3902459.pdf
"28. http://www.msif.org/includes/documents/cm_docs/2013/m/ msif-atlas-of-ms-2013-report.pdf?f=1 Palace J, Bregenzer T, Tremlett H, et al.BMJ Open 2014; 4:e004073.",Non-OADS,/arxiv_data1/oa_pdf/fc/7f/bmjopen-2013-004073.PMC3902459.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004136).,Non-OADS,/arxiv_data1/oa_pdf/6c/22/bmjopen-2013-004136.PMC3902460.pdf
20. http://www.consort-statement.org/ (assessed 9 Sep 2013).21.,Non-OADS,/arxiv_data1/oa_pdf/6c/22/bmjopen-2013-004136.PMC3902460.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/00/bc/bmjopen-2013-004089.PMC3902462.pdf
Pew internet & American life project 19 May 2013: http://pewinternet.org/Static-Pages/Trend-Data-(Adults)/Whos-Online.aspx (accessed 3 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/00/bc/bmjopen-2013-004089.PMC3902462.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004182).,Non-OADS,/arxiv_data1/oa_pdf/eb/bb/bmjopen-2013-004182.PMC3902463.pdf
http://www.npcnow.org/issuearea/ebm.asp 2.,Non-OADS,/arxiv_data1/oa_pdf/eb/bb/bmjopen-2013-004182.PMC3902463.pdf
http://www.nice.org.uk/ aboutnice/howwework/how_we_work.jsp 3.,Non-OADS,/arxiv_data1/oa_pdf/eb/bb/bmjopen-2013-004182.PMC3902463.pdf
http://www.nice.org.uk/TA159 5.,Non-OADS,/arxiv_data1/oa_pdf/eb/bb/bmjopen-2013-004182.PMC3902463.pdf
http://www.hesonline.nhs.,Non-OADS,/arxiv_data1/oa_pdf/eb/bb/bmjopen-2013-004182.PMC3902463.pdf
http://www.nhis.info/7.,Non-OADS,/arxiv_data1/oa_pdf/eb/bb/bmjopen-2013-004182.PMC3902463.pdf
http://www.rightcare.nhs.uk/ resources 10.,Non-OADS,/arxiv_data1/oa_pdf/eb/bb/bmjopen-2013-004182.PMC3902463.pdf
http://www.rightcare.,Non-OADS,/arxiv_data1/oa_pdf/eb/bb/bmjopen-2013-004182.PMC3902463.pdf
http://www.nice.org.uk/usingguidance/niceimplementationprogramme/nice_implementation_programme.jsp 12.,Non-OADS,/arxiv_data1/oa_pdf/eb/bb/bmjopen-2013-004182.PMC3902463.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003986).,Non-OADS,/arxiv_data1/oa_pdf/f9/14/bmjopen-2013-003986.PMC3902464.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004062).,Non-OADS,/arxiv_data1/oa_pdf/ba/fa/bmjopen-2013-004062.PMC3902465.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ba/fa/bmjopen-2013-004062.PMC3902465.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004221).,Non-OADS,/arxiv_data1/oa_pdf/82/dc/bmjopen-2013-004221.PMC3902466.pdf
Information available on: http://www.adrreports.eu.,Non-OADS,/arxiv_data1/oa_pdf/82/dc/bmjopen-2013-004221.PMC3902466.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/82/dc/bmjopen-2013-004221.PMC3902466.pdf
doi:10.1136/bmjopen-2013- 004178 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004178).,Non-OADS,/arxiv_data1/oa_pdf/9e/2f/bmjopen-2013-004178.PMC3902485.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b9/9f/srep03873.PMC3902486.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3873 | DOI: 10.1038/srep03873 7",Non-OADS,/arxiv_data1/oa_pdf/b9/9f/srep03873.PMC3902486.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003747).,Non-OADS,/arxiv_data1/oa_pdf/26/36/bmjopen-2013-003747.PMC3902487.pdf
http://www.scotland.gov.uk/ Topics/Statistics/SIMD (accessed 15 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/26/36/bmjopen-2013-003747.PMC3902487.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004147).,Non-OADS,/arxiv_data1/oa_pdf/cc/96/bmjopen-2013-004147.PMC3902490.pdf
2012. http://www.dh.gov.uk (Search for: 17827).,OADS,/arxiv_data1/oa_pdf/cc/96/bmjopen-2013-004147.PMC3902490.pdf
2008. http://www.mrc.ac.uk/ complexinterventionsguidance (accessed Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/cc/96/bmjopen-2013-004147.PMC3902490.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/07/62/srep03850.PMC3902491.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3850 | DOI: 10.1038/srep03850 9",Non-OADS,/arxiv_data1/oa_pdf/07/62/srep03850.PMC3902491.pdf
79. http://www.ebi.ac.uk/thornton-srv/software/PoreWalker/.,Non-OADS,/arxiv_data1/oa_pdf/82/17/srep03885.PMC3902492.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/82/17/srep03885.PMC3902492.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3885 | DOI: 10.1038/srep03885 11",Non-OADS,/arxiv_data1/oa_pdf/82/17/srep03885.PMC3902492.pdf
doi:10.1136/bmjopen-2013- 004165 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004165).,Non-OADS,/arxiv_data1/oa_pdf/b7/48/bmjopen-2013-004165.PMC3902503.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/48/bmjopen-2013-004165.PMC3902503.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003976).,Non-OADS,/arxiv_data1/oa_pdf/ba/44/bmjopen-2013-003976.PMC3902504.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004052).,Non-OADS,/arxiv_data1/oa_pdf/ff/6a/bmjopen-2013-004052.PMC3902505.pdf
2009. http://www.sst.dk/Udgivelser/2009/Pakkeforloeb%20for%20ustabil%20angina%20pectoris%20UAP%20og%20akut%20myokardieinfakt%20uden%20st-elevation%20NSTEMI.aspx 7.,Non-OADS,/arxiv_data1/oa_pdf/ff/6a/bmjopen-2013-004052.PMC3902505.pdf
doi:10.1136/bmjopen-2013- 004166 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004166).,Non-OADS,/arxiv_data1/oa_pdf/76/3f/bmjopen-2013-004166.PMC3902506.pdf
"According to the Swedish Social InsuranceAgency, the total cost of a 1-week sick leave based on the average salary in Sweden 2011 (including sick-pay, general payroll tax, vacation-pay and overhead costs)exceeds US$1300 (http://www.scb.se).",Non-OADS,/arxiv_data1/oa_pdf/76/3f/bmjopen-2013-004166.PMC3902506.pdf
2013. http://www.socialstyrelsen.se/statistik/statistikdatabas/dagkirurgi(accessed 14 Sep 2013).,OADS,/arxiv_data1/oa_pdf/76/3f/bmjopen-2013-004166.PMC3902506.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004303).,Non-OADS,/arxiv_data1/oa_pdf/24/cf/bmjopen-2013-004303.PMC3902507.pdf
5. http://www.ic.nhs.uk/thermometer (accessed 07/05/2013).6.,Non-OADS,/arxiv_data1/oa_pdf/24/cf/bmjopen-2013-004303.PMC3902507.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004027).,Non-OADS,/arxiv_data1/oa_pdf/e3/d3/bmjopen-2013-004027.PMC3902508.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004001).,Non-OADS,/arxiv_data1/oa_pdf/7b/72/bmjopen-2013-004001.PMC3902509.pdf
"Additional information can be found on the CARDIA Study website http://www.cardia.dopm.uab.edu/ Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license,which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/7b/72/bmjopen-2013-004001.PMC3902509.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ Scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8a/59/srep03865.PMC3902510.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3865 | DOI: 10.1038/srep03865 7",Non-OADS,/arxiv_data1/oa_pdf/8a/59/srep03865.PMC3902510.pdf
doi:10.1136/bmjopen-2013- 004105 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004105).,Non-OADS,/arxiv_data1/oa_pdf/80/09/bmjopen-2013-004105.PMC3902512.pdf
The study was registered in the Clinical Trial Database (http://www.controlled-trials.com/ISRCTN74848736).,Non-OADS,/arxiv_data1/oa_pdf/80/09/bmjopen-2013-004105.PMC3902512.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004017).,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/bmjopen-2013-004017.PMC3902513.pdf
"Data sharing statement All datasets used in this study are available to the public through the California Office of Statewide Health Planning and Development (OSHPD), either by download or by request at http://oshpd.ca.govOpen Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/bmjopen-2013-004017.PMC3902513.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/bmjopen-2013-004017.PMC3902513.pdf
http://www.ihi.org/communities/blogs/_layouts/ihi/community/blog/itemview.aspx?List=81ca4a47-4ccd-4e9e-89d9-14d88ec59e8d&ID=19.,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/bmjopen-2013-004017.PMC3902513.pdf
http://economix.blogs.nytimes.com/2013/03/15/what-hospitals-charge-the-uninsured/ (accessed 1 Apr2013).,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/bmjopen-2013-004017.PMC3902513.pdf
http://economix.blogs.nytimes.com/2009/01/23/how-do-hospitals-get-paid-a-primer/ (accessed 1 Apr2013).,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/bmjopen-2013-004017.PMC3902513.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/56/a7/bmjopen-2013-004189.PMC3902515.pdf
"Diagnostic and treatment protocol for human infections with avian influenza A (H7N9) (2nd edition, 2013), 2013. http://www.moh.gov.cn/mohgjhzs/s7952/201304/98ceede1daf74a45b1105f18c4e23ece.shtml (accessed 10 Jun 2013).",Non-OADS,/arxiv_data1/oa_pdf/56/a7/bmjopen-2013-004189.PMC3902515.pdf
"Life expectancy: Life tables China, 2011. http://apps.who.int/gho/ data/view.main.60340?lang=en (accessed 10 Jun 2013).",OADS,/arxiv_data1/oa_pdf/56/a7/bmjopen-2013-004189.PMC3902515.pdf
GBD 2010 Disability Weights 2010. http://ghdx.healthmetricsand evaluation.org/global-burden-disease-study-2010-gbd-2010-data-downloads (accessed 10 Jun 2013).,OADS,/arxiv_data1/oa_pdf/56/a7/bmjopen-2013-004189.PMC3902515.pdf
"Highly pathogenic avian influenza in Mexico (H7N3) —a significant threat to poultry production not to be underestimated.Empres Watch: EMPRES WATCH, 2012. http://www.fao.org/docrep/016/an395e/an395e.pdf (accessed 15 Jun 2013).",Non-OADS,/arxiv_data1/oa_pdf/56/a7/bmjopen-2013-004189.PMC3902515.pdf
doi:10.1136/bmjopen-2013- 003949 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003949).,Non-OADS,/arxiv_data1/oa_pdf/25/28/bmjopen-2013-003949.PMC3902524.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004266).,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
METHODS Data are from the UK ’s population-based HMRN (http://www.hmrn.org).,OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
"24Brieﬂy, within the HMRN region, patient care is provided by a uni ﬁed clinical network operating across 14 hospitals organised within ﬁve multidisciplinary teams working to common guide- lines covering investigation, treatment and follow-up(http://www.yorkshire-cancer-net.org.uk).",Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
All diagnoses and subsequent monitoring within the clinical network (>2000 patients a year) are made using the latest WHOclassiﬁcation 25at a single integrated haematopathology laboratory (http://www.hmds.info).,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
"Predicated on these struc- tures, our population-based patient cohort (http://www.hmrn.org) was initiated to serve the research and clin- ical needs, and as such the capture and follow-up of all patients diagnosed in our study area is a paramountobjective.",Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
UK Data Service Census Support.Downloaded from: http://casweb.mimas.ac.uk 27.,OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
2011. https://www.gov.uk/government/ publications/english-indices-of-deprivation-2010 31.,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
2006. http://www.lshtm.ac.uk/ncde/cancersurvival/tools.htm 32.,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
http://www.cancerresearchuk.org/cancer-info/cancerstats/types/nhl/treatment/diagnosis-and-treatment (accessed26 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
NICE 2013. http://guidance.nice.org.uk/TA/Wave0/615/Consultation/DraftGuidance (accessed 26 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
2012. http://www.ncin.org.uk/cancer_type_ and_topic_specific_work/cancer_type_specific_work/haematological_cancers/ 42.,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
2003. http://guidance.nice.org.uk/TA70 (accessed 3 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
2012. http://guidance.nice.org.uk/TA251 (accessed 3 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
2012. http://guidance.nice.org.uk/TA241 (accessed 3 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/ff/c5/bmjopen-2013-004266.PMC3902525.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003885).,Non-OADS,/arxiv_data1/oa_pdf/22/0e/bmjopen-2013-003885.PMC3902527.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/22/0e/bmjopen-2013-003885.PMC3902527.pdf
http://www.cdc.gov/flu/professionals/diagnosis/larolesprocedures.htm (accessed 26 Nov2012).,Non-OADS,/arxiv_data1/oa_pdf/22/0e/bmjopen-2013-003885.PMC3902527.pdf
http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm(accessed 26 Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/22/0e/bmjopen-2013-003885.PMC3902527.pdf
http://idsc.nih.go.jp/iasr/prompt/graph/sinin1e-1.gif (accessed 30 Oct 2013).,OADS,/arxiv_data1/oa_pdf/22/0e/bmjopen-2013-003885.PMC3902527.pdf
"The attachment of RapidTesta FLU II (Sekisui Medical, Tokyo, Japan), http://www.eidia.co.jp/product/diagnose/attach/attach_pdf/ippan/rapid-flu-2.pdf (accessed 30 Oct 2013).",OADS,/arxiv_data1/oa_pdf/22/0e/bmjopen-2013-003885.PMC3902527.pdf
http://www.cdc.gov/h1n1flu/ (accessed 20 Jun2013).,OADS,/arxiv_data1/oa_pdf/22/0e/bmjopen-2013-003885.PMC3902527.pdf
http://www.accessdata.fda.gov/cdrh_docs/pdf10/K103209.pdf (accessed30 Oct 2013).,OADS,/arxiv_data1/oa_pdf/22/0e/bmjopen-2013-003885.PMC3902527.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003832).,Non-OADS,/arxiv_data1/oa_pdf/ae/34/bmjopen-2013-003832.PMC3902528.pdf
http://en.wikipedia.org/wiki/Environmental_health_officer 2.,Non-OADS,/arxiv_data1/oa_pdf/ae/34/bmjopen-2013-003832.PMC3902528.pdf
http://www.socialistsanddemocrats.eu/gpes/public/detail.htm?id=137927&request_locale=EN&section=NER&category=NEWS 6.,Non-OADS,/arxiv_data1/oa_pdf/ae/34/bmjopen-2013-003832.PMC3902528.pdf
http://www.moh.gov.cn/wsb/pzcjd/200804/25191.shtml 9.,Non-OADS,/arxiv_data1/oa_pdf/ae/34/bmjopen-2013-003832.PMC3902528.pdf
2012. http://www.asph.org/userfiles/KSA.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/ae/34/bmjopen-2013-003832.PMC3902528.pdf
1998.http://mirror.undp.org/magnet/Docs/cap/CAPTECH3.htm 19.,OADS,/arxiv_data1/oa_pdf/ae/34/bmjopen-2013-003832.PMC3902528.pdf
http://www.eht-journal.net/index.php/ehtj/article/view/7087/7978 23.,Non-OADS,/arxiv_data1/oa_pdf/ae/34/bmjopen-2013-003832.PMC3902528.pdf
BMC Public Health 2006;6:99.http://www.biomedcentral.com/1471 –2458/ 6/99 25.,Non-OADS,/arxiv_data1/oa_pdf/ae/34/bmjopen-2013-003832.PMC3902528.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004109).,Non-OADS,/arxiv_data1/oa_pdf/d5/c4/bmjopen-2013-004109.PMC3902529.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1. International Agency for Research on Cancer (IARC).,Non-OADS,/arxiv_data1/oa_pdf/d5/c4/bmjopen-2013-004109.PMC3902529.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004313).,Non-OADS,/arxiv_data1/oa_pdf/8f/e5/bmjopen-2013-004313.PMC3902530.pdf
Available  from: http://www.ccras.nic.in/researchactivities/maleria.htm.,Non-OADS,/arxiv_data1/oa_pdf/96/84/AYU-34-233.PMC3902585.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=clinical+trial+a yurveda.,Non-OADS,/arxiv_data1/oa_pdf/96/84/AYU-34-233.PMC3902585.pdf
Available from: http://www.idf.org/ new‑idf‑data‑reveals‑diabetes‑epidemic‑continues‑escalate.,Non-OADS,/arxiv_data1/oa_pdf/1a/17/AYU-34-263.PMC3902591.pdf
Available from: http://www.worlddiabetesfoundation.org.,Non-OADS,/arxiv_data1/oa_pdf/1a/17/AYU-34-263.PMC3902591.pdf
Available from: http://www.who.int/diabetes/en/.,Non-OADS,/arxiv_data1/oa_pdf/1a/17/AYU-34-263.PMC3902591.pdf
Available from: http://www.androgen.com.,Non-OADS,/arxiv_data1/oa_pdf/0d/85/AYU-34-273.PMC3902593.pdf
Available from: http://www.cdph.ca.gov/health info.com.,Non-OADS,/arxiv_data1/oa_pdf/8c/3a/AYU-34-276.PMC3902594.pdf
Available from: http://www.medicalschemes.com.,Non-OADS,/arxiv_data1/oa_pdf/8c/3a/AYU-34-276.PMC3902594.pdf
Available from: http://www.whfoods.com/genpage.php?tname=george.,Non-OADS,/arxiv_data1/oa_pdf/8c/3a/AYU-34-276.PMC3902594.pdf
Available from: http://en.wikipedia.org/wiki/Saponification_value [Last accessed  on 2011 Dec 12].,OADS,/arxiv_data1/oa_pdf/66/b6/AYU-34-294.PMC3902597.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/7b/2d/IJMPO-34-145.PMC3902608.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/8d/58/IJMPO-34-147.PMC3902609.pdf
Available from: http://www.oncologyindia.org/myelstone/.,Non-OADS,/arxiv_data1/oa_pdf/ca/ba/IJMPO-34-154.PMC3902612.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/8e/03/IJMPO-34-164.PMC3902614.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/cf/f7/IJMPO-34-182.PMC3902620.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/cf/f7/IJMPO-34-182.PMC3902620.pdf
URL: http://www.nccn.org/professionals/physician- gls/pdf/cml.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/cc/IJMPO-34-224.PMC3902632.pdf
Available from: http://www.controlled-trials.com/ISRCTN31181395.,Non-OADS,/arxiv_data1/oa_pdf/cd/cc/IJMPO-34-224.PMC3902632.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004119).,Non-OADS,/arxiv_data1/oa_pdf/85/4a/bmjopen-2013-004119.PMC3902654.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/85/4a/bmjopen-2013-004119.PMC3902654.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004274).,Non-OADS,/arxiv_data1/oa_pdf/83/f1/bmjopen-2013-004274.PMC3902656.pdf
2012.http://www.ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2012.pdf?bcsi_scan_628cd39dca2568d2=FnAPsXbe9HUkDWZzifxo42fFriUBAAAAVj/yAQ==&bcsi_scan_filename=Annual-Epidemiological-Report-2012.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/83/f1/bmjopen-2013-004274.PMC3902656.pdf
2011.http://www.cclinparisnord.org/Inciso/RappRAISIN2011.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/83/f1/bmjopen-2013-004274.PMC3902656.pdf
Available from: http://www.pib.nic.in/newsite/erelease.,Non-OADS,/arxiv_data1/oa_pdf/a6/0f/JFMPC-2-215.PMC3902674.pdf
Available from: http://www.njcmindia.org/ home/download/345.,Non-OADS,/arxiv_data1/oa_pdf/a6/0f/JFMPC-2-215.PMC3902674.pdf
Available from: http://www.jcdr.net/articles/ PDF/1820/3652_E(V)_F(J)_Pf3(V)_PFA(A_).pdf.,OADS,/arxiv_data1/oa_pdf/a6/0f/JFMPC-2-215.PMC3902674.pdf
Available from: http://www.nrhm-mis.nic.in/ui/who/ PDF/Report%20of%20the%20Health%20Survey%20&%20 Development%20Committee%20Vol%20I.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/0f/JFMPC-2-215.PMC3902674.pdf
Available from: http://www.thehindu.com/ news/national/public-health-system-in-india-has-collapsed- ramesh/article4101836.ece.,Non-OADS,/arxiv_data1/oa_pdf/a6/0f/JFMPC-2-215.PMC3902674.pdf
Available  from: http://www.medicalcareers.nhs.uk/specialty_pages/ general_practice.aspx.,Non-OADS,/arxiv_data1/oa_pdf/a6/0f/JFMPC-2-215.PMC3902674.pdf
Available  from: http://www.mciindia.org/tools/announcement/ MCI_booklet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/0f/JFMPC-2-215.PMC3902674.pdf
Available from: http://www.thehindu.,Non-OADS,/arxiv_data1/oa_pdf/a6/0f/JFMPC-2-215.PMC3902674.pdf
"Available  from http://www.joe.org/joe/1995october/rb1.php [Last  accessed on 2013, Aug 15].",Non-OADS,/arxiv_data1/oa_pdf/7b/ec/JFMPC-2-227.PMC3902677.pdf
Available from:  http://www.unescap.org/stat/meet/vs-Jun2010/session1- Dominga.pdf.,OADS,/arxiv_data1/oa_pdf/d8/08/JFMPC-2-234.PMC3902678.pdf
Available from: http://hdr.undp.org/en/media/ hdr04_complete.pdf [Last retrieved on 2012 Sept 14].,Non-OADS,/arxiv_data1/oa_pdf/9c/15/JFMPC-2-250.PMC3902681.pdf
Available from: http://www.who.int/tb/ publications/global_report/ [Last retrieved on 2012 Oct 14].,OADS,/arxiv_data1/oa_pdf/9c/15/JFMPC-2-250.PMC3902681.pdf
Available from: http://www.tbcindia.nic.in/pdfs/ TB%20India%202007.pdf [Last retrieved on 2012 Sept 14].,Non-OADS,/arxiv_data1/oa_pdf/9c/15/JFMPC-2-250.PMC3902681.pdf
Available from: http://www.ecdc.europa.,Non-OADS,/arxiv_data1/oa_pdf/9c/15/JFMPC-2-250.PMC3902681.pdf
Available from: http://www.tbcindia.nic.in/ pdfs/Annual%20Report%20TB%202006.pdf [Last retrieved  on 2012 Nov 23].,Non-OADS,/arxiv_data1/oa_pdf/9c/15/JFMPC-2-250.PMC3902681.pdf
Available from:  http://www.who.int/tb/publications/global_report/2009/ update/tbu_9.pdf [Last retrieved on 2012 Nov 23].,Non-OADS,/arxiv_data1/oa_pdf/9c/15/JFMPC-2-250.PMC3902681.pdf
Available from: http://www.tbrieder.org/publications/books_english/toman_2.pdf [Last  retrieved on 2012 Nov 23].,Non-OADS,/arxiv_data1/oa_pdf/9c/15/JFMPC-2-250.PMC3902681.pdf
Available  from: http://www.WHO/htm/mal/2005.1101.,OADS,/arxiv_data1/oa_pdf/1e/b4/JFMPC-2-256.PMC3902682.pdf
Available from:  http://hbr.org/2012/01/tackling-social-problems/ar/pr.,Non-OADS,/arxiv_data1/oa_pdf/9a/76/JFMPC-2-263.PMC3902683.pdf
Available from: http://www.euroqol.org.,Non-OADS,/arxiv_data1/oa_pdf/25/6f/JFMPC-2-270.PMC3902685.pdf
Available from:  http://www.biomedcentral.com/1472-6963/11/217 [Last  accessed on 2012 Dec 5].,Non-OADS,/arxiv_data1/oa_pdf/2a/80/JFMPC-2-277.PMC3902687.pdf
Available from: http://www.dh.gov.uk/ prod_consum_dh/groups/dh_digitalassets/@dh/@en/ documents/digitalasset/dh_4064945.pdf [Last accessed  on 2012 Sep 18].,OADS,/arxiv_data1/oa_pdf/2a/80/JFMPC-2-277.PMC3902687.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK92265/ [Last accessed on 2013 Jan 22].24.,Non-OADS,/arxiv_data1/oa_pdf/2a/80/JFMPC-2-277.PMC3902687.pdf
Available from: http://nrhmmanipur.org/wp- content/uploads/2011/01/AYUSH_Doctors_list.pdf [Last  accessed on 2013 Mar 28].,Non-OADS,/arxiv_data1/oa_pdf/36/d2/JFMPC-2-301.PMC3902695.pdf
Available  from: http://www.saching.com/Articles/School-Yoga- Programme-A-New-Initiative-of-NRHM-7482.html [Last  accessed on 2013 Apr 18].,Non-OADS,/arxiv_data1/oa_pdf/36/d2/JFMPC-2-301.PMC3902695.pdf
http://www.paho.org/  english/ad/fch/ai/Stigma_report_english.pdf  □2.,Non-OADS,/arxiv_data1/oa_pdf/4e/71/AMS-9-19541.PMC3902701.pdf
http://www.ptfmalaysia.org/statistic.htm  17.,OADS,/arxiv_data1/oa_pdf/4e/71/AMS-9-19541.PMC3902701.pdf
Available: http://webappa.cdc.gov/sasweb/ncipc/leadcaus10 .,OADS,/arxiv_data1/oa_pdf/30/84/AMS-9-21687.PMC3902705.pdf
Available  from: http://www.fda.gov/cder/foi/appletter/2008/  022148s000ltr .pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/70/AMS-9-21936.PMC3902716.pdf
Accessed from http://www.imf.org/external/pubs/ft/weo/2012/01/weodata/index.aspx.,OADS,/arxiv_data1/oa_pdf/e0/70/AMS-9-21936.PMC3902716.pdf
"By the aid of on -line  Primer 3 softwar e (http://frodo.wi.m it.edu), the  primer pairs use d to amplify the c oding exons and  exon/intron b oundaries of GATA4 by pol ymerase  chain reaction  (PCR) were designed as  shown in  Table I.",Non-OADS,/arxiv_data1/oa_pdf/73/53/AMS-9-22043.PMC3902718.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.406 Infect Chemother 2013;45(4):406-414 pISSN 2093-2340 · eISSN 2092-6448 Received:  May 21, 2013   Revised:  September 18, 2013  Accepted: October 16, 2013 Corresponding Author : Dong-Gun Lee, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, Seoul St. Mary's  Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82-2-2258-6003, Fax: +82-2-535-2494 E-mail: symonlee@catholic.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/c2/ic-45-406.PMC3902809.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.406  •  Infect Chemother 2013;45(4) :406-414 www.icjournal.org  407 Introduction Invasive aspergillosis (IA) is a major life-threatening infec - tion in neutropenic patients and stem cell transplantation re - cipients [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/99/c2/ic-45-406.PMC3902809.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.406  •  Infect Chemother 2013;45(4) :406-414 www.icjournal.org  409 ment failure.,Non-OADS,/arxiv_data1/oa_pdf/99/c2/ic-45-406.PMC3902809.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.406  •  Infect Chemother 2013;45(4) :406-414 www.icjournal.org  411 The overall incidence of AEs was 34% (35/104).,Non-OADS,/arxiv_data1/oa_pdf/99/c2/ic-45-406.PMC3902809.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.406  •  Infect Chemother 2013;45(4) :406-414 www.icjournal.org  413   6.,Non-OADS,/arxiv_data1/oa_pdf/99/c2/ic-45-406.PMC3902809.pdf
Available at: http://www.fda.gov/ohrms/dockets/ ac/01/briefing/3792b2_01_Pfizer.pdf.,Non-OADS,/arxiv_data1/oa_pdf/99/c2/ic-45-406.PMC3902809.pdf
Available at: http://ctep.cancer.gov/protocolDevelop - ment/electronic_applications/ctc.htm.,Non-OADS,/arxiv_data1/oa_pdf/99/c2/ic-45-406.PMC3902809.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.446 Infect Chemother 2013;45(4):446-450 pISSN 2093-2340 · eISSN 2092-6448 Received: April 25, 2013   Revised:  May 24, 2013  Accepted: May 27, 2013 Corresponding Author : Jin-Soo Lee, MD, PhD Department of Internal Medicine, Inha University Hospital, 27 Inhang-ro,   Jung-gu, Incheon 400-712, Korea Tel: +82-32-890-2202, Fax: +82-32-882-6578 E-mail: ljinsoo@inha.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/b3/ic-45-446.PMC3902810.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.446  •  Infect Chemother 2013;45(4) :446-450 www.icjournal.org  447 There are many clinical manifestations of Bartonella infec - tion.,Non-OADS,/arxiv_data1/oa_pdf/93/b3/ic-45-446.PMC3902810.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.446  •  Infect Chemother 2013;45(4) :446-450 www.icjournal.org  449 of bartonellosis.,Non-OADS,/arxiv_data1/oa_pdf/93/b3/ic-45-446.PMC3902810.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.441 Infect Chemother 2013;45(4):441-445 pISSN 2093-2340 · eISSN 2092-6448 Received: April 17, 2013   Revised:  July 25, 2013  Accepted: July 25, 2013 Corresponding Author : Yong Kyun Cho, MD, PhD Division of Infectious Disease, Gachon University Gil Medical Center,   21 Namdongdae-ro 774-gil, Namdong-gu, Incheon 405-760, Korea Tel: +82-32-460-8431, Fax: +82-32-460-8448 E-mail: karmacho@gmail.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/45/ic-45-441.PMC3902811.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.441  •  Infect Chemother 2013;45(4) :441-445 www.icjournal.org  443 set, following the method of Oliveira et al.",OADS,/arxiv_data1/oa_pdf/7a/45/ic-45-441.PMC3902811.pdf
The MLST database  (http://saureus.mlst.net) revealed a sequence type of 1-4-1-8- 4-4-3 (ST 72).,OADS,/arxiv_data1/oa_pdf/7a/45/ic-45-441.PMC3902811.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.441  •  Infect Chemother 2013;45(4) :441-445 www.icjournal.org  445 tönen TT , Oka M. Clinical sequelae and sacroiliac joint  changes by computed tomography after recovery from  septic sacroiliitis.",Non-OADS,/arxiv_data1/oa_pdf/7a/45/ic-45-441.PMC3902811.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.415 Infect Chemother 2013;45(4):415-421 pISSN 2093-2340 · eISSN 2092-6448 Received:  June 14, 2013   Revised:  September 6, 2013  Accepted: October 18, 2013 Corresponding Author : Eun Hwa Choi, MD Department of Pediatrics, Seoul National University College of Medicine,   101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82-2-2072-3624, Fax: +82-2-766-7283 E-mail: eunchoi@snu.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/6b/ic-45-415.PMC3902812.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.415  •  Infect Chemother 2013;45(4) :415-421 www.icjournal.org  417 2.,Non-OADS,/arxiv_data1/oa_pdf/54/6b/ic-45-415.PMC3902812.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.415  •  Infect Chemother 2013;45(4) :415-421 www.icjournal.org  419 of an antimicrobial treatment was 18.0 (6.2) hours for the car - bapenem group, and 25.3 (19.7) hours for the non-carbapen - em group; showing no statistically significant difference be - tween the two groups ( P = 0.28).",OADS,/arxiv_data1/oa_pdf/54/6b/ic-45-415.PMC3902812.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.415  •  Infect Chemother 2013;45(4) :415-421 www.icjournal.org  421 9.,OADS,/arxiv_data1/oa_pdf/54/6b/ic-45-415.PMC3902812.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.394 Infect Chemother 2013;45(4):394-405 pISSN 2093-2340 · eISSN 2092-6448 Received: April 17, 2013   Revised:  September 29, 2013  Accepted: October 2, 2013 Corresponding Author : Shin-Woo Kim, MD Department of Internal Medicine, Kyungpook National University Hospital,   130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea Tel: +82-53-420-6525, Fax: +82-53-426-2046 E-mail: ksw2kms@knu.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/e6/ic-45-394.PMC3902813.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.394  •  Infect Chemother 2013;45(4) :394-405 www.icjournal.org  395 Introduction Community-acquired pneumonia (CAP) is a common in - fectious disease.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/ic-45-394.PMC3902813.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.394  •  Infect Chemother 2013;45(4) :394-405 www.icjournal.org  397 use the 2009 Korean CAP treatment guidelines in practice?, ”  98 (62.4%) said “Yes” and 53 (33.8%) said “No” (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/f3/e6/ic-45-394.PMC3902813.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.394  •  Infect Chemother 2013;45(4) :394-405 www.icjournal.org  399 Table 5.,Non-OADS,/arxiv_data1/oa_pdf/f3/e6/ic-45-394.PMC3902813.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.394  •  Infect Chemother 2013;45(4) :394-405 www.icjournal.org  401 sion of CAP patients?,”  “I use clinical judgment rather than  objective standards” was the most common response (47/76,  61.8%) among pulmonologists and infectious disease special - ists, as well as in other physicians (34/43, 79.1%).",Non-OADS,/arxiv_data1/oa_pdf/f3/e6/ic-45-394.PMC3902813.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.394  •  Infect Chemother 2013;45(4) :394-405 www.icjournal.org  403 Discussion In the United States and Korea, CAP has the sixth highest  mortality rate [6].",Non-OADS,/arxiv_data1/oa_pdf/f3/e6/ic-45-394.PMC3902813.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.394  •  Infect Chemother 2013;45(4) :394-405 www.icjournal.org  405 J Clin Microbiol Infect Dis 2002;21:35-42.,OADS,/arxiv_data1/oa_pdf/f3/e6/ic-45-394.PMC3902813.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.387 Infect Chemother 2013;45(4):387-393 pISSN 2093-2340 · eISSN 2092-6448 Received: July 2, 2013   Revised:  August 23, 2013  Accepted: September 2, 2013 Corresponding Author : Tae Hyong Kim, MD.",Non-OADS,/arxiv_data1/oa_pdf/b6/bb/ic-45-387.PMC3902814.pdf
"Department of Internal Medicine, Soonchunhyang University Seoul Hospital,   59 Daesagwan-ro, Yongsan-gu, Seoul 140-743, Korea Tel: +82-2-709-9194, Fax: +82-2-709-9083 E-mail: geuncom@schmc.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/bb/ic-45-387.PMC3902814.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.387  •  Infect Chemother 2013;45(4) :387-393 www.icjournal.org  389 coccus pyogenes infection cases was hospital acquired.,Non-OADS,/arxiv_data1/oa_pdf/b6/bb/ic-45-387.PMC3902814.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.387  •  Infect Chemother 2013;45(4) :387-393 www.icjournal.org  391 of the patients and a relatively mild disease progression in the  other 6 patients.,Non-OADS,/arxiv_data1/oa_pdf/b6/bb/ic-45-387.PMC3902814.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.387  •  Infect Chemother 2013;45(4) :387-393 www.icjournal.org  393 Montoya JG, Wade JC; Infectious Diseases Society of  America.",Non-OADS,/arxiv_data1/oa_pdf/b6/bb/ic-45-387.PMC3902814.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.375 Infect Chemother 2013;45(4):375-386 pISSN 2093-2340 · eISSN 2092-6448 Received: December 19, 2013 Corresponding Author : Woo Joo Kim, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, Guro Hospital, Korea  University College of Medicine, Gurodong-ro 148, Guro-gu, Seoul 152-703, Korea Tel: +82-2-2626-3051, Fax: +82-2-2626-1105 E-mail: wjkim@korea.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/77/ic-45-375.PMC3902815.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.375  •  Infect Chemother 2013;45(4) :375-386 www.icjournal.org  377 78- 7979- 8080- 8181- 8282- 8383- 8484- 8585- 8686- 8787- 8888- 8989- 9090- 9191- 9292- 9393- 9494- 9595- 9696- 9797- 9898- 9999- 0000- 0101- 0202- 0303- 0404- 0505- 0606- 0707- 0808- 0909- 1010-  1111- 1212- 1313- 14 A(H1N1) California/7/2009 Brisbane/59/2007 Solomon Is - lands/3/2006 New Caledonia/20/99 Beijing/262/95 Bayern/7/95 Singapore/6/86 Chile/1/83 Brazil/11/78 USSR/90/77 A(H3N2) Victoria/361/2011 a Perth/16/2009 Brisbane/10/2007 Wisconsin/67/2005 California/7/2004 Fujian/411/2002 Moscow/10/99 Sydney/5/97 Wuhan/359/95 Johannesburg/33/94 Shangdong/9/93 Beijing/32/92 Beijing/353/89 Guizhou/54/89 Shanghai/11/87 Sichuan/02/87 Leningrad/360/1986 Christchurch/4/85- Mississippi/1/85 Philippines/2/82 Bangkok/01/1979 Texas/1/77 B Massachusetts/2/2012 Wisconsin/1/2010 Brisbane/60/2008b Florida/4/2006 Malaysia/2506/2004 Shanghai/361/2002 Hong Kong/330/2001 Sichuan/379/99 Yamanashi/166/98 Shangdong/7/97 Beijing/184/93 Panama/45/90 Yamagata/16/88 Beijing/1/87 Ann Arbor/1/86 USSR/100/83 Singapore/222/79 Hong Kong/05/1972 Figure 2.  WHO recommendations on the composition of influenza vaccines from 1978-1979 to 2013-2014 for the northern hemisphere [16-18].,Non-OADS,/arxiv_data1/oa_pdf/5e/77/ic-45-375.PMC3902815.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.375  •  Infect Chemother 2013;45(4) :375-386 www.icjournal.org  379 Recently introduced influenza vaccines Several strategies for the development of better influenza  vaccines have been introduced recently.,Non-OADS,/arxiv_data1/oa_pdf/5e/77/ic-45-375.PMC3902815.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.375  •  Infect Chemother 2013;45(4) :375-386 www.icjournal.org  381 Studies have demonstrated that QIV provides non-inferior im - munogenicity against three influenza vaccine strains com - pared with TIV [85-87].,Non-OADS,/arxiv_data1/oa_pdf/5e/77/ic-45-375.PMC3902815.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.375  •  Infect Chemother 2013;45(4) :375-386 www.icjournal.org  383 months of 2009 pandemic influenza A H1N1 virus circula - tion: a modelling study.,Non-OADS,/arxiv_data1/oa_pdf/5e/77/ic-45-375.PMC3902815.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/5e/77/ic-45-375.PMC3902815.pdf
Available at: http://www.who.int/ influenza/vaccines/virus/recommendations/en/.,Non-OADS,/arxiv_data1/oa_pdf/5e/77/ic-45-375.PMC3902815.pdf
World health organization  recommendations for composition of influenza vaccines  Available at: http://www.fludb.org/brc/vaccineRecom - mend.do?decorator=influenza.,Non-OADS,/arxiv_data1/oa_pdf/5e/77/ic-45-375.PMC3902815.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.375  •  Infect Chemother 2013;45(4) :375-386 www.icjournal.org  385 nusi A, Claeys C, Durand C, Duval X, El Idrissi M, Falsey  AR, Feldman G, Frey SE, Galtier F , Hwang SJ, Innis BL, Ko - vac M, Kremsner P , McNeil S, Nowakowski A, Richardus  JH, Trofa A, Oostvogels L; Influence65 study group.",OADS,/arxiv_data1/oa_pdf/5e/77/ic-45-375.PMC3902815.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.431 Infect Chemother 2013;45(4):431-434 pISSN 2093-2340 · eISSN 2092-6448 Received:  June 26, 2013   Revised:  August 11, 2013  Accepted: August 14, 2013 Corresponding Author : Moon-Hyun Chung, MD, PhD  Department of Internal Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu,  Incheon 400-712, Korea Tel: +82-32-890-2202, Fax: +82-32-882-6578 E-mail: mhchungid@daum.net Alternate Corresponding Author:  Jin-Soo Lee, MD, PhD  Department of Internal Medicine, Inha University Hospital, 27 Inhang-ro, Jung-gu,  Incheon 400-712, Korea Tel: +82-32-890-2202, Fax: +82-32-882-6578 E-mail: ljinsoo@inha.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/4c/ic-45-431.PMC3902816.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.431  •  Infect Chemother 2013;45(4) :431-434 www.icjournal.org  433 enumerated.,OADS,/arxiv_data1/oa_pdf/51/4c/ic-45-431.PMC3902816.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.462 Infect Chemother 2013;45(4):462-464 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Chang-Seop Lee, MD, PhD Department of Internal Medicine, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju 561-756, Korea Tel: +82-63-250-2391, Fax: +82-63-254-1609 E-mail: lcsmd@jbnu.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/40/ic-45-462.PMC3902817.pdf
http://dx.doi.org/10.3947/ic.2013.45.4.462  •  Infect Chemother 2013;45(4) :462-464 www.icjournal.org 463,Non-OADS,/arxiv_data1/oa_pdf/fb/40/ic-45-462.PMC3902817.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.351 Infect Chemother 2013;45(4):351-366 pISSN 2093-2340 · eISSN 2092-6448 Received: December 19, 2013 Corresponding Author : Moon H. Nahm, MD Department of Pathology and Microbiology, School of Medicine, University of Alabama   at Birmingham, Birmingham.",Non-OADS,/arxiv_data1/oa_pdf/b9/b0/ic-45-351.PMC3902818.pdf
"BBRB 614, 1530 Third Ave. South, Birmingham, AL 35294   Tel: 205-934-0163, Fax: 205-975–2149 E-mail: nahm@uab.edu This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/b0/ic-45-351.PMC3902818.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.351  •  Infect Chemother 2013;45(4) :351-366 www.icjournal.org  353 some S. pneumoniae  strains may be bile-insoluble [22].,Non-OADS,/arxiv_data1/oa_pdf/b9/b0/ic-45-351.PMC3902818.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.351  •  Infect Chemother 2013;45(4) :351-366 www.icjournal.org  355 antibiotic treatment.,Non-OADS,/arxiv_data1/oa_pdf/b9/b0/ic-45-351.PMC3902818.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.351  •  Infect Chemother 2013;45(4) :351-366 www.icjournal.org  357 may be useful as the diagnostic yield of conventional microbi - ological methods is poor with pleural fluids.,Non-OADS,/arxiv_data1/oa_pdf/b9/b0/ic-45-351.PMC3902818.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.351  •  Infect Chemother 2013;45(4) :351-366 www.icjournal.org  359 nia.,Non-OADS,/arxiv_data1/oa_pdf/b9/b0/ic-45-351.PMC3902818.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.351  •  Infect Chemother 2013;45(4) :351-366 www.icjournal.org  361 pneumonia in infants and children older than 3 months of  age: clinical practice guidelines by the Pediatric Infectious  Diseases Society and the Infectious Diseases Society of  America.,Non-OADS,/arxiv_data1/oa_pdf/b9/b0/ic-45-351.PMC3902818.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.351  •  Infect Chemother 2013;45(4) :351-366 www.icjournal.org  363 nosis of empyema in children: comparative evaluations by  culture, polymerase chain reaction, and pneumococcal  antigen detection in pleural fluids.",Non-OADS,/arxiv_data1/oa_pdf/b9/b0/ic-45-351.PMC3902818.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.351  •  Infect Chemother 2013;45(4) :351-366 www.icjournal.org  365 and a PsaA immune complex ELISA for detection of  pneumococcal serum antibody.,Non-OADS,/arxiv_data1/oa_pdf/b9/b0/ic-45-351.PMC3902818.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.435 Infect Chemother 2013;45(4):435-440 pISSN 2093-2340 · eISSN 2092-6448 Received: October 16, 2013   Revised:  October 26, 2013  Accepted: October 27, 2013 Corresponding Author : Seung Baik Han, MD Department of Emergency Medicine, Inha University School of Medicine ,  27 Inhang-ro, Jung-gu, Incheon 400-711, Korea Tel: +82-32-890-2304, Fax: +82-32-890-2529   E-mail: LIFSAV@inha.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/17/ic-45-435.PMC3902819.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.435  •  Infect Chemother 2013;45(4) :435-440 www.icjournal.org  437 neutrophil cytoplasmic antibody, and antibody panel for ex - tractable nuclear antigen, were negative.",OADS,/arxiv_data1/oa_pdf/77/17/ic-45-435.PMC3902819.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.435  •  Infect Chemother 2013;45(4) :435-440 www.icjournal.org  439 and gradually decreased after negative conversion of blood  cultures; (2) there was no evidence of other infections (viral,  bacterial, and fungal); (3) there was no evidence of known al - lergy; and (4) there was no evidence of autoimmune disease  or malignancy.",Non-OADS,/arxiv_data1/oa_pdf/77/17/ic-45-435.PMC3902819.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.367 Infect Chemother 2013;45(4):367-374 pISSN 2093-2340 · eISSN 2092-6448 Received: September 29, 2013 Corresponding Author : Tae Sun Shim, MD Department of Pulmonary and Critical Care Medicine, Asan Medical Center,   University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu,   Seoul 138-736, Korea Tel: +82-2-3010-3892, Fax: +82-2-3010-6968  E-mail: shimts@amc.seoul.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/63/ic-45-367.PMC3902820.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.367  •  Infect Chemother 2013;45(4) :367-374 www.icjournal.org  369 and drug susceptibility tests (DST), the DST results only be - came available 3–4 months after anti-TB treatment initiation.",Non-OADS,/arxiv_data1/oa_pdf/a5/63/ic-45-367.PMC3902820.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.367  •  Infect Chemother 2013;45(4) :367-374 www.icjournal.org  371 Six drugs with antimicrobial activity (phenothiazine, metro - nidazole, doxycycline, disulfiram, tigecycline, and co-trimoxa - zole) are not included in the WHO guidelines for MDR-TB  treatment but have been proposed as potential candidates for  evaluation against M. tuberculosis  [28].",Non-OADS,/arxiv_data1/oa_pdf/a5/63/ic-45-367.PMC3902820.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.367  •  Infect Chemother 2013;45(4) :367-374 www.icjournal.org  373 13.,Non-OADS,/arxiv_data1/oa_pdf/a5/63/ic-45-367.PMC3902820.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.422 Infect Chemother 2013;45(4):422-430 pISSN 2093-2340 · eISSN 2092-6448 Received:  January 2, 2013   Revised:  August 22, 2013  Accepted: October 23, 2013 Corresponding Author : June Myung Kim, MD, PhD Department of Internal Medicine, Yonsei University College of Medicine,   50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82-2-2228-1946, Fax: +82-2-393-6884 E-mail: jmkim@yuhs.ac This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/58/ic-45-422.PMC3902821.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.422  •  Infect Chemother 2013;45(4) :422-430 www.icjournal.org  423 Introduction Surgical site infection (SSI) is the most common type of  healthcare-associated infection in patients undergoing sur - gery and remains a major source of postoperative morbidity  [1] Among surgical patients, SSIs account for 38% of health - care-associated infections [2].",Non-OADS,/arxiv_data1/oa_pdf/7b/58/ic-45-422.PMC3902821.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.422  •  Infect Chemother 2013;45(4) :422-430 www.icjournal.org  425 were observed more frequently in the non-SSI group (33.8%  vs. 49.4%; P = 0.010).,OADS,/arxiv_data1/oa_pdf/7b/58/ic-45-422.PMC3902821.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.422  •  Infect Chemother 2013;45(4) :422-430 www.icjournal.org  427 coccus aureus  (n = 3), and methicillin-sensitive coagulase- negative staphylococci (n = 1).",Non-OADS,/arxiv_data1/oa_pdf/7b/58/ic-45-422.PMC3902821.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.422  •  Infect Chemother 2013;45(4) :422-430 www.icjournal.org  429 gical wound infections.,Non-OADS,/arxiv_data1/oa_pdf/7b/58/ic-45-422.PMC3902821.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.451 Infect Chemother 2013;45(4):451-454 pISSN 2093-2340 · eISSN 2092-6448 Received: April 2, 2013   Revised:  June 23, 2013  Accepted: July 30, 2013 Corresponding Author : Sang Taek Heo, MD Department of Internal Medicine, Jeju National University School of Medicine,  102 Jejudaehak-ro, Jeju 690-751, Korea Tel: +82-64-717-1296, Fax: +82-64-717-1131,  E-mail: neosangtaek@naver.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/38/ic-45-451.PMC3902822.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.451  •  Infect Chemother 2013;45(4) :451-454 www.icjournal.org  453 observation of the organisms by dark-field examination, the  use of serologic tests, and the application of other new tests  such as immunofluorescent staining and polymerase chain  reaction assays [11, 12].",Non-OADS,/arxiv_data1/oa_pdf/ff/38/ic-45-451.PMC3902822.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.4.455 Infect Chemother 2013;45(4):455-461 pISSN 2093-2340 · eISSN 2092-6448 Received: October 21, 2013 Corresponding Author : The Committee for Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS of the Korean Society for AIDS.",Non-OADS,/arxiv_data1/oa_pdf/fd/51/ic-45-455.PMC3902823.pdf
"The Korean Society for AIDS, 50 Yonsei-ro, Seodaemun-gu, Yonsei University College of Medicine, Seoul 120-746, Korea Tel: +82-2-2228-5493, Fax: +82-2-3299-2789, E-mail: kosa@kosaids.or.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/51/ic-45-455.PMC3902823.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.4.455  •  Infect Chemother 2013;45(4) :455-461 www.icjournal.org  457 trolled trial has defined the optimal time of initiation, the  available data are consistent with, and further strengthen, the  recommendation for the early initiation of HAART.",Non-OADS,/arxiv_data1/oa_pdf/fd/51/ic-45-455.PMC3902823.pdf
Supplementary material can be found with this article on - line http://www.icjournal.org/src/sm/ic-45-455-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fd/51/ic-45-455.PMC3902823.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.455  •  Infect Chemother 2013;45(4) :455-461 www.icjournal.org  459 13.,Non-OADS,/arxiv_data1/oa_pdf/fd/51/ic-45-455.PMC3902823.pdf
  http://dx.doi.org/10.3947/ic.2013.45.4.455  •  Infect Chemother 2013;45(4) :455-461 www.icjournal.org  461 HIV-infected persons.,Non-OADS,/arxiv_data1/oa_pdf/fd/51/ic-45-455.PMC3902823.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/e7/gkt1003.PMC3902893.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/11/gkt1011.PMC3902894.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/76/gkt875.PMC3902899.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/9f/gkt885.PMC3902900.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/a5/gkt896.PMC3902903.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/7e/gkt910.PMC3902912.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/bc/gkt914.PMC3902914.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/9b/gkt921.PMC3902919.pdf
Data were obtained from GEO database(http://www.ncbi.nlm.nih.gov/geo/).,OADS,/arxiv_data1/oa_pdf/aa/9b/gkt921.PMC3902919.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/9c/gkt922.PMC3902920.pdf
All cartoon molecular diagrams were generated using Pymol (http://www.pymol.org).,Non-OADS,/arxiv_data1/oa_pdf/15/9c/gkt922.PMC3902920.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/42/gkt924.PMC3902922.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/40/gkt929.PMC3902923.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/b2/gkt934.PMC3902927.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/43/gkt936.PMC3902929.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/6f/gkt951.PMC3902941.pdf
Sequencing data for H2AZ and Pol2 in resting CD4 +T cells were downloaded from http://dir.nhlbi.nih.gov/papers/lmi/epigenomes/hgtcell.aspx.,OADS,/arxiv_data1/oa_pdf/a3/6f/gkt951.PMC3902941.pdf
H3K9me3 ChIP-seq data in CD4 +T cells were downloaded from http://dir.nhlbi.nih.,OADS,/arxiv_data1/oa_pdf/a3/6f/gkt951.PMC3902941.pdf
Processing of nucleosome data and identiﬁcation of nucleosome core positioning MNase-digestion-based sequencing data for resting and activated mononucleosomes in CD4 +T cells (21) were obtained at http://dir.nhlbi.nih.gov/papers/lmi/epigenomes/hgtcellnucleosomes.aspx.,OADS,/arxiv_data1/oa_pdf/a3/6f/gkt951.PMC3902941.pdf
"Data for DSB locations, cancer mutations and CFSs Genome-wide locations of DSBs induced by aphidicolin (aphidicolin-sensitive breakome) and those induced by neocarzinostatin (neocarzinostatin-sensitive breakome) were downloaded from http://breakome.eu (25).Normalized H2AX levels in 200-bp sliding windowswere mapped to the inside of the obtained break regions(50 bins) and their ±500-kb ﬂanking regions (50 bins).Because the number of the break regions was not large enough, smoothing with cubic spline ( Rfunction) was used to obtain a ﬁtted line across the 100 bins.",OADS,/arxiv_data1/oa_pdf/a3/6f/gkt951.PMC3902941.pdf
ACCESSION NUMBER All the raw data generated in this work are deposited in GEO under accession number GSE44309 (reviewer link:http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=frglxqwskqeqyjk&acc=GSE44309).,OADS,/arxiv_data1/oa_pdf/a3/6f/gkt951.PMC3902941.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/cf/gkt955.PMC3902942.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/d3/gkt956.PMC3902943.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/56/gkt964.PMC3902945.pdf
bThe program SEDFIT (http://www.analyticalultracentrifugation.com) was used to calculate the MWs by using sedimentation coefﬁcients from each protein peak.,OADS,/arxiv_data1/oa_pdf/9c/56/gkt964.PMC3902945.pdf
"http://www.pymol.org/citing (11 October 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/9c/56/gkt964.PMC3902945.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/d6/gkt969.PMC3902947.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/f4/gkt985.PMC3902948.pdf
Almost300 different mutations of the GAA gene have been identiﬁed to date and are listed in the Pompe center database (http://www2.eur.nl/fgg/ch1/pompe).,OADS,/arxiv_data1/oa_pdf/5c/31/gkt987.PMC3902950.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/31/gkt987.PMC3902950.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/6b/gkt988.PMC3902951.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/2e/gkt991.PMC3902952.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/0e/gkt993.PMC3902953.pdf
"‡UCL Institute of Child Health, London, UK.Ageing & Society , , –.fCambridge University Press  The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/ ./>.",Non-OADS,/arxiv_data1/oa_pdf/ea/fa/S0144686X12001110a.PMC3903102.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp) OPEN Long-term inﬂammation increases risk of commonmental disorder: a cohort study Molecular Psychiatry (2014) 19,149–150; doi:10.1038/mp.2013.35; published online 9 April 2013 The inﬂammation hypothesis of depression, or more broadly, common mental disorders, proposes that chronic inﬂammationplays an important role in the pathophysiology of these conditions.1,2The hypothesis is supported by experiments of inﬂammatory stimuli, antidepressant trials and studies on depression-related genes and pathogen host defense,2–5but direct population-based evidence from long-term inﬂammation is scarce.",Non-OADS,/arxiv_data1/oa_pdf/9f/f0/mp201335a.PMC3903110.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp) Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/9f/f0/mp201335a.PMC3903110.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Molecular Psychiatry (2014), 145 – 152 &2014 Macmillan Publishers LimitedLetters to the Editor 152",Non-OADS,/arxiv_data1/oa_pdf/96/4d/mp201310a.PMC3903111.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp) OPEN CSF biomarkers for Alzheimer’s pathology and theeffect size of APOE e4 Molecular Psychiatry (2014) 19,148–149; doi:10.1038/mp.2013.18; published online 19 February 2013 New research and clinical criteria for Alzheimer’s disease (AD) have recently been proposed, which include biomarker information on Alzheimer’s plaque and tangle pathology, or AD-typical structural brain changes, as supporting or essential elements of an ADdiagnosis.1–3In a large group of patients with both genetic and cerebrospinal ﬂuid (CSF) biomarker data, we here show thatbiomarker-assisted diagnosis-making almost doubles the effectsize of the association between the e4 variant of the apolipoprotein E ( APOE ) gene and AD.",Non-OADS,/arxiv_data1/oa_pdf/52/62/mp201318a.PMC3903112.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp) OPEN Long-term inﬂammation increases risk of commonmental disorder: a cohort study Molecular Psychiatry (2014) 19,149–150; doi:10.1038/mp.2013.35; published online 9 April 2013 The inﬂammation hypothesis of depression, or more broadly, common mental disorders, proposes that chronic inﬂammationplays an important role in the pathophysiology of these conditions.1,2The hypothesis is supported by experiments of inﬂammatory stimuli, antidepressant trials and studies on depression-related genes and pathogen host defense,2–5but direct population-based evidence from long-term inﬂammation is scarce.",Non-OADS,/arxiv_data1/oa_pdf/52/62/mp201318a.PMC3903112.pdf
Reads were preprocessed using Sickle (https://github.com/najoshi/sickle) using default settings to remove low quality bases on both ends of each read.,Non-OADS,/arxiv_data1/oa_pdf/29/57/ncomms3120.PMC3903129.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/29/57/ncomms3120.PMC3903129.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Castelle, C. J. et al.",Non-OADS,/arxiv_data1/oa_pdf/29/57/ncomms3120.PMC3903129.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3120 10 NATURE COMMUNICATIONS | 4:2120 | DOI: 10.1038/ncomms3120 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/29/57/ncomms3120.PMC3903129.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Rampinini E, Impellizzeri FM, Castagna C, et al .",Non-OADS,/arxiv_data1/oa_pdf/7f/84/bjsports-2013-092950.PMC3903139.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Bishop D, Burnett A, Farrow D, et al.",Non-OADS,/arxiv_data1/oa_pdf/66/ef/bjsports-2013-092794.PMC3903140.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1 Aughey RJ.,Non-OADS,/arxiv_data1/oa_pdf/53/51/bjsports-2013-092834.PMC3903141.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Chapman RF, Levine BD.",Non-OADS,/arxiv_data1/oa_pdf/75/7b/bjsports-2013-092837.PMC3903142.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Wilber RL.,Non-OADS,/arxiv_data1/oa_pdf/43/c9/bjsports-2013-092741.PMC3903143.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Wadley G, Le Rossignol P. The relationship between repeated sprint ability and the aerobic and anaerobic energy systems.",Non-OADS,/arxiv_data1/oa_pdf/be/03/bjsports-2013-092826.PMC3903144.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Aughey RJ, Goodman CA, McKenna MJ.",Non-OADS,/arxiv_data1/oa_pdf/82/d8/bjsports-2013-092776.PMC3903145.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Levine BD, Stray-Gundersen J.",Non-OADS,/arxiv_data1/oa_pdf/59/d4/bjsports-2013-092841.PMC3903146.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Douglas CG, Haldane JS, Henderson Y, et al.",Non-OADS,/arxiv_data1/oa_pdf/5b/bf/bjsports-2013-092840.PMC3903147.pdf
Sportscience 2003;7. http://www.sportsci.org/jour/03/wghtrials.htm.,Non-OADS,/arxiv_data1/oa_pdf/5b/bf/bjsports-2013-092840.PMC3903147.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Levine BD, Stray-Gundersen J.",Non-OADS,/arxiv_data1/oa_pdf/cf/29/bjsports-2013-092829.PMC3903148.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ To cite D’Hooghe M. Br J Sports Med 2013; 47:i1.,Non-OADS,/arxiv_data1/oa_pdf/e1/ce/bjsports-2013-093006.PMC3903149.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ To cite Millet GP, Faiss R, Brocherie F, et al.Br J Sports Med 2013; 47:i6–i7.",Non-OADS,/arxiv_data1/oa_pdf/95/30/bjsports-2013-092793.PMC3903151.pdf
The temperature in Melbourne the week before the camp averaged 15°C (http://www.wunderground.com/history/airport/YMML/2011/10/17/W eeklyHistory.html).,Non-OADS,/arxiv_data1/oa_pdf/5a/16/bjsports-2013-092559.PMC3903152.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/REFERENCES 1 Gray AJ, Jenkins DG.",Non-OADS,/arxiv_data1/oa_pdf/5a/16/bjsports-2013-092559.PMC3903152.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Friedmann B, Frese F, Menold E, et al.",Non-OADS,/arxiv_data1/oa_pdf/5a/d9/bjsports-2013-092744.PMC3903153.pdf
2003.http://www.sportsci.org/jour/03/wghtrials.htm 15 Jelkmann W. Proin ﬂammatory cytokines lowering erythropoietin production.,Non-OADS,/arxiv_data1/oa_pdf/5a/d9/bjsports-2013-092744.PMC3903153.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Bartsch P, Saltin B.",Non-OADS,/arxiv_data1/oa_pdf/cf/ea/bjsports-2013-092761.PMC3903154.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bangsbo J, Mohr M, Krustrup P. Physical and metabolic demands of training and match-play in the elite football player.",Non-OADS,/arxiv_data1/oa_pdf/a9/53/bjsports-2013-092746.PMC3903155.pdf
"Additional information Accession codes: Microarray data have been deposited in Gene Expression Omnibus under the accession code GSE47515.Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Jiang, P. et al.",OADS,/arxiv_data1/oa_pdf/11/c0/ncomms3196.PMC3903179.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3196 16 NATURE COMMUNICATIONS | 4:2196 | DOI: 10.1038/ncomms3196 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/11/c0/ncomms3196.PMC3903179.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/a5/ncomms3345.PMC3903184.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Winstel, V. et al.",Non-OADS,/arxiv_data1/oa_pdf/b8/a5/ncomms3345.PMC3903184.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3345 ARTICLE NATURE COMMUNICATIONS | 4:2345 | DOI: 10.1038/ncomms3345 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/b8/a5/ncomms3345.PMC3903184.pdf
Available from http://www.geneious.com/ (2011).,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/ncomms3348.PMC3903269.pdf
"http://life.bio.sunysb.edu/ morph/ (State University of New York at Stony Brook, 2010).",Non-OADS,/arxiv_data1/oa_pdf/0a/bb/ncomms3348.PMC3903269.pdf
"http://life.bio.sunysb.edu/ morph/(State University of New York at Stony Brook, 2010).",Non-OADS,/arxiv_data1/oa_pdf/0a/bb/ncomms3348.PMC3903269.pdf
"http://www.r-project.org/ (R Development Core Team, 2011).",Non-OADS,/arxiv_data1/oa_pdf/0a/bb/ncomms3348.PMC3903269.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/ncomms3348.PMC3903269.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Krause-Kyora, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/bb/ncomms3348.PMC3903269.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3348 ARTICLE NATURE COMMUNICATIONS | 4:2348 | DOI: 10.1038/ncomms3348 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0a/bb/ncomms3348.PMC3903269.pdf
chive ( http://vamps.mbl.edu ) with the accession number “SLS_PHY_Bv6v4.” SUPPLEMENTAL MATERIAL Supplemental material for this article may be found at http://mbio.asm.org /lookup/suppl/doi:10.1128/mBio.00682-13/-/DCSupplemental .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
64:807– 838. http://dx.doi.org/ 10.1146/annurev-arplant-050312-120106 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
10:828 – 840. http://dx.doi.org/10.1038/nrmicro2910 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1038/ nature11336 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1128/AEM.01867-10 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1128/ AEM.69.4.1875-1883.2003 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1073/ pnas.061629598 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1128/AEM.00133-11 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
43:195-229-229. http://dx.doi.org/10.1023/A:1020684815474 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1016/S0168- 6496(97)00036-6 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1007/s00248-009-9495-y .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
78:6187– 6193. http://dx.doi.org/10.1128/ AEM.00888-12 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1038/ismej.2010.9 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1111/j.1462-2920.2010.02258.x .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/ 10.1007/s00248-012-0053-7 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
23:431– 436. http://dx.doi.org/10.1016/ j.copbio.2011.11.017 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1038/ismej.2011.177 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1038/ ismej.2009.122 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1038/ismej.2009.110 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1128/AEM.66.1.369-374.2000 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.2307/3871382 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1093/nar/29.1.181 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/ 10.1038/ismej.2011.209 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/ 10.1371/journal.pgen.1000255 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1093/ bioinformatics/btq461 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1038/nmeth.f.303 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/ 10.1073/pnas.0905240106 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
60:440 – 452. http://dx.doi.org/10.1007/s00248-010-9725-3 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1186/gb-2011-12-6-r60 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1890/0012- 9658(2006)87[1387:NTATEO]2.0.CO;2 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1111/2041-210X.12114 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1086/652373 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1007/s10144-004-0182-z .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
Oecologia 136:489 – 498. http://dx.doi.org/10.1007/s00442-003-1311-7 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1086/669266 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1128/mBio.00584-12 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/ 10.1111/j.0269-8463.2005.00965.x .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1016/j.tree.2006.08.003 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1128/AEM.66.4.1328-1333.2000 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
http://dx.doi.org/10.1371/journal.pgen.1002784 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
18:39. http://dx.doi.org/10.2134/ jeq1989.00472425001800010007x .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
Methods 9:671– 675. http://dx.doi.org/ 10.1038/nmeth.2089 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
Methods59:81– 89. http://dx.doi.org/10.1016/j.mimet.2004.06.005 .,OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
194:4709 – 4717. http://dx.doi.org/ 10.1128/JB.00566-12 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e9/mBio.00682-13.PMC3903271.pdf
"In line with this vari-ability, strains ascribed to the same SG may come from differenthosts and geographical locations ( http://www.shigatox.net/new /reference-strains/ecor.html ), as already pointed out in a previous work performed with a comparable set of E. coli isolates (19).",Non-OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
Genomic sequences were retrieved from public nucleotide databases ( http://www.xbase.ac.uk/main/browse/ ;http: //www.ncbi.nlm.nih.gov/genomes/ ).,OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
"In the case of ECOR strains, partial sequences of genes used for multilocus sequence typing were downloadedfrom the Environmental Research Institute, University of Cork ( http: //MLST.ucc.ie ;dinB ,icdA ,pabB ,polB ,putP,trpA ,trpB, and uidA genes), and from the Institut Pasteur ( http://www.pasteur.fr/recherche/genopole /PF8/mlst/ ;adk,fumC ,gyrB ,icdA ,mdh ,purA , and recA genes) websites.",Non-OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
Phylogenetic analyses of nucleotide sequences (for casand MLST genes) were carried out with the program MEGA version 4 (54) from alignments conducted with CLUSTALW ( http://genome.jp /tools/clustalw/ ) and manually edited to correct mismatches.,OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
"Analyses of recombination at the cas-E1 sequence variants were per- formed with the program GENECONV 1.81 (Department of Mathemat-ics, Washington University, St. Louis, MO; http://www.math.wustl.edu /~sawyer/geneconv ).",OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
IS-Finder ( https://www-is.biotoul.fr/ ) was used for the identiﬁcation of insertion elements.,OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
Consensus leader sequences were obtained withWebLogo ( http://weblogo.berkeley.edu/logo.cgi ).,OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
"CAI values were calcu- lated using the application at http://genomes.urv.es/CAIcal/ (30), with the codon usage frequencies of the entire genome of E. coli K-12-MG1655 (http://www.kazusa.or.jp/codon/ ) as a reference.",OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
http://dx.doi.org/10.1371/journal.pone.0035888 .,Non-OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
http://dx.doi.org/10.1371/ journal.pone.0041706 .CRISPR-Cas Evolution in E. coli January/February 2014 Volume 5 Issue 1 e00767-13®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
http://dx.doi.org/10.1186/gb-2007-8-4-r61 .,Non-OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
BMC Genomics 9:560. http://dx.doi.org/ 10.1186/1471-2164-9-560 .,OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
http://dx.doi.org/10.1007/978-1-4419-7686-4_5 .,Non-OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
Direct 3:38.http://dx.doi.org/ 10.1186/1745-6150-3-38 .,Non-OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
http://dx.doi.org/10.1371/journal.pone.0011126 .,Non-OADS,/arxiv_data1/oa_pdf/22/37/mBio.00767-13.PMC3903273.pdf
http://dx.doi.org/10.1111/j.1469- 0691.2009.03109.x .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
"http://dx.doi.org/10.1111/j.1600-065X.2010.00993.x .3.Zenewicz LA, Shen H. 2007.",Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/10.1016/j.micinf.2007.05.008 .,OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/10.4161/ viru.2.5.17703 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
7:623– 628. http://dx.doi.org/10.1038/nrmicro2171 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/ 10.1073/pnas.0702729104 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/10.1126/science.1200120 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/ 10.1128/IAI.01243-10 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/ 10.4161/viru.3.1.18531 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/ 10.1101/cshperspect.a010272 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/10.1073/ pnas.0901259106 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
10:95.http://dx.doi.org/10.1186/ 1741-7007-10-95 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/10.1002/pmic.201000812 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000146 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
BMCGenomics 11:688. http://dx.doi.org/10.1186/1471-2164-11-688 .,OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
BMC Genomics 14:47.http://dx.doi.org/10.1186/1471-2164-14- 47.,OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
40: 658 – 674. http://dx.doi.org/10.1107/S0021889807021206 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/10.1107/ S0907444996012255 .,Non-OADS,/arxiv_data1/oa_pdf/b8/40/mBio.00775-13.PMC3903274.pdf
http://dx.doi.org/10.1128/CMR.00052-09 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/j.1758-2229.2011.00247.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1038/nrmicro1967 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1146/annurev-cellbio-100109-104034 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/j.1600- 0854.2012.01344.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/cmi.12235 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
8:478 – 480. http://dx.doi.org/ 10.1016/S0966-842X(00)01852-7 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/j.1462- 5822.2005.00493.x .Real-Time PtdIns Dynamics in Legionella Infection January/February 2014 Volume 5 Issue 1 e00839-13®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/j.1462-2920.2007.01238.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1016/ j.mib.2008.05.005 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/ j.1462-5822.2009.01413.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
Sci- ence 295:679 – 682. http://dx.doi.org/10.1126/science.1067025 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1016/j.devcel.2006.05.013 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1016/ j.chom.2011.08.002 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1003598 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000822 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1016/j.chom.2013.06.001 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
Nature 443:651– 657. http://dx.doi.org/10.1038/ nature05185 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1038/nrm2334 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
Nature 438: 597– 604. http://dx.doi.org/10.1038/ nature04397 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
6:487– 492. http://dx.doi.org/10.1038/ncb0604-487 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1016/j.plipres.2009.06.001 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
Cell 11:671– 682. http://dx.doi.org/ 10.1016/j.devcel.2006.09.001 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1038/ nrm2328 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1016/j.bbalip.2006.03.019 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1038/ncb1104-1026 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/ j.1462-5822.2006.00793.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/j.1365-2958.2009.06608.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
9:635– 646. http://dx.doi.org/ 10.1038/nrmicro2602 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1371/ journal.ppat.0020046 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/ 10.1111/j.1462-5822.2008.01219.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
284:4846 – 4856. http://dx.doi.org/10.1074/ jbc.M807505200 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
EMBO Rep. 11:598 – 604. http://dx.doi.org/10.1038/ embor.2010.97 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
101: 841– 846. http://dx.doi.org/10.1073/ pnas.0304916101 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
Trafﬁc 10: 76 – 87. http://dx.doi.org/10.1111/j.1600-0854.2008.00851.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
14:852– 868. http://dx.doi.org/10.1111/j.1462-5822.2012.01761.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1128/ JB.06306-11 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
11:442– 460. http://dx.doi.org/10.1111/j.1462- 5822.2008.01266.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1074/jbc.M113.474239 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1038/12993 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/ 10.1016/j.ymgme.2006.04.005 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1038/ sj.emboj.7601274 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
42:603– 617. http://dx.doi.org/10.1046/j.1365-2958.2001.02645.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
123:4039 – 4051. http://dx.doi.org/ 10.1242/jcs.072124 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/j.1462-5822.2005.00528.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
8:793– 805. http://dx.doi.org/10.1111/j.1462-5822.2005.00666.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1038/nature06336 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
Chapter 3:Unit 3.34. http://dx.doi.org/10.1002/ 0471143030.cb0334s46 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1084/jem.20031706 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1046/j.1365- 2958.2003.03826.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1111/j.1462-5822.2010.01432.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/ 10.1111/j.1365-2958.2005.04490.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1172/JCI35433 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1083/ jcb.135.5.1249 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1074/jbc.274.3.1240 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1371/ journal.pone.0003324 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1128/ IAI.69.8.5157-5161.2001 .,OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1248/bpb.b11- 00011 .,Non-OADS,/arxiv_data1/oa_pdf/bc/d9/mBio.00839-13.PMC3903275.pdf
http://dx.doi.org/10.1016/j.tree.2010.01.007 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1126/science.1146498 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
49:1– 6. http://dx.doi.org/10.3896/IBRA.1.49.1.01 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/ 10.1111/j.1758-2229.2011.00312.x .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1051/apido/2010014 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
91: 61– 63. http://dx.doi.org/10.1016/j.jip.2005.10.002 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1603/ EC10355 .TRSV Infection in A.mellifera January/February 2014 Volume 5 Issue 1 e00898-13®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
Apidologie 42:650 – 658. http://dx.doi.org/10.1007/ s13592-011-0061-5 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1371/journal.pone.0014357 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
54:447– 468. http://dx.doi.org/ 10.1146/annurev.ento.54.110807.090454 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
98:4910 – 4915. http://dx.doi.org/10.1073/ pnas.081288198 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1094/ PHYTO.1999.89.2.124 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1094/Phyto-77-167 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
Apidologie42:457– 460. http://dx.doi.org/10.1007/s13592-011-0009-9 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1073/ pnas.96.24.13910 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1126/ science.1087139 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/ 10.1098/rstb.2001.0997 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1126/science.279.5349.393 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1016/ S0966-842X(02)02428-9 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
31:375– 402. http://dx.doi.org/10.1146/ annurev.phyto.31.1.375 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1094/PHI-I-2006-0414- 01.,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
70:33– 80. http://dx.doi.org/10.1016/S0065-3527(07)70002-7 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
Apidologie16:421– 436. http://dx.doi.org/10.1051/apido:19850407 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/ 10.1126/science.1220941 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1016/ j.virol.2005.07.012 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/ 10.1016/j.jip.2011.09.010 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1371/journal.pone.0006481 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1603/EC09429 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/ 10.1016/j.jip.2006.11.001 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/ 10.1111/j.1462-2920.2008.01687.x .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1016/j.jip.2005.08.005 .59.,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/ 10.1016/j.jip.2004.07.005 .,OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.3390/v3122425 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1099/vir.0.81401-0 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
71:436 – 441. http://dx.doi.org/10.1128/AEM.71.1.436-441.2005 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.1093/molbev/msm092 .,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
http://dx.doi.org/10.2307/ 2408678 .TRSV Infection in A.mellifera January/February 2014 Volume 5 Issue 1 e00898-13®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/fa/48/mBio.00898-13.PMC3903276.pdf
Viruses 5:806 – 823. http://dx.doi.org/ 10.3390/v5030806 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1146/annurev-biochem-072911-172315 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/ 10.1126/science.1138140 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1038/nature09523 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1038/emboj.2012.352 .Programmable Removal of Bacterial Strains January/February 2014 Volume 5 Issue 1 e00928-13®mbio.asm.org 7,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
9:467– 477. http://dx.doi.org/10.1038/ nrmicro2577 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1099/ mic.0.023960-0 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1038/nbt.2508 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
Science 339:823– 826. http://dx.doi.org/10.1126/science.1232033 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
Science 339: 819 – 823. http://dx.doi.org/ 10.1126/science.1231143 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1016/j.tig.2010.05.008 .,OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
10:230. http://dx.doi.org/10.1186/1471- 2148-10-230 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
80:481– 491. http://dx.doi.org/10.1111/j.1365- 2958.2011.07586.x .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
192:6291– 6294. http://dx.doi.org/10.1128/JB.00644-10 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/ 10.1073/pnas.1113519108 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1093/nar/gkt520 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1371/journal.pgen.1003454 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1126/science.1159689 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/ 10.1111/j.1365-2958.2010.07073.x .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/ 10.1371/journal.pgen.1003844 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
10:841– 851. http://dx.doi.org/ 10.4161/rna.24203 .,OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
394: 653– 680. http://dx.doi.org/10.1016/ j.jmb.2009.09.021 .,OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
Nature 413:852– 856. http://dx.doi.org/10.1038/35101614 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
Science 337: 816 – 821. http://dx.doi.org/10.1126/ science.1225829 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1038/emboj.2011.41 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
31:839 – 843. http://dx.doi.org/10.1038/nbt.2673 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
31:827– 832. http://dx.doi.org/10.1038/nbt.2647 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1093/nar/gkt714 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
31:822– 826. http://dx.doi.org/ 10.1038/nbt.2623 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1128/AAC.47.4.1301-1307.2003 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
Science 187: 653– 654. http://dx.doi.org/10.1126/ science.803710 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
27:76 – 83. http://dx.doi.org/10.1016/ j.biotechadv.2008.09.002 .,OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1016/ j.mib.2011.07.028 .,OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1093/nar/gkr606 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1038/nbt.2355 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
Rep. 3:2510. http://dx.doi.org/10.1038/srep02510 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1111/j.1365- 2958.2009.06976.x .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/ 10.1093/nar/gkr183 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1002/jgm.804 .,OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1016/B978-0-12- 385120-8.00015-2 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
67: 4361– 4364. http://dx.doi.org/10.1128/AEM.67.9.4361-4364.2001 .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1111/j.1574-6968.1996.tb08163.x .,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1128/ mBio.00033-13 .Programmable Removal of Bacterial Strains January/February 2014 Volume 5 Issue 1 e00928-13®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/a0/c7/mBio.00928-13.PMC3903277.pdf
http://dx.doi.org/10.1371/ journal.pone.0009560 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
J.6:1– 6. http://dx.doi.org/10.2174/1874357901206010001 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1128/ JVI.01718-08 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
9:427– 439. http://dx.doi.org/10.1038/nrmicro2574 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.3390/v3040336 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
86:8440 – 8451. http://dx.doi.org/10.1128/JVI.00609-12 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1099/vir.0.82231-0 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1128/JVI.00835- 09.,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1083/ jcb.200509155 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1016/j.cell.2005.10.035 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1083/ jcb.200503059 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
9:838 – 846. http://dx.doi.org/ 10.1038/ncb1610 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/ 10.1242/jcs.035873 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/ 10.1128/JVI.01334-09 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1083/jcb.200504029 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1007/s00418-012-0988-2 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1016/S0304- 3835(03)00079-X .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1289/ehp.89803 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/ 10.1128/JVI.79.12.7609-7616.2005 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1016/j.chom.2006.12.001 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/ 10.1128/JVI.01004-12 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1038/emboj.2011.245 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1016/j.neulet.2008.05.031 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1016/ j.tcb.2010.01.001 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1083/jcb.200104037 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/ 10.1083/jcb.148.3.531 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1242/ jcs.004366 .Coﬁlin Activity Regulation Controls HSV-1 Infection January/February 2014 Volume 5 Issue 1 e00958-13®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1016/j.antiviral.2010.11.012 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000141 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
86:6677– 6687. http://dx.doi.org/10.1128/ JVI.06860-11 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
Nature 424: 456 – 461. http://dx.doi.org/10.1038/ nature01818 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1001099 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1038/nm.2341 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1074/ jbc.271.20.11930 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1128/JVI.02848-06 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1111/ j.1471-4159.2010.06951.x .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
"http://dx.doi.org/ 10.1038/35060098 .53.Naranatt PP, Akula SM, Zien CA, Krishnan HH, Chandran B.",Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1128/JVI.77.2.1524-1539.2003 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1128/JVI.01877-10 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1091/ mbc.E07-09-0895 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1128/JVI.00504-07 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1038/35044547 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.2174/ 156720510791050902 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/ 10.1128/JVI.01080-06 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1016/j.chom.2009.06.004 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
81:860 – 880. http://dx.doi.org/ 10.1111/j.1365-2958.2011.07726.x .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/ 10.1016/j.cell.2008.06.036 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1073/ pnas.1002894107 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1128/ JVI.79.16.10308-10329.2005 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1099/vir.0.024166-0 .Zheng et al.,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1128/ JVI.00622-12 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
95:37– 48. http://dx.doi.org/10.1016/ j.antiviral.2012.05.002 .,OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.3851/IMP2661 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/10.1371/journal.ppat.1001238 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1000512 .Coﬁlin Activity Regulation Controls HSV-1 Infection January/February 2014 Volume 5 Issue 1 e00958-13®mbio.asm.org 15,Non-OADS,/arxiv_data1/oa_pdf/70/18/mBio.00958-13.PMC3903278.pdf
Complete PE_PGRS amino acid sequences of MTBC strain H37Rv were retrieved from GenBank ( http://www.ncbi.nlm .nih.gov/Genbank/ ).,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
"In order to represent the diverse human popu- lation, prediction analyses were performed using the most prevalentHLA-A, -B, and -DR alleles in representative populations as deﬁned by theAllele Frequency Database ( http://www.allelefrequencies.net/ ).",OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1038/nrmicro2145 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1126/ science.1225416 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/ 10.1038/nrmicro2097 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1016/j.cell.2005.01.037 .,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1038/ 352595a0 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1038/352565a0 .M.,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
Sci-ence 331:430 – 434. http://dx.doi.org/10.1126/science.1198545 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1038/31159 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1146/annurev.micro.62.081307.162832 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1371/journal.pone.0007815 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/ 10.1371/journal.pbio.0060311 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1038/ng.590 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1038/ng.2744 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
19:460 – 463. http://dx.doi.org/10.3201/ eid1903.120256 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
24:351– 427. http://dx.doi.org/10.1128/ CMR.00042-10 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
77:4631– 4673. http://dx.doi.org/10.1128/ IAI.00592-09 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1146/ annurev.immunol.22.012703.104635 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000392 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1084/jem.193.3.271 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1371/ journal.ppat.1002063 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
27:393– 815. http://dx.doi.org/10.1146/ annurev.immunol.021908.132703 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
3:578 – 668. http://dx.doi.org/10.1016/S1473-3099(03)00741-2 .,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1111/j.1600-065X.2008.00693.x .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/ 10.1038/ni1102-1026 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
6:95. http://dx.doi.org/10.1186/1471-2148-6-95 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
103: 8060 – 8065. http://dx.doi.org/10.1073/ pnas.0602606103 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
43:4954 – 4960. http://dx.doi.org/ 10.1128/JCM.43.10.4954-4960.2005 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1016/j.tube.2008.01.001 .,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
24:189 – 402. http://dx.doi.org/10.1146/ annurev.ge.24.120190.001201 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/ 10.1007/s00251-008-0341-z .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
6:9. http://dx.doi.org/10.1186/1745-7580-6-9 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
24:817– 826. http://dx.doi.org/10.1038/nbt1215 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
BMC Bioinformatics 8:238. http://dx.doi.org/10.1186/1471- 2105-8-238 .,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
BMC Bioinformatics 6:132. http://dx.doi.org/10.1186/1471- 2105-6-132 .,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/ 10.1371/journal.pcbi.1000048 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
6:107. http://dx.doi.org/10.1186/1471-2148-6-107 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1371/journal.pone.0030593 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1099/mic.0.041996-0 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1016/j.tube.2007.03.003 .,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1074/jbc.M604379200 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1016/j.ddmod.2010.10.001 .,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1046/ j.1365-2958.2002.02813.x .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
"http://dx.doi.org/10.1093/ bioinformatics/17.12.1236 .54.Achkar JM, Casadevall A.",OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1016/j.chom.2013.02.009 .,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1128/IAI.69.9.5606-5611.2001 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1038/nri3259 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1007/BF02900361 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
Nucleic Acids Res.25:4876 – 4958. http://dx.doi.org/10.1093/nar/25.24.4876 .,OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1093/nar/gki198 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1093/molbev/msm092 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
J. Immunol.188:4235– 4283. http://dx.doi.org/10.4049/jimmunol.1103640 .,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1128/CVI.00111- 09.,Non-OADS,/arxiv_data1/oa_pdf/26/c8/mBio.00960-13.PMC3903279.pdf
http://dx.doi.org/10.1086/668770 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1128/AAC.00057-10 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
190: 8053– 8064. http://dx.doi.org/10.1128/JB.00834-08 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1128/AAC.00256-11 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/ 10.1371/journal.pgen.0020007 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/ 10.1128/AAC.01464-06 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1371/journal.pone.0054287 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1016/ j.ijantimicag.2012.09.008 .,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1038/nrmicro1789 .,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1002/iub.532 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1111/j.1469- 0691.2005.01320.x .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1128/AAC.49.7.2941-2948.2005 .Genome Dynamics of Multidrug-Resistant A. baumannii January/February 2014 Volume 5 Issue 1 e00963-13®mbio.asm.org 11,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1111/j.1574-6968.2006.00195.x .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1111/ j.1469-0691.2007.01828.x .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
55:4922– 4925. http://dx.doi.org/10.1128/AAC.00704-11 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1093/jac/dks448 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1093/jac/dkr413 .,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1093/jac/ dks459 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1093/ jac/dkq095 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1128/AAC.01674-09 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
75:37– 41. http://dx.doi.org/10.1016/ j.jhin.2010.01.012 .,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1371/ journal.pone.0033443 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1371/journal.pone.0010034 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1128/JCM.02431-09 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
50:4114 – 4123. http://dx.doi.org/10.1128/AAC.00778-06 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1093/jac/dkq191 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1111/j.1469-0691.2008.02010.x .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
45: 453– 460. http://dx.doi.org/10.1128/JCM.01971-06 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1016/ j.ijantimicag.2012.12.010 .,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1128/AAC.05678-11 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1128/AAC.49.7.2949-2953.2005 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
55:4506 – 4512. http://dx.doi.org/10.1128/AAC.01134-10 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
54: 4168 – 4177. http://dx.doi.org/10.1128/AAC.00542-10 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1371/journal.pone.0062160 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1016/ j.resmic.2010.10.010 .,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1371/ journal.pone.0001805 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1371/journal.pone.0062768 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
89:816 – 830. http://dx.doi.org/10.1111/mmi.12300 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1128/ JB.01258-08 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1371/ journal.pone.0059388 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/ 10.1371/journal.pone.0055142 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1099/mic.0.26541-0 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1371/ journal.pone.0046984 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/ 10.1128/AAC.01783-12 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1101/ gr.154328.112 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
49:438 – 443. http://dx.doi.org/10.1086/600391 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1086/652759 .,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/ 10.1038/nmeth.2474 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1093/nar/gkp958 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1093/nar/gkl1043 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
Proteins28:405– 420. http://dx.doi.org/10.1002/(SICI)1097-0134(199707)28:3 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1093/nar/gkr1133 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1101/gr.2289704 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
Bioin-formatics 21:456 – 463. http://dx.doi.org/10.1093/bioinformatics/bti191 .,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1093/nar/gks757 .,Non-OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
http://dx.doi.org/10.1089/106652702761034136 .Genome Dynamics of Multidrug-Resistant A. baumannii January/February 2014 Volume 5 Issue 1 e00963-13®mbio.asm.org 13,OADS,/arxiv_data1/oa_pdf/8f/fb/mBio.00963-13.PMC3903280.pdf
Tiling array data have been de- posited in NCBI’s Gene Expression Omnibus ( http://www.ncbi.nlm.nih .gov/geo ) and are accessible through GEO series accession no.,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
"http://dx.doi.org/10.1073/ pnas.0910586106 .6.Slepak T, Tang M, Addo F, Lai K. 2005.",OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1016/ j.ymgme.2005.08.002 .,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
Acta 48:460 – 469. http://dx.doi.org/ 10.1016/0006-3002(61)90044-0 .,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1016/j.ymgme.2007.09.012 .,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1002/iub.262 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1074/jbc.M009583200 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1002/ jcp.20820 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1007/s10545-006-0382-0 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1099/ 00221287-138-10-2007 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1128/JB.01689-06 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1146/annurev.micro.62.081307.162903 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
37:445– 449. http://dx.doi.org/10.1007/s10863-005-9488-6 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/ 10.1016/0009-9120(92)80043-G .,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
295:605– 612. http://dx.doi.org/10.1006/jmbi.1999.3347 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1046/j.1365-2958.1999.01430.x .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1128/ JB.183.2.545-556.2001 .,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1146/ annurev.mi.30.100176.002535 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1128/ MMBR.00001-08 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
207:435– 440. http://dx.doi.org/10.1007/BF00331612 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
Cell 144:646 – 674. http://dx.doi.org/10.1016/j.cell.2011.02.013 .,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1016/ j.cmet.2007.10.002 .,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
2:2006.0008. http://dx.doi.org/10.1038/msb4100050 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/ 10.1016/0378-1119(95)00193-A .,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1073/ pnas.0601180103 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/10.1093/nar/gkg125 .,Non-OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
http://dx.doi.org/ 10.1016/S0021-9673(01)96624-5 .Lee et al.,OADS,/arxiv_data1/oa_pdf/db/f9/mBio.00972-13.PMC3903281.pdf
"All of the predicted open reading frames (ORFs) wereannotated by comparison with the revised in-house KEGG database ( http: //www.genome.jp/kegg ) (40) and the Clusters of Orthologous Groups (COG) sequence database (41) within the STRING database (version 9.0)( http://string-db.org ), using BLAST searches with an Evalue cutoff of 10/H110025(42).",OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
"To generate heat maps of COG and KEGG genes, the normalizednumbers were standardized to Zscores and then analyzed using Cluster 3 ( http://rana.lbl.gov/EisenSoftware.htm ) (45).",OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1126/ science.229.4715.717 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
75:361– 422. http://dx.doi.org/10.1128/MMBR.00039-10 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1007/s00792-006-0049-7 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1099/ ijs.0.02551-0 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1111/ j.1462-2920.2011.02530.x .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1371/ journal.pone.0013530 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1038/ismej.2009.79 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
5:414 – 426. http://dx.doi.org/10.1038/ismej.2010.144 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1016/j.gca.2009.10.045 .,OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
Nature 395: 490 – 493. http://dx.doi.org/10.1038/26730 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/ 10.1007/s11434-011-4619-4 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1130/G32389.1 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1029/2010GL043542 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1016/j.mib.2005.04.005 .,OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1111/1462-2920.12165 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
2:69.http://dx.doi.org/ 10.3389/fmicb.2011.00069 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
70:6282– 6289. http://dx.doi.org/10.1128/ AEM.70.10.6282-6289.2004 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/10.1111/j.1574-6941.2008.00502.x .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
http://dx.doi.org/ 10.1146/annurev-marine-120709-142712 .,OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
Extremophiles 12: 627– 640. http://dx.doi.org/10.1007/s00792-008-0167-5 .,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/mBio.00980-13.PMC3903282.pdf
